VITAMIN D: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

abba, k., sudarsanam, t. D., Grobler, L., and Volmink, J. nutritional supplements for people being treated for active tuberculosis. cochrane.database.syst.rev. 2008;(4):cd006086. see summary.

Achiron, A., Barak, Y., Miron, S., Izhak, Y., Faibel, M., and Edelstein, S. treatment with alfacalcidol in multiple sclerosis. clin.neuropharmacol. 2003;26(2):53. see summary.

acott, p. D., Wong, J. a., lang, b. a., and crocker, j. F. Pamidronate treatment of pediatric patients with fractures on chronic steroid therapy. pediatric nephrole. 2005;20(3):368-373. see summary.

ada, s., sahin, s., boztepe, g., karaduman, a., and kolemen, f. no additional effect of topical calcipotriol over narrowband uvb phototherapy in patients with generalized vitiligo. photodermatol.photoimmunol.photomed. 2005;21(2):79-83. see summary.

agnew mc, agnew rg tisdall ff. the production and prevention of dental caries. j am dent assoc. 1933; 20:193-212.

al-said, and. a., al-rached, h. s., al-qahtani, h. a., and jan, m. meter. severe proximal myopathy with remarkable recovery after treatment with vitamin d. can.j neurol.sci 2009;36(3):336-339. see summary.

alborzi, p., patel, n. A. Peterson, C. Bills, J. e., bekele, d. m., bunaye, z., light, r. p., and agarwal, r. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a double-blind randomized pilot trial. hypertension 2008;52(2):249-255. see summary.

Albrecht, L., Bourcier, M., Ashkenas, J., Papp, K., Shear, N., Toole, J., Sell, R., and Wasel, N. Topical psoriasis therapy in the era of biologics: evidence-based treatment recommendations. j cutan.med.surg. 2011;15(6):309-321. see summary.

Ali, O., Shim, M., Fowler, E., Greenberg, M., Perkins, D., Oppenheim, W., and Cohen, p. Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study. jclin endocrinol.metab 2007;92(3):932-937. see summary.

aloia, j. F. and li-ng, m. re: epidemic influenza and vitamin d. epidemiol.infect. 2007;135(7):1095-1096. see summary.

aloia, j. F., Vaswani, A., Ellis, K., Yuen, K., and Cohn, S. h. a model for involutional bone loss. j lab clin.med. 1985;106(6):630-637. see summary.

aloia, j. f., vaswani, a., yes, j. K., Ellis, K., Yasumura, S., and Cohn, S. h. Calcitriol in the treatment of postmenopausal osteoporosis. i’m j med. 1988;84(3pt 1):401-408. see summary.

aloia, j. f., vaswani, a., yes, j. K., Ross, p. l., flasher, e., and dilmanian, f. a. calcium supplements with and without hormone replacement therapy to prevent postmenopausal bone loss. ann.intern.med. 1-15-1994;120(2):97-103. see summary.

ambrus, c., marton, a., nemeth, z. k., and mucsi, i. Bone mineral density in patients on maintenance dialysis. int urol.nephrol. 2010;42(3):723-739. see summary.

ameri, p., ronco, d., casu, m., denegri, a., bovio, m., menoni, s., ferone, d., and murialdo, g. High prevalence of vitamin d deficiency and its association with left ventricular dilatation: an echocardiography study in elderly patients with chronic heart failure. nutr metab cardiovasc.dis. 2010;20(9):633-640. see summary.

amin, s., lavalley, m. p., simms, r. w., and felson, d. t. The comparative efficacy of drug therapies used for the treatment of corticosteroid-induced osteoporosis: a meta-regression. j bone miner res 2002;17(8):1512-1526. see summary.

amin, s., lavalley, m. p., simms, r. w., and felson, d. t. the role of vitamin d in corticosteroid-induced osteoporosis: a meta-analytic approach. arthritis rheum 1999;42(8):1740-1751. see summary.

Amital, H., Szekanecz, Z., Szucs, G., Danko, K., Nagy, E., Csepany, T., Kiss, E., Rovensky, J., Tuchynova, A. Kozakova, D. Doria A. Corocher N. Agmon-Levin N. Barak V. Orbach H. Zandman-Goddard G. and Shoenfeld Y. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement SLE patients with vitamin D? ann.rheum.dis. 2010;69(6):1155-1157. see summary.

Andersen, R., Brot, C., Mejborn, H., Molgaard, C., Skovgaard, L. t., trolle, e., and ovesen, l. Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. eur.j clin.nutr 2009;63(9):1150-1153. see summary.

andersen, r., molgaard, c., skovgaard, l. t., brot, c., teller, k. D., J. Jakobsen, C. Lambberg-Allardt, and L. Ovesen. Effect of vitamin d supplementation on bone and vitamin d status among pakistani immigrants in denmark: a randomized, double-blind, placebo-controlled intervention study. br j nutr 2008;100(1):197-207. see summary.

anderson pg, williams chm halderson h et al. The influence of vitamin d in the prevention of dental caries. j am dent assoc. 1934; 21:1349-1366.

anderson, g. l., limacher, m., assaf, a. R. Bassford T. Beresford S. A. Black, H. Bonds, D. Brunner, R. Brzyski, R. Caan, B. Chlebowski, R. Curb, D. Gass, M. Hays, J. Heiss, G. Hendrix S. Howard B. V. Hsia J. Hubbell A. Jackson R. Johnson K. C., Judd, H., Kotchen, J. m., kuller, l., lacroix, a. z., lane, d., langer, r. D. Lasser, N. Lewis, C. E. Manson J. Margolis K. Ockene J. O’Sullivan M. J. Phillips, L. Apprentice, R. L. Ritenbaugh C. Robbins J. Rossouw J. E. Sarto, G. Stefanick, M. L., Van, L. Horn, J. Wactawski-wende, R. Wallace, and S. Wassertheil-Smoller. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. jam 4-14-2004;291(14):1701-1712. see summary.

anderson, j. l., May, h. t., horn, b. d., bair, t. l., corridor, n. L., Carlquist, J. f., lappe, d. L., and Muhlestein, J. b. Relationship of vitamin d deficiency to cardiovascular risk factors, disease status, and incident events in a general health care population. am j cardiol 10-1-2010;106(7):963-968. see summary.

andjelkovic, z., vojinovic, j., pejnovic, n., popovic, m., dujic, a., mitrovic, d., pavlica, l. and Stefanovic, D. Immunomodulatory and disease-modifying effects of high-dose 1alpha(oh)d3 in patients with rheumatoid arthritis. clin exp. rheumatol 1999;17(4):453-456. see summary.

annweiler, c. and beauchet, or. relationship between bone, fracture and exercise: the key role of vitamin d. internal arch med 9-28-2009;169(17):1638. see summary.

Annweiler C., Allali G., Allain P., Bridenbaugh S., Schott A. m., kressig, r. w., and beauchet, o. vitamin d and cognitive performance in adults: a systematic review. eur j neurol. 2009;16(10):1083-1089. see summary.

Annweiler, C., Fantino, B., Le, Gall D., Schott, A. m., berrut, g., and beauchet, o. severe vitamin d deficiency is associated with late-stage dementia in hospitalized geriatric patients. j am geriatr soc 2011;59(1):169-171. see summary.

annweiler, c., schott, a. m., berrut, g., fantino, b., and beauchet, o. Changes in physical performance related to vitamin d: a systematic review. j nutr health aging 2009;13(10):893-898. see summary.

annweiler, c., schott, a. M. Rolland, Y. Blain, H. Herrmann, F. r., and beauchet, o. Dietary vitamin d intake and cognition in older women: a large population-based study. neurology 11-16-2010;75(20):1810-1816. see summary.

antico, a., tampoia, m., tozzoli, r., and bizzaro, n. can vitamin d supplementation reduce the risk or modify the course of autoimmune diseases? a systematic review of the literature. autoimmune.rev. 2012;12(2):127-136. see summary.

arca, e., tastán, h. b., erbil, a. h., sezer, e., koc, e., and kurumlu, z. Narrowband ultraviolet b as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. j dermatol 2006;33(5):338-343. see summary.

burn, n. K., Crozier, S., Smith, H., Anderson, F., Edwards, C., Raphael, H., and Cooper, C. knee pain, knee osteoarthritis and risk of fracture. rheumatic arthritis. 2006-08-15;55(4):610-615. see summary.

Ardissino, G., Schmitt, C. p., testa, s., claris-appiani, a., and mehls, o. Calcitriol pulse therapy is no more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. european study group on vitamin d in children with renal insufficiency. pediatricr.nephrol 2000;14(7):664-668. see summary.

arnaud, s. b., rigorous, g. b., and haworth, j. c. Serum 25-hydroxyvitamin D in childhood rickets. pediatrics 1976;57(2):221-225. see summary.

Arnson, Y., Amital, H., Agmon-Levin, N., Alon, D., Sanchez-Castanon, M., Lopez-Hoyos, M., Matucci-Cerinic, M., Szucs, G. , Shapira, Y., Szekanecz, Z., and Shoenfeld, Y. Serum vitamin d concentrations of 25-oh are related to various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. autoimmune.rev. 2011;10(8):490-494. see summary.

arpadi, s. m., mcmahon, d., abrams, e. J. Bamji M. Purswani M. Engelson E. S., Horlick, M., and Shane, E. Effect of bimonthly oral cholecalciferol supplementation on serum 25-hydroxyvitamin d concentrations in hiv-infected children and adolescents. pediatrics 2009;123(1):e121-e126. see summary.

Arthur, R. S., Piraino, B., Candib, D., Cooperstein, L., Chen, T., West, C., and Puschett, J. Effect of low-dose calcitriol and calcium therapy on bone histomorphometry and urinary calcium excretion in osteopenic women. electrolyte miner metab 1990;16(6):385-390. see summary.

Ashcroft, D. m., li wan, po a., williams, h. c., and griffiths, c. me. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. dermatol arch 2000; 136(12): 1536-1543. see summary.

Attia, S., Eickhoff, J., Wilding, G., Mcneel, D., Blank, J., Ahuja, H., Jumonville, A., Eastman, M., Shevrin, D., Glode, m., alberti, d., staab, m. J., Horvath, D., Straus, J., Marnocha, R., and Liu, G. Randomized, double-blind phase II evaluation of docetaxel with or without doxercalciferol in patients with androgen-independent metastatic prostate cancer. clin.cancer res 4-15-2008;14(8):2437-2443. see summary.

autier, p., gandini, s., and mullie, p. a systematic review: influence of vitamin d supplementation on the serum concentration of 25-hydroxyvitamin d. jclin.endocrinol.metab 2012;97(8):2606-2613. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in older people. Cochrane Database System Rev 2005;(2):cd001880. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in older people. Cochrane Database System Rev 2006;(4):cd001880. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in older people. Cochrane Database System Rev 2010;(1):cd001880. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in the elderly. Cochrane Database System Rev 2000;(2):cd001880. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in the elderly. Cochrane Database System Rev 2000;(4):cd001880. see summary.

avenell, a. and manual, h. h. Nutritional supplements for hip fracture aftercare in the elderly. Cochrane Database System Rev 2004;(1):cd001880. see summary.

avenell, a., cook, j. a., maclennan, g. s., and macpherson, g. c. Vitamin d supplementation to prevent infection: a substudy of a randomized placebo-controlled trial in older people (registry trial, isrctn 51647438). age aging 2007;36(5):574-577. see summary.

avenell, a., cook, j. a., maclennan, g. s., and mcpherson, g. c. Vitamin d supplementation and type 2 diabetes: a substudy of a randomized placebo-controlled trial in older people (registry trial, isrctn 51647438). age aging 2009;38(5):606-609. see summary.

avenell, a., gillespie, w. J., Gillespie, L. d., and o’connell, d. I vitamin d and vitamin d analogs for the prevention of fractures associated with involutional and postmenopausal osteoporosis. Cochrane Database System Rev 2005;(3):cd000227. see summary.

avenell, a., gillespie, w. J., Gillespie, L. d., and o’connell, d. vitamin d and vitamin d analogs for the prevention of fractures associated with involutional and postmenopausal osteoporosis. cochrane.database.syst.rev. 2009;(2):cd000227. see summary.

avenell, a., grant, a. M., McGee, M., McPherson, G., Campbell, M. k., and mcgee, m. a. the effects of an open-label design on recruitment, compliance, and retention of trial participants: comparison of a randomized controlled trial with a blinded placebo-controlled design. clinical trials 2004;1(6):490-498. see summary.

bacchetta, j., harambat, j., and cochat, p. [Long-term steroid therapy in children: is adjunctive therapy relevant in nephrotic syndrome?]. arch pediatrician 2008;15(11):1685-1692. see summary.

bacigalupi, r. m., postolova, a., and davis, r. yes Evidence-based non-surgical treatments for vitiligo: a review. i am j clin.dermatol. 1-8-2012;13(4):217-237. see summary.

bailey, e. e., reference, e. H. Alikhan, A. Hession, M. T., and Armstrong, A. w. Combination therapies for psoriasis: a systematic review and meta-analysis. arch.dermatol. 2012;148(4):511-522. see summary.

bak, m., serdaroglu, e., and guclu, r. Prophylactic calcium and vitamin d treatments in steroid-treated children with nephrotic syndrome. pediatr.nephrol. 2006;21(3):350-354. see summary.

baker, l. R. Abrams, L. Roe, c. j., faugere, m. c., fanti, p., subayti, y., and malluche, h. h. Administration of 1.25(oh)2d3 in moderate renal failure: a prospective double-blind trial. kidney int 1989;35(2):661-669. see summary.

baker, l. R., Muir, J. w., sharman, v. l., abrams, yes. m., green wood, r. n., cat, w. R., Goodwin, F. j., swamp, f. p., adami, s., obnoxiously, w. Y . controlled trial of calcitriol in hemodialysis patients. clin nephrol. 1986;26(4):185-191. see summary.

baker, m. R., McDonnell, H., Peacock, M., and Nordin, B. me. Plasma concentrations of 25-hydroxyvitamin d in patients with femoral neck fractures. br med j 3-3-1979;1(6163):589. see summary.

baker, p. n., wheel, s. j., sanders, t. A., Thomas, J. e., Hutchinson, c. J. Clarke, K. Berry, J. L., Jones, R. l., seed, p. t., and poston, l. a prospective study of micronutrient status in adolescent pregnancy. am j clin.nutr 2009;89(4):1114-1124. see summary.

Bakhtiyarova, S., Lesnyak, O., Kyznesova, N., Blankenstein, M. a., and lips, p. Vitamin d status among elderly hip fracture patients and control subjects in Yekaterinburg, Russia. osteoporosis int 2006;17(3):441-446. see summary.

balion, c., griffith, l. E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Llewellyn, D. j., and raina, p. vitamin d, cognition, and dementia: a systematic review and meta-analysis. neurology 9-25-2012;79(13):1397-1405. see summary.

bardare m, grassi a, dell’era l, corona f and bianchi m. Alendronate in the treatment of osteoporosis in rheumatic diseases of childhood. ann rheumdis 2000;59:742.

barker, j. n., ashton, r. E. Marks R. Harris R. i., and bunk-jones, j. Topical maxacalcitol for the treatment of psoriasis vulgaris: a dose-finding, double-blind, placebo-controlled study with active comparator. br j dermatol 1999;141(2):274-278. see summary.

barnard, k. and colon-emeric, c. Extraskeletal effects of vitamin d in older adults: cardiovascular disease, mortality, mood, and cognition. am j geriatric pharmacother. 2010;8(1):4-33. see summary.

barnett, c. meter. and beer, t. meter. prostate cancer and vitamin d: what does the evidence really suggest? urol.clin.north am 2011;38(3):333-342. see summary.

bartley, j. prevalence of vitamin d deficiency among patients attending a multidisciplinary tertiary pain clinic. n.z.med.j 2008-11-28;121(1286):57-62. see summary.

bartoszewska, m., kamboj, m., and patel, d. r. vitamin d, muscle function and exercise performance. pediatric clin north am 2010;57(3):849-861. see summary.

bartram, s. a., pedestrian, r. t., rawlings, d. J., Francis, R. m., and Thompson, b. p. a randomized controlled trial of calcium with vitamin d, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with crohn’s disease. aliment.pharmacol ther. 2003;18(11-12):1121-1127. see summary.

Batchelor, F., Hill, K., Mackintosh, S., and Said, C. what works in preventing falls after stroke?: a systematic review and meta-analysis. stroke 2010;41(8):1715-1722. see summary.

bathroom-hextall, f. J., Jenkinson, C., Humphreys, R., and Williams, H. c. dietary supplements for established atopic eczema. cochrane.database.syst.rev. 2012;2:cd005205. see summary.

Bayer M, Stepan J and Kutilek S. alendronate in the treatment of osteoporosis in childhood. osteological bull 2002;7:23-24.

baysal, v., yildirim, m., erel, a., and kesici, d. Is the combination of calcipotriol and puva effective in vitiligo? j eur.acad.dermatol.venereol. 2003;17(3):299-302. see summary.

beer, t. m., ryan, c. w., venner, p. m., petrylak, d. p., chatta, g. S., Ruether, J. d., redfern, c. H., Fehrenbacher, L., Saleh, M. n., water house, d. m., carducci, m. A. Vicar D. Dreicer R. Higano C. s., Ahmann, f. r., chi, k. n., henner, w. d., creek, a., and clow, f. w. Double-blind randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from Ascension investigators. jclin.oncol. 2007-2-20;25(6):669-674. see summary.

bellantone, r., lombardi, c. p., raffaelli, m., boscherini, m., alesina, p. f., de, crea c., traini, e., and princi, p. Is routine supplementation therapy (calcium and vitamin d) useful after total thyroidectomy? surgery 2002;132(6):1109-1112. see summary.

benhamou, c. L. Tourliere, D. Gauvain, J. b., picaper, g., audran, m., and jallet, p. Calciotropic hormones in elderly with and without hip fracture. osteoporosis int 1995;5(2):103-107. see summary.

benson, j., wilson, a., stock, n., and trim, n. muscle pain as an indicator of vitamin d deficiency in an urban australian aboriginal population. med.j aust. 7-17-2006;185(2):76-77. see summary.

berggren, m., stenvall, m., olofsson, b., and gustafson, y. evaluation of a fall prevention program in older people after femoral neck fracture: one-year follow-up. osteoporos.int 2008;19(6):801-809. see summary.

bergman, g. J. Fan, T. McFetridge, J. t., and sen, s. yes Efficacy of vitamin d3 supplementation in preventing fractures in older women: a meta-analysis. curr med.res opinion. 2010;26(5):1193-1201. see summary.

bergman, p., norlin, a. c., hansen, s., rekha, r. S., Agerberth, B., Bjorkhem-Bergman, L., Ekstrom, L., Lindh, J. d., and anderson, j. Vitamin d3 supplementation in patients with frequent respiratory tract infections: a double-blind, randomized intervention study. bmj open. 2012;2(6) see abstract.

berk, m., jacka, f. n., williams, l. J., Ng, F., Dodd, S., and Pasco, J. a. is this vitamin d to worry about? vitamin d insufficiency in a sample of hospitalized patients. aust n.z j psychiatry 2008;42(10):874-878. see summary.

berl, t., berns, a. s., huffer, w. e., alfrey, a. c., arnaud, c. d., and schrier, r. r. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis. contrib.nephrol. 1980; 18:72-81. see summary.

berruti, a., tucci, m., terrone, c., gorzegno, g., scarpa, r. m., angeli, a., and dogliotti, l. history and management of bone loss related to prostate cancer treatment. drugs aging 2002;19(12):899-910. see summary.

berth-jones, j., chu, a. c., dodd, w. a., gangpule, m., griffiths, w. a., haydey, r. p., klaber, m. R., Murray, S. J., Rogers, S., and Jurgensen, H. J. a multicentre parallel group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. br j dermatol 1992;127(3):266-271. see summary.

bhoopalam, n., campbell, s. C., Moritz, T., Broderick, W. r., iyer, p., arcenas, a. g., van veldhuizen, p. J., Friedman, N., Reda, D., Warren, S., and Garewal, H. Intravenous zoledronic acid to prevent osteoporosis in a population of veterans with multiple risk factors for bone loss on androgen deprivation therapy. jurol. 2009;182(5):2257-2264. see summary.

bianchi, m. L. Cimaz, R. Bardare, M. Zuliana, F. Lepore, L. Boncompagni, A. Galbiati, E. Corona, F. Luisetto, G. Giuntini, D. Picco, p., brandi, m. l., and falcini, f. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. rheumatic arthritis. 2000;43(9):1960-1966. see summary.

Bianda, T., Linka, A., Junga, G., Brunner, H., Steinert, H., Kiowski, W. and schmid, c. prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. calcif.tissue int 2000;67(2):116-121. see summary.

Bierschenk, L., Alexander, J., Wasserfall, C., Haller, M., Schatz, D., and Atkinson, M. Vitamin d levels in subjects with and without type 1 diabetes residing in a solar-rich environment. diabetes care 2009;32(11):1977-1979. see summary.

bijlsma, j. w. Vitamin D plus calcium supplementation is effective in managing corticosteroid-induced osteoporosis. clin exp.rheumatol. 2000;18(1):3-4. see summary.

bijlsma, j. w., lightning makers, j. A. Mosch, C. Hoekstra, A. Derksen, R. h., baart, de la faille, and duursma, s. a. Effect of oral calcium and vitamin d on glucocorticoid-induced osteopenia. clin exp.rheumatol. 1988;6(2):113-119. see summary.

ef folder. implement a structured exercise program for frail nursing home residents with dementia. problems and challenges. j aging physical activity 1995;3:383-395.

Binkley, N., Novotny, R., Krueger, D., Kawahara, T., Daida, and. G. Lensmeyer G. Hollis B. w., and drezner, m. k. low vitamin d status despite abundant sun exposure. j clin.endocrinol.metab 2007;92(6):2130-2135. see summary.

birkenhager-frenkel, d. h., pols, h. A. Zeelenberg, J. Eijgelsheim, J. j., schot, r., nigg, a. L. Weimar, W. Mulder, p. g., and birkenhager, j. c. Effects of 24r,25-dihydroxyvitamin d3 in combination with 1 alpha-hydroxyvitamin d3 in renal failure prior to dialysis: biochemistry and histomorphometry of cancellous bone. j bone miner.res 1995;10(2):197-204. see summary.

bischoff ha, staehelin hb and dick w. fall prevention with vitamin d a randomized controlled trial. j bone miner res 2001;16:163.

bischoff-ferrari, h. a. the role of falls in predicting fractures. curr.osteoporos.rep 2011;9(3):116-121. see summary.

bischoff-ferrari, h. A. Conzelmann, M. Stahelin, H. b., dick, w., carpenter, m. eg, adkin, a. L., R. Theiler, M. Pfeifer, and J. Allum. h. Is fall prevention by vitamin d mediated by a change in postural or dynamic balance? osteoporosis int 2006;17(5):656-663. see summary.

bischoff-ferrari, h. A. Dawson-Hughes, B. Baron, J. A. Burckhardt, P. Li, R. Spiegelman, D. Specker, B. Orav, J. e., wong, j. b., staehelin, h. b., o’reilly, e., kiel, d. p., and willett, w. c. Calcium intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. am j clin nutr 2007;86(6):1780-1790. see summary.

bischoff-ferrari, h. A. Dawson-Hughes, B. Baron, J. a., kanis, j. a., orav, e. J., Staehelin, H. b., kiel, d. P., Burckhardt, P., Henschkowski, J., Spiegelman, D., Li, R., Wong, J. b., feskanich, d., and willett, w. c. Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. j bone miner res 2011;26(4):833-839. see summary.

bischoff-ferrari, h. A. Dawson-Hughes B. Platz A. Orav E. J., Stahelin, H. b., willett, w. c., can, u., egli, a., Mueller, n. J. Looser S. Bretscher B. Minder E. Vergopoulos A. and Theiler R. Effect of high-dose cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. arch.intern.med. 5-10-2010;170(9):813-820. see summary.

bischoff-ferrari, h. A. Dawson Hughes, B. Staehelin, H. b., orav, j. e., stuck, a. E., Theiler, R., Wong, J. b., egli, a., kiel, d. p., and henschkowski, j. Fall prevention with supplemental and active forms of vitamin d: a meta-analysis of randomized controlled trials. bmj 2009;339:b3692. see summary.

bischoff-ferrari, h. A. Giovanni, E. Willett, W. C., Dietrich, T., and Dawson-Hughes, B. estimation of optimal serum concentrations of 25-hydroxyvitamin d for multiple health outcomes. am j clin nutr 2006;84(1):18-28. see summary.

bischoff-ferrari, h. A. Willett, W. c., orav, e. j., lips, p., meunier, p. j., lions, r. A. Blink, L. Wark, J. Jackson, R. D., Cauley, J. a., meyer, h. e., pfeifer, m., sanders, k. m., stahelin, h. b., theiler, r., and dawson-hughes, b. A pooled analysis of vitamin d dose requirements for fracture prevention. n.engl.j med. 7-5-2012;367(1):40-49. see summary.

bischoff-ferrari, h. A. Willett, W. c., wong, j. b., stuck, a. eg, staehelin, h. b., orav, e. J., Thomas, A. Kiel, D. p., and henschkowski, j. Prevention of nonvertebral fractures with oral vitamin d and dose dependence: a meta-analysis of randomized controlled trials. arch intern.med. 3-23-2009;169(6):551-561. see summary.

bischoff-ferrari, h. a. zhang and. kiel d. p., and felson, d. t. Positive association between serum 25-hydroxyvitamin d level and bone density in osteoarthritis. rheumatic arthritis. 2005-12-15;53(6):821-826. see summary.

bjelakovic, g., gluud, l. L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R. g., bjelakovic, m., and gluud, c. Vitamin d supplementation for prevention of mortality in adults. cochrane.database.syst.rev. 2011;(7):cd007470. see summary.

Bjorkman, M., Sorva, A., and Tilvis, R. Parathyroid hormone responses to vitamin d supplementation: a systematic review of clinical trials. arch gerontol.geriatr 2009;48(2):160-166. see summary.

Bjorkman, M., Sorva, A., and Tilvis, R. Vitamin D supplementation does not have a significant effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. clin aging exp.res 2008;20(4):316-321. see summary.

black, d. m., delmas, p. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. a., cosman, f., lakatos, p., leung, p. C. Man Z. Mautalen C. Mesenbrink P. Hu H. Caminis J. Tong K. Rosario-Jansen T. Krasnow J. Hue T. F., Sellmeyer, D., Eriksen, E. f., and cummings, s. r. Zoledronic acid once a year for the treatment of postmenopausal osteoporosis. n.engl.j.med. 3-5-2007;356(18):1809-1822. see summary.

blank, r. d. and bockman, r. yes a review of clinical trials of osteoporosis therapies using fracture as an endpoint. j clin densitom. 1999;2(4):435-452. see summary.

block, g. a. Therapeutic interventions for chronic kidney disease: mineral and bone disorders: focus on mortality. curr.opin.nephrol.hypertens. 2011;20(4):376-381. see summary.

Blumberg, A. Wildbolz, A. Descoeudres, C. Hennes, U. Dambacher, M. A., Fischer, J. a., and weidmann, p. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in maintenance hemodialysis patients. clin nephrol. 1980;13(5):208-214. see summary.

body, j. J., Bergmann, P., Boonen, S., Devogelaer, J. P. Gielen E. Goemaere S. Kaufman J. m., rozenberg, s., and reginster, j. Y. Extraskeletal benefits and risks of calcium, vitamin d, and anti-osteoporosis drugs. osteoporos.int 2012;23 supplement 1:s1-23. see summary.

Boldo, A., Campbell, P., Luthra, P., and White, W. b. Should the concentration of vitamin D be measured in all patients with hypertension? j clin hipertens.(greenwich.) 2010;12(3):149-152. see summary.

bolland, m. J., Grey, A., and Reid, I. r. vitamin d and cataracts Is it time for a moratorium on vitamin d meta-analyses? bmj 2009;339:b4394. see summary.

bolland, m. J. Grey, A. Avenell, A. Bet, G. d., and reid, i. r. Calcium supplementation with or without vitamin d and risk of cardiovascular events: reanalysis of the limited access women’s health initiative dataset and meta-analysis. bmj 2011;342:d2040. see summary.

Bollerslev, J., Marcocci, C., Sosa, M., Nordenstrom, J., Bouillon, R., and Mosekilde, L. Current evidence for the recommendation of surgery, medical treatment and vitamin D replacement in mild primary hyperparathyroidism. eur.j endocrinol. 2011;165(6):851-864. see summary.

bolton-smith, c., mcmurdo, m. eg, paterson, c. r., topo, p. a., harvey, j. m., fenton, s. t., prynne, c. j., mishra, g. d., and shearer, m. J. Two-year randomized controlled trial of vitamin k1 (phylloquinone) and vitamin d3 plus calcium on bone health in older women. j.bone miner.res. 2007;22(4):509-519. see summary.

bonakdaran, s., ayatollahi, h., mojahedi, m. j., sharifipore, f., and shakeri, m. Impact of oral calcitriol treatment on glucose intolerance and dyslipidemia(s) in hemodialysis patients. saudi.j kidney dis.transpl. 2008;19(6):942-947. see summary.

bonnetblanc, j. meter. [soriasis]. ann.dermatol.venereol. 2006;133(3):298-299. see summary.

bonnick, s., saag, k. g., kiel, d. P., McClung, M., Hochberg, M., Burnett, S. M. Sebba, A. Kagan, R. Chen, E. Thompson, D. e., and de papp, a. me. comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate for two years. jclin endocrinol.metab 2006;91(7):2631-2637. see summary.

Boonen, S., Broos, P., Verbeke, G., Aerssens, J., Van, E. Herck, Jans, I., Dequeker, J., and Bouillon, R. Calciotropic hormones and bone remodeling markers in age-related femoral neck osteoporosis (type II): Alterations consistent with secondary hyperparathyroidism-induced bone resorption. j gerontol.a biol.sci med sci 1997;52(5):m286-m293. see summary.

boonen, s., laan, r. f., barton, i. p., and Watts, n. b. Effect of osteoporosis treatments on the risk of nonvertebral fractures: review and meta-analysis of intention-to-treat studies. osteoporos.int. 2005;16(10):1291-1298. see summary.

borissova, a. m., tankova, t., kirilov, g., dakovska, l., and kovacheva, r. the effect of vitamin d3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. practice int j clin. 2003;57(4):258-261. see summary.

boucher, b. J. Mannan, N. Noon, K. Hales, C. n., and evans, s. J. Glucose intolerance and impaired insulin secretion in relation to vitamin d deficiency in East London Asians. diabetology 1995;38(10):1239-1245. see summary.

bourke, j. f., berth-jones, j., and hutchinson, p. me. occlusion increases the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris. clin exp.dermatol 1993;18(6):504-506. see summary.

Boutsen, Y., Jamart, J., Esselinckx, W., Stoffel, M., and Devogelaer, J. p. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. calcif tissue int 1997;61(4):266-271. see summary.

boyle, m. p., noschese, m. l., watts, s. L., Davis, M. e., stenner, s. e., and lechtzin, n. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. am j respir.crit care med 7-15-2005;172(2):212-217. see summary.

brandão, c. m., lime, m. eg, silva, a. l., silva, g. d., war, a. a., jr., and acurcio, fde a. treatment of postmenopausal osteoporosis in women: a systematic review. cad.saude publishes 2008;24 supplement 4:s592-s606. see summary.

brazier m, kamel s, lorget f, maamer m, tavera c, heurtebize n, degrees f, mathieu m, garabedian m, sebert jl and fardellone p. Biological effects of vitamin d and calcium supplementation in postmenopausal women with low bone mass receiving alendronate. clinical drug research 2002;22:849-857.

brazier, m., degrees, f., kamel, s., mathieu, m., morel, a., maamer, m., sebert, j. l., and fardellone, p. Clinical and laboratory safety of one-year use of a combined calcium + vitamin d tablet in elderly ambulatory women with vitamin d insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. clinther 2005;27(12):1885-1893. see summary.

brekke, h. k. and Ludvigsson, J. Vitamin d supplementation and diabetes-related autoimmunity in the abis study. pediatr.diabetes 2007;8(1):11-14. see summary.

brodsky rh, schick b vollmer h. prevention of dental caries by massive doses of vitamin d. i am j dis child. 1941;62:1183-1187.

brodsky rh. factors in the etiology and arrest of dental caries. j amdent asoc. 1933; 20:1440-1458.

brohult, j. and Johnson, B. Effects of large doses of calciferol in patients with rheumatoid arthritis. a double-blind clinical trial. scand j rheumatol 1973;2(4):173-176. see summary.

brondum-jacobsen, p., benn, m., jensen, g. b., and Nordestgaard, b. gram. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and premature death: population-based study and meta-analysis of 18 and 17 studies. arterioscler.thromb.vasc.biol. 2012;32(11):2794-2802. see summary.

brondum-jacobsen, p., nordestgaard, b. g., schnohr, p., and benn, m. 25-hydroxyvitamin d and symptomatic ischemic stroke: an original study and meta-analysis. ann.neurol. 2013;73(1):38-47. see summary.

brooke, o. eg, brown, i. r., bone, c. d., carter, n. d., cleft, h. J., Maxwell, J. d., robinson, v.p., and winder, s. meter. Vitamin D supplementation in pregnant Asian women: effects on calcium status and fetal growth. br med j 3-15-1980;280(6216):751-754. see summary.

Brophy, S., Davies, H., Mannan, S., Brunt, H., and Williams, R. Interventions for latent autoimmune diabetes (lada) in adults. cochrane.database.syst.rev. 2011;(9):cd006165. see summary.

brown sa, aris rm, leigh mw, retsch-bogart gz, caminiti mj, jennings-grant t, lester ge, and ontjes da. Baseline bmd status in children and young adults with cf: calcitriol intervention study. pediatric pulmonology 2005;40(suppl):354.

brumsen, c., hamdy, b. a., and papapoulos, s. me. Long-term effects of bisphosphonates on the growing skeleton. studies of young patients with severe osteoporosis. medicine (baltimore) 1997;76(4):266-283. see summary.

brunner, r. L. Cochrane B. Jackson R. D. Larson, J. Lewis, C. Limacher, M., Rosal, M., Shumaker, S., and Wallace, R. calcium supplements, vitamin d and physical function in women’s health initiative. j am diet asoc. 2008;108(9):1472-1479. see summary.

brunner, r. L. Wactawski-wende, J. Caan, B. j., cochrane, b. b., chlebowski, r. t., gas, m. L., Jacobs, E. t., lacroix, a. Z. Lane, D. Larson, J. Margolis, K. l., thousand, a. e., sarto, g. e., vitolines, m. z., and wallace, r. b. The effect of calcium plus vitamin d on invasive cancer risk: results from the women’s health initiative (whi) calcium plus vitamin d randomized clinical trial. nutrcancer 2011;63(6):827-841. see summary.

buccianti g, valenti g and miradoli r. treatment of uremic osteodystrophy. a clinical trial with calcitonin, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. dialysis and transplant 1981;10(6):523-528.

Buckley, D. b. a double-blind comparison of 0.1% dithranol in a 17% urea base (“psoradrate”) and base alone in the treatment of chronic active psoriasis. curr med res opinion. 1978;5(6):489-494. see summary.

buechner, s. a. common penile skin disorders. bju.int 2002;90(5):498-506. see summary.

bull, c. [geriatrics]. rev med suisse 2006-4-1;2(47):19, 21-19, 24. see abstract.

bunout, d., barrier, g., leiva, l., gattas, v., de la maza, m. p., avendano, m., and hirsch, s. Effects of vitamin d supplementation and physical training on physical performance in elderly chileans with vitamin d deficiency. exp.gerontol 2006;41(8):746-752. see summary.

Burgaz, A., Orsini, N., Larsson, S. c., and wolk, a. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. j hypertensive. 2011;29(4):636-645. see summary.

burleigh, e., mccoll, j., and potter, j. does vitamin d prevent hospital patients from falling? a randomized controlled trial. age aging 2007;36(5):507-513. see summary.

burton, j. m., kimball, s., vieth, r., bar-or, a., dosch, h. M. Cheung R. Gagne D. D’Souza C. Ursell M. and o’connor, p. a phase i/ii dose escalation trial of vitamin d3 and calcium in multiple sclerosis. neurology 8-6-2010;74(23):1852-1859. see summary.

Buttigliero, C., Monagheddu, C., Petroni, P., Saini, A., Dogliotti, L., Ciccone, G., and Berruti, A. Prognostic role of vitamin d status and efficacy of vitamin d supplementation in cancer patients: a systematic review. oncologist. 2011;16(9):1215-1227. see summary.

caca-biljanovska, n. g., vlckova-laskoska, m. t., dervendi, d. v., pesic, n. p., and laskoski, d. yes treatment of generalized morphea with oral 1,25-dihydroxyvitamin d3. adv.exp.med biol. 1999;455:299-304. see summary.

camargo, c. A., Jr., Ganmaa, D., Frazier, A. L., Kirchberg, F. f., stuart, j. J., Kleinman, K., Summerzul, N., and Rich-Edwards, J. w. randomized trial of vitamin d supplementation and risk of acute respiratory infection in mongolia. pediatrics 2012;130(3):e561-e567. see summary.

camargo, c. a., jr., raffles-shiman, s. l., litonjua, a. A., Rich-Edwards, J. w., weiss, s. t., gold, d. R., Kleinman, K., and Gillman, M. w. Maternal vitamin d intake during pregnancy and risk of recurrent wheezing in children at 3 years of age. am.j clin. nutr 2007;85(3):788-795. see summary.

cameron, i. d., gillespie, l. d., robertson, m. c., murray, g. r., hill, k. d., cumming, r. g., and kerse, n. Interventions for the prevention of falls in older people in care centers and hospitals. cochrane.database.syst.rev. 2012;12:cd005465. see summary.

cameron, i. D., Murray, G. R., Gillespie, L. d., robertson, m. c., hill, k. d., cumming, r. g., and kerse, n. Interventions for the prevention of falls in older people in nursing care facilities and hospitals. Cochrane Database System Rev 2010;(1):cd005465. see summary.

camilleri mj, calobrisi sd. skin rashes in the diaper area. current issues dermatol 1999;11:214-243.

Caniggia, A., Delling, G., Nuti, R., Lore, F., and Vattimo, A. Clinical, biochemical, and histological results of a double-blind trial with 1,25-dihydroxyvitamin d3, estradiol, and placebo in postmenopausal osteoporosis. acta vitaminol.enzymol. 1984;6(2):117-128. see summary.

cannell, j. J. and Hollis, B. w. use of vitamin d in clinical practice. alternative medicine rev 2008;13(1):6-20. see summary.

cao, s., luo, p. f., li, w., spike, w. q., cong, x. n., and wei, p. meter. Genetic polymorphisms of the vitamin d receptor and tuberculosis among the Han Chinese ethnic group. chin med.j (eng) 2012;125(5):920-925. see summary.

carbon, l. d., rosenberg, e. w., tolley, e. a., holick, m. f., hughes, t. a., watsky, m. a., wheelbarrow, k. d., chen, t. c., wilkin, b. k., bhattacharya, s. k., disheveled, j. c., sayre, r. m., and weber, k. t. 25-hydroxyvitamin d, cholesterol and ultraviolet irradiation. metabolism 2008;57(6):741-748. see summary.

carlin, a. m., rao, d. S., Yager, K. m., parij, n. j., and kapke, a. Treatment of vitamin d depletion after en and de roux gastric bypass: a prospective randomized clinical trial. sug.obes.relat dis. 2009;5(4):444-449. see summary.

carlson, l. a., derblom, h., and lanner, a. Effect of different doses of vitamin d on serum cholesterol and triglyceride levels in healthy men. atherosclerosis 1970;12(2):313-317. see summary.

Carlton, S., Clopton, D., and Cappuzzo, K. a. Vitamin d deficiency: appropriate replacement therapies and the effects of vitamin d toxicity. consult pharmacy 2010;25(3):171-177. see summary.

Carroll, C., Cooper, K., Papaioannou, D., Hind, D., Peregrine, H., and Tappenden, P. Supplemental calcium in colorectal cancer chemoprevention: a systematic review and meta-analysis. clinther 2010;32(5):789-803. see summary.

cecilia, d., jodar, e., fernandez, c., resines, c., and hawkins, f. Effect of alendronate in elderly patients after repair of a minor trauma hip fracture. osteoporos.int 2009;20(6):903-910. see summary.

cesur, y., caksen, h., gundem, a., kirimi, e., and odabas, d. Comparison of low and high dose vitamin d treatment in nutritional vitamin d deficiency rickets. j pediatr.endocrinol metab 2003;16(8):1105-1109. see summary.

Cesur Y. Dogan M. Ariyuca S. Basaranoglu M. Bektas M. s., peker, e., akbayram, s., and caksen, h. Evaluation of children with nutritional rickets. jpediatr.endocrinol.metab 2011;24(1-2):35-43. see summary.

Chaidemenos, G., Stratigos, A., Papakonstantinou, M., and Tsatsou, F. prevention of malignant melanoma. hypocracy. 2008;12(1):17-21. see summary.

chan, j. c., Mcenery, p. t., chinchilli, v. m., abitbol, ​​c. l., boineau, f. eg, friedman, a. l., lum, g. m., roy, s., iii, ruley, e. j., and fight, c. F. a prospective, double-blind study of growth retardation in children with chronic renal failure and the efficacy of treatment with calcitriol versus dihydrotachysterol. failure to thrive in children with kidney disease investigators. j pediatrician 1994;124(4):520-528. see summary.

chandra, r. k. Effect of vitamin and trace element supplementation on cognitive function in elderly subjects. nutrition 2001;17(9):709-712. [withdrawn]. see summary.

change, h. c., chen, c. l., chiu, t. l., chen, s. i., yen, a. m., and chen, t. h. Effectiveness of recombinant human erythropoietin, vitamin d3, and iron therapy on long-term survival of patients with end-stage renal disease receiving hemodialysis: analysis of 702 patients after 10 years of follow-up. public health nutrition 2009;12(12):2410-2415. see summary.

change, yes. yes exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: implications for prostate cancer treatment. urology 12-22-2003;62(6 suppl 1):29-35. see summary.

chapuy, m. c., Arlot, m. e., Delmas, p. d., and meunier, p. J. Effect of treatment with calcium and cholecalciferol for three years on hip fractures in elderly women. bmj 4-23-1994;308(6936):1081-1082. see summary.

charan, j., goyal, j. p., saxena, d., and yadav, p. vitamin d for the prevention of respiratory tract infections: a systematic review and meta-analysis. j pharmacol pharmacother. 2012;3(4):300-303. see summary.

chen, j. T. Shiraki M. Hasumi K. Tanaka N. Katase K. Kato T. Hirai Y. Nakamura T. and Ogata, E. 1-alpha-hydroxyvitamin d3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 1997;20(6):557-562. see summary.

chen, l. l., li, h., zhang, p. p., and wang, s. meter. Association between vitamin d receptor polymorphisms and periodontitis: a meta-analysis. j periodontol. 2012;83(9):1095-1103. see summary.

Chen, P., Hu, P., Xie, D., Qin, Y., Wang, F., and Wang, H. Meta-analysis of vitamin d, calcium, and breast cancer prevention. treat breast cancer. 2010;121(2):469-477. see summary.

Cheng, J., Zhang, W., Zhang, X., Li, X., and Chen, J. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis. clin.j am soc.nephrol. 2012;7(3):391-400. see summary.

Cheng S, Lyytikainen A, Kroger H, Lamberg-Allardt C, Alen M, Koistinen A, Wang Q. J. Suuriniemi, M. Suominen, H. Mahonen, A. Nicholson, p. h., ivaska, k. K. Korpela R. Ohlsson C. Vaananen K. h., and tylavsky, f. Effects of calcium, dairy, and vitamin D supplementation on bone mass accumulation and body composition in 10- to 12-year-old girls: a 2-year randomized trial. am j clin nutr 2005;82(5):1115-1126. see summary.

Chevalley, T., Rizzoli, R., Nydegger, V., Slosman, D., Rapin, C. H., Michel, J. p., vasey, h., and bonjour, j. p. Effects of calcium supplementation on femoral bone mineral density and vertebral fracture rate in elderly patients replete with vitamin d. osteoporos.int 1994;4(5):245-252. see summary.

chiaverini, c., passeron, t. and Ortonne, J. p. treatment of vitiligo with topical calcipotriol. j eur acad dermatol venereol. 2002;16(2):137-138. see summary.

Chlebna-sokol, D., Blaszczyk, A., Rusinska, A., and Loba-jakubowska, E. [treatment of osteoporosis and osteopenia in children-own experience]. przegl.lek. 2003;60(1):5-11. see summary.

Chowdhury R., Stevens S., Ward H., Chowdhury S., Sajjad A., and Franco O. h. Circulating vitamin D, calcium, and cerebrovascular disease risk: a systematic review and meta-analysis. eur.j epidemiology 2012;27(8):581-591. see summary.

christakos, s., ajibade, d. v., dhawan, p., fechner, a. j., and mady, l. J. vitamin d: metabolism. endocrinol.metab clin north am 2010;39(2):243-53, table. see summary.

christensen ob, mork nj and ashton r. Comparison of a treatment phase and a follow-up phase of short contact dithranol and calcipotriol in outpatients with chronic plaque psoriasis. j dermatol treatment 1999;10:261-265.

christensen rs, alex nh, perloff jj, georgitis wj, and mcdermott mt. coherence therapy for steroid-induced osteoporosis, one year report. 77th annual meeting of the endocrine society, washington, dc. 6-14-1995;

christesen, h. T., Elvander, C., Lamont, R. f., and jorgensen, j. yes The impact of vitamin d in pregnancy on the extraskeletal health of children: a systematic review. acta obstet.gynecol.scand. 2012;91(12):1368-1380. see summary.

christesen, h. T., Falkenberg, T., Lamont, R. f., and jorgensen, j. yes the impact of vitamin d on pregnancy: a systematic review. acta obstet.gynecol.scand. 2012;91(12):1357-1367. see summary.

christiansen, c., christensen, m. S. Mcnair P. Hagen C. Stocklund K. e., and transbol, i. Prevention of early postmenopausal bone loss: a 2-year controlled study in 315 normal women. eur. j clin invest 1980;10(4):273-279. see summary.

christiansen, c., christensen, m. s., rodbro, p., hagen, c., and transbol, i. Effect of 1,25-dihydroxy-vitamin d3 alone or combined with hormonal treatment in the prevention of postmenopausal osteoporosis. eur. j clin invest 1981;11(4):305-309. see summary.

christiansen, c., rodbro, p., and lund, m. Effect of vitamin d on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. br med j 4-28-1973;2(5860):208-209. see summary.

christiansen, c., rodbro, p., and nielsen, c. t. Iatrogenic osteomalacia in epileptic children. a controlled therapeutic trial. paediatric record scand 1975;64(2):219-224. see summary.

christiansen, c., rodbro, p., christensen, m. s., hartnack, b., and transbol, i. deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. lancet 9-30-1978;2(8092 pt 1):700-703. see summary.

chung, m., balk, e. M., Brendel, M., Ip, S., Lau, J., Lee, J., Lichtenstein, A., Patel, K., Raman, G., Tatsioni, A., Terasawa, T., and Trikalinos , you a. vitamin d and calcium: a systematic review of health outcomes. evid.rep technol.assess.(full.rep) 2009;(183):1-420. see summary.

chung, m., lee, j., terasawa, t., lau, j. and trikalinos, t. a. Vitamin d with or without calcium supplementation for cancer and fracture prevention: an updated meta-analysis for the us. uu. Preventive Services Task Force. ann.intern.med. 20-12-2011;155(12):827-838. see summary.

Church, J., Goodall, S., Norman, R., and Haas, M. An economic evaluation of fall prevention strategies in residential and community care for the elderly in nsw. public health bull n.s.w. 2011;22(3-4):60-68. see summary.

Cimaz, R., Gattorno, M., Sormani, M. P. Falcini, F. Zuliana, F. Lepore, L. Bardare, M. Chiesa, S. Corona, F. Dubini, A. Lenhardt, A. Martini, G. Masi, l., and bianchi, m. I Changes in bone turnover markers and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases. j rheumatol 2002;29(8):1786-1792. see summary.

coburn, j. w., maung, h. m., elangovan, l., germain, m. J., Lindberg, J. s., sprague, s. m., williams, m. e., and Bishop, c. w. doxercalciferol safely suppresses pth levels in patients with secondary hyperparathyroidism associated with stage 3 and 4 chronic kidney disease. am j nephropathy. 2004;43(5):877-890. see summary.

cockburn, f., belton, b. r., purvis, r. j., giles, m. m., brown, j. k., turner, t. L., Wilkinson, E. m., forfar, j. o., barrie, w. j., mckay, g. s., and pocock, s. J. Maternal vitamin d intake and mineral metabolism in mothers and their newborns. br.med.j 7-5-1980;281(6232):11-14. see summary.

coco, m., glicklich, d., faugere, m. C. Burris L. Bognar I. Durkin P. Tellis V. Greenstein S. Schechner R. Figueroa K. McDonough P. Wang G. and malluche, h. Prevention of bone loss in kidney transplant recipients: a prospective, randomized trial of intravenous pamidronate. j am soc nephrol 2003;14(10):2669-2676. see summary.

coen g, gallucci mt and bonucci e. treatment of renal osteodystrophy (rod) with 25-ohd3 and 1,25 (oh)2d3: synergistic effect not related to the synthesis of 24,25 (oh)2d3. kidney international 1982;22(1):96.

coen g, mazzaferro s, manni m, napoletano i, fondi g and sardella d. treatment with small doses of 1, 25-dihydroxyvitamin d3 in chronic renal failure prior to dialysis may reduce the rate of deterioration of renal function. ital j mineral electrolyte metab 1994;8:117-121.

compile, c. w., badellino, k. o., and boullata, j. Yo. vitamin d and the bariatric surgical patient: a review. obes.surg 2008;18(2):220-224. see summary.

cook, l. S., Nelson, H. K., Lorenzetti, D. l., and reads, r. c. a systematic review of the literature on vitamin d and ovarian cancer. am j obstet gynecol 2010;203(1):70-78. see summary.

Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. f., maguire, c., hind, d., and tappenden, p. Colorectal cancer chemoprevention: systematic review and economic evaluation. health.technology.assessment 2010;14(32):1-206. see summary.

Cooper, L., Clifton-Bligh, p. b., nery, m. L., Figtree G., Twigg S., Hibbert E., and Robinson B. gram. Vitamin d supplementation and bone mineral density in early postmenopausal women. am j clin nutr 2003;77(5):1324-1329. see summary.

corless d, ellis m dawson and fraser f. Using assessments of activities of daily living to measure the efficacy of vitamin d supplementation in elderly patients with prolonged stays. brjoccupther 1987;50:60-62.

Corless, D., Dawson, E., Fraser, F., Ellis, M., Evans, S. j., perry, j. d., reisner, c., silver, c. p., beer, m., boucher, b. j., and . Do vitamin d supplements improve physical abilities in elderly hospitalized patients? age aging 1985;14(2):76-84. see summary.

Cortet, B., Lartigau, E., Caty, A., Moulinier, F., Staerman, F., Villamizar-Vesga, J., and Villers, A. [Androgen deprivation therapy for prostate cancer and risk of osteoporosis]. prog.urol. 2012;22 supplement 2:s31-s38. see summary.

costenbader, k. H., Feskanich, D., Holmes, M., Karlson, E. w., and benito-garcia, e. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. ann.rheum.dis. 2008;67(4):530-535. see summary.

coyne, d. w. Vitamin D compounds in chronic kidney disease. ann.intern med 6-17-2008;148(12):969-970. see summary.

Coyne, D., Acharya, M., Qiu, P., Abboud, H., Batlle, D., Rosansky, S., Fadem, S., Levine, B., Williams, L., Andress, d. l., and sprague, s. meter. paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 ckd. i am j kidney disease. 2006;47(2):263-276. see summary.

crandall, c. j., newberry, s. j., diamond, a., lim, and. w., gelad, w. f., suttorp, m. J. Motala, A. Ewing, B. Roth, B. Shanman, R., Timmer, M., and Shekelle, p. gram. 2012; see summary.

Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., and Rosen, C. Meta-analysis of therapies for postmenopausal osteoporosis. ix: Summary of meta-analysis of therapies for postmenopausal osteoporosis. endocr.rev. 2002;23(4):570-578. see summary.

Cranney, A., Guyatt, G., Krolicki, N., Welch, V., Griffith, L., Adachi, J. d., shea, b., tugwell, p., and wells, g. a meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. osteoporosis int 2001;12(2):140-151. see summary.

Cranney, A., Horsley, T., O’Donnell, S., Weiler, H., Puil, L., Ooi, D., Atkinson, S., Ward, L., Moher, D., Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, and Mamaladze V. efficacy and safety of vitamin d in relation to bone health. evid.rep technol.assess.(full.rep) 2007;(158):1-235. see summary.

Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G. and Guyatt, G. Meta-analysis of therapies for postmenopausal osteoporosis. iii. meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. endocr.rev. 2002;23(4):517-523. see summary.

Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Adachi J, Wells G, Shea B. and Guyatt, G. Meta-analysis of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. endocr.rev. 2002;23(4):524-528. see summary.

Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Shea, B., Wells, G., Adachi, J., Waldegger, L. and Guyatt, G. Meta-analysis of therapies for postmenopausal osteoporosis. saw. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. endocr.rev. 2002;23(4):540-551. see summary.

cranney, a., weiler, h. a., o’donnell, s., and puil, l. summary of an evidence-based review on the efficacy and safety of vitamin d in relation to bone health. am j clin nutr 2008;88(2):513s-519s. see summary.

Cranney, A., Welch, V., Adachi, J. D., Guyatt, G., Krolicki, N., Griffith, L., Shea, B., Tugwell, P., and Wells, G. Etidronate for the treatment and prevention of postmenopausal osteoporosis. Cochrane Database System Rev 2001;(4):cd003376. see summary.

Cranney, A., Welch, V., Adachi, J. D., Homik, J., Shea, B., Suarez-Almazor, M. e., tugwell, p., and wells, g. calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database System Rev 2000;(2):cd001983. see summary.

Cranney, A., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., Black, D., Adachi, J., Shea, B., Tugwell, p., and guyatt, g. Meta-analysis of therapies for postmenopausal osteoporosis. ii. Meta-analysis of alendronate for the treatment of postmenopausal women. endocr.rev. 2002;23(4):508-516. see summary.

crew, k. D. Shane E. Cremers S. McMahon D. j., irani, d., and hershman, d. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. j clin oncol. 5-1-2009;27(13):2151-2156. see summary.

cunliffe, w. J. Berth-Jones, J. Claudy, A. Fairiss, G. Goldin, D. Gratton, D. Henderson, C. A. Holden, C. a., maddin, w. S., Ortonne, J. p., and . Comparative study of calcipotriol ointment (mc 903) and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. j am acad.dermatol. 1992; 26 (5pt 1): 736-743. see summary.

cunningham, b. b., landells, i. d., langman, c., sailboat, d. e., and paller, a. yes Topical calcipotriene for morphea/linear scleroderma. j am acad dermatol 1998;39(2 pt 1):211-215. see summary.

cuppari, l., carvalho, a. b., and draibe, s. a. Vitamin d status of patients with chronic kidney disease living in a sunny country. jrennutr 2008;18(5):408-414. see summary.

daniel, d. and pirotta, m. v. fibromyalgia: should we screen for and treat vitamin d deficiency? aust.fam.medical 2011;40(9):712-716. see summary.

datta, m. and schwartz, g. gram. Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. oncologist. 2012;17(9):1171-1179. see summary.

datta, s., alfaham, m., davies, d. P., Dunstan, F., Woodhead, S., Evans, J., and Richards, B. Vitamin d deficiency in pregnant women from a non-European ethnic minority population: an intervention study. jog 2002;109(8):905-908. see summary.

davison, b. j., oliffe, j. l., pickles, t., and mroz, l. Factors influencing men undergoing active surveillance for treatment of low-risk prostate cancer. oncol.nurs.forum 2009;36(1):89-96. see summary.

dawson-hughes, b., dallal, g. e., krall, e. A. Harris, S. Sokoll, L. j., and falconer, g. Effect of winter vitamin d supplementation and overall bone loss in healthy postmenopausal women. ann.intern.med. 10-1-1991;115(7):505-512. see summary.

dawson-hughes, b., dallal, g. e., krall, e. a., sadowski, l., sahyoun, n., and tannenbaum, s. a controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. n.engl.j med. 9-27-1990;323(13):878-883. see summary.

dawson-hughes, b., harris, s. s., krall, e. a., dallal, g. e., falconer, g., and green, c. I rates of bone loss in postmenopausal women randomly assigned to one of two doses of vitamin d. am j clin nutr 1995;61(5):1140-1145. see summary.

mcd day, sedwick hj. Fat-soluble vitamins and dental caries in children. j nourish 1934;8:309-328.

from boer, i. h., tinsmith, l. F. Connelly S. Curb J. d., howard, b. V., Kestenbaum, B., Larson, J. C., Manson, J. eg, Margolis, K. L., Siscovick, D. s., and Weiss, n. yes Calcium plus vitamin d supplementation and the risk of incident diabetes in the women’s health initiative. diabetes care 2008;31(4):701-707. see summary.

de gruijl, f. r. and Pavel, S. The effects of an 8-week mid-winter course of sunbed exposures below sunburn on tanning, vitamin d status, and colds. photochem.photobiol.sci 2012;11(12):1848-1854. see summary.

dejong, e. m., mork, n. j., seijger, m. m. de la brassine, m. lauharanta, j. jansen, c. T., Guilhou, J. J. Guillot B. Ostrojic A. Souteyrand P. Vaillant L. Barnes L. Rogers S. Klaber M. r., and van de Kerkhof, p. c. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicenter randomized placebo-controlled trial. br j dermatol 2003;148(2):318-325. see summary.

de nijs, r. N., Jacobs, J. w., algra, a., lems, w. f., and bijlsma, j. w. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin d3 analogs: a review with meta-analysis of randomized controlled trials including organ transplant studies. osteoporosis int 2004;15(8):589-602. see summary.

de sevaux, r. eg, hoitsma, a. j., corstens, f. h., and wetzels, j. F. Vitamin D and Calcium Treatment Reduces Bone Loss After Kidney Transplantation: A Randomized Study. j am soc nephrol 2002;13(6):1608-1614. see summary.

from torrent de la jara, pecoud, a., and favrat, b. Musculoskeletal pain in female asylum seekers and hypovitaminosis d3. bmj 7-17-2004;329(7458):156-157. see summary.

De Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving H. H. Pritchett, Y. Remuzzi, G., Ritz, E. and Andress, D. Selective vitamin d receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (vital study): a randomized controlled trial. lancet 6-11-2010;376(9752):1543-1551. see summary.

de-regil, l. m., Palacios, c., Ansary, a., Kulier, r., and Pena-rosas, j. p. vitamin d supplements for women during pregnancy cochrane.database.syst.rev. 2012;2:cd008873. see summary.

del, Puente a., Esposito, a., Savastano, s., Carpinelli, a., Postiglione, l., and Oriente, p. Dietary calcium intake and serum vitamin D are important determinants of changes in bone mass in women. a longitudinal study. clin aging exp.res 2002;14(5):382-388. see summary.

delfino m, fabbrocini g and sammarco e. efficacy of calcipotriol versus lactic acid cream in the treatment of lamellar and x-linked ichthyoses. j dermatol treatment 1994;5:151-152.

delvin, e. e., go out, b. l., glorieux, f. h., adeleine, p., and david, l. yes Vitamin d supplementation during pregnancy: effect on neonatal calcium homeostasis. jpediatrician 1986;109(2):328-334. see summary.

Dequeker, J., Borghs, H., Van, Cleemput J., Nevens, F., Verleden, G., and Nijs, J. Transplant osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol. z.rheumatol. 2000;59 supplement 1:53-57. see summary.

Deroisy, R., Collette, J., Albert, A., Jupsin, I., and Reginster, J. Y. supplementation containing calcium and vitamin d is more effective than calcium alone in reducing secondary hyperparathyroidism in postmenopausal women with low circulating levels of 25(oh)vitamin d. clin aging exp.res 2002;14(1):13-17. see summary.

Devaux, S., Castela, A., Archier, E., Gallini, A., Joly, P., Misery, L., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B. Jullien D. Le Maître M. Richard M. A. Ortonne, J. p., and Paul, c. Topical vitamin d analogs alone or in association with topical steroids for psoriasis: a systematic review. j eur.acad.dermatol.venereol. 2012;26 supplement 3:52-60. see summary.

dhesi, j. k., bearne, l. m., moniz, c., hurley, m. V., Jackson, S. h., swift, c. g., and allain, t. J. Neuromuscular and psychomotor function in elderly who fall and the relationship with vitamin d status. j bone miner.res 2002;17(5):891-897. see summary.

dhesi, j. K., Jackson, S. h., bearne, l. m., moniz, c., hurley, m. v., swift, c. g., and allain, t. J. Vitamin D supplementation improves neuromuscular function in older people who fall. age aging 2004;33(6):589-595. see summary.

di, monaco m., vallero, f., di, monaco r., mautino, f., and cavanna, a. Primary hyperparathyroidism in elderly patients with hip fracture. j bone miner. metab 2004;22(5):491-495. see summary.

di, munno o., beghe, f., favini, p., di, giuseppe p., pontrandolfo, a., occhipinti, g., and pasero, g. prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin d and calcium. clin rheumatol. 1989;8(2):202-207. see summary.

diamond t, mcguigan l, schonell m, levy s and rae d. a 2-year open-label randomized controlled trial comparing calcitriol with cyclic etidronate for the treatment of glucocorticoid-induced osteoporosis. j bone miner res 1997;12(suppl1):s511.

diamond, t. h., higano, c. s., blacksmith, m. r., costume, t. a., and singer, f. r. Osteoporosis in men with prostate carcinoma receiving androgen deprivation therapy: recommendations for diagnosis and therapies. cancer 1-3-2004;100(5):892-899. see summary.

Dickersin, K., Scherer, R., and Lefebvre, C. identify relevant studies for systematic reviews. bmj 12-11-1994;309(6964):1286-1291. see summary.

Dixon, T., Mitchell, P., Beringer, T., Gallacher, S., Moniz, C., Patel, S., Pearson, G. and Ryan, P. an overview of the prevalence of 25-hydroxy-vitamin d insufficiency among elderly patients with and without fragility fracture in the uk. curr med res opinion. 2006;22(2):405-415. see summary.

djukanovic, l., pejanovic, s., dragojlovic, z. and Stosovic, M. treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-ohd3 plus a pharmacological dose of 24.25(oh)2d3. Ren fails. 1994;16(6):715-723. see summary.

doria, a., zen, m., canova, m., bettio, s., bassi, n., nalotto, l., rampudda, m., ghirardello, a. and Iaccarino, L. diagnosis and treatment of SLE: when early is early. autoimmune.rev. 2010;10(1):55-60. see summary.

douglas, w. S. Poulin Y. Decroix J. Ortonne J. P. Mrowietz, U. Gulliver, W. Krogstad, A. L., Larsen, F. G. Iglesias, L. Buckley, C., and Bibby, A. J. a new formulation of calcipotriol/betamethasone with a rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. acta derm.venereol. 2002;82(2):131-135. see summary.

du, x., zhu, k., trube, a., zhang, q., ma, g., hu, x., fraser, d. R., and Greenfield, H. School milk intervention trial improves growth and bone mineral accumulation in 10- to 12-year-old Chinese girls in Beijing. br.j nutr 2004;92(1):159-168. see summary.

Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, Chevrant-Breton J, Beylot C, Bazex J. a., and Jurgensen, h. J. efficacy and safety of calcipotriol ointment (mc 903) in psoriasis vulgaris. a randomized, double-blind, comparative right/left, vehicle-controlled study. j am acad dermatol 1992;27(6 pt 1):983-988. see summary.

dukas, l., schacht, e., mazor, z. and Stahelin, H. b. Alfacalcidol treatment in the elderly significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min. osteoporos.int 2005;16(2):198-203. see summary.

Durakovic, C., Malabanan, A., and Holick, M. F. rationale for the use and clinical response of hexafluoro-1,25-dihydroxyvitamin d3 for the treatment of plaque psoriasis: a pilot study. br j dermatol 2001;144(3):500-506. see summary.

Durakovic, C., Ray, S., and Holick, M. F. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin d2) is a novel, safe, and effective treatment for plaque psoriasis: a pilot study. br j dermatol 2004;151(1):190-195. see summary.

dykman, t. R., Haralson, K. m., gluck, o. S., Murphy, W. a., teitelbaum, s. l., hahn, t. j., and hahn, b. h. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. arthritis rheum 1984;27(12):1336-1343. see summary.

eastham, j. a. Bone health in men receiving androgen deprivation therapy for prostate cancer. jurol. 2007;177(1):17-24. see summary.

ebeling, p. r. and Russell, R. gram. teriparatide (rhpth 1-34) for the treatment of osteoporosis. int j clin.pract. 2003;57(8):710-718. see summary.

eid p, scuderi g, aroldi a, ciammella m, and nencioni t. Bone loss after renal transplantation: hrt versus calcitriol in postmenopausal recipients. osteoporosis international 1996;6(suppl1):294.

eke, f. you and born in winter, m. h. Effect of low-dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure. archdis.child 1983;58(10):810-813. see summary.

el-agroudy, a. e., el-husseini, a. a., el-sayed, m., and ghoneim, m. a. prevention of bone loss in kidney transplant recipients with vitamin d. j am soc nephrol 2003;14(11):2975-2979. see summary.

El-Hajj, Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Salamoun M., Khalife H., Choucair M., Arabi A., and Vieth R . Effect of vitamin d replacement on musculoskeletal parameters in school-age children: a randomized controlled trial. jclin endocrinol metab 2006;91(2):405-412. see summary.

el-husseini, a. a., el-agroudy, a. e., el-sayed, m. f., sobh, m. a., and goneim, m. a. Treatment of osteopenia and osteoporosis in children and adolescents with kidney transplants. pediatr.transplantation. 2004;8(4):357-361. see summary.

el-husseini, a. a., el-agroudy, a. e., el-sayed, m., sobh, m. a., and goneim, m. a. a prospective randomized study for the treatment of bone loss with vitamin d during renal transplantation in children and adolescents. i am j transplant. 2004;4(12):2052-2057. see summary.

el-reshaid, k., el-reshaid, w., sugathan, t., al-mohannadi, s., and sivanandan, r. Comparison of the efficacy of two injectable forms of vitamin d3 and one oral alpha in the treatment of secondary hyperparathyroidism in patients on maintenance hemodialysis. i am j nephrol. 1997;17(6):505-510. see summary.

elamine, m. b., abu elnour, b. o., elamine, k. b., fatourechi, m. m., alkatib, a. A., Almandoz, J. p., liu, h., lane, m. a., mullan, r. J. Hazem, A. Erwin, p. j., hensrud, d. d., murad, m. h., and montori, v. m. vitamin d and cardiovascular outcomes: a systematic review and meta-analysis. j clin.endocrinol.metab 2011;96(7):1931-1942. see summary.

elders, p. j., netelenbos, j. c., lips, p., van ginkel, f. c., khoe, e., leeuwenkamp, ​​o. r., hackeng, w. h., and van der stelt, p. F. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. j clin endocrinol metab 1991;73(3):533-540. see summary.

elemraid, m. a., mackenzie, i. j., fraser, w. d., and brain, b. J. Nutritional factors in the pathogenesis of ear disease in children: a systematic review. ann trop. paediatr. 2009;29(2):85-99. see summary.

Elliot-Gibson, V., Bogoch, E. r., jamal, s. a., and beaton, d. me. Practice patterns in the diagnosis and treatment of osteoporosis after fragility fracture: a systematic review. osteoporosis int 2004;15(10):767-778. see summary.

more, e. f., van suijlekom-smit, l. w., and orange, a. p. treatment of linear scleroderma with oral 1,25-dihydroxyvitamin d3 (calcitriol) in seven children. dermatol pediatrician 1999;16(1):53-58. see summary.

emkey r, procaccini r and gaich g. the effect of calcitonin on bone mass in steroid-induced osteoporosis. arthritis rheum 1994;37(suppl9):s183.

erem, c., tanakol, r., alagol, f., omer, b., and cetin, o. Relationship of bone turnover parameters, endogenous hormones and vit d deficiency with hip fracture in elderly postmenopausal women. practice int j clin. 2002;56(5):333-337. see summary.

erkkola, m., kaila, m., nwaru, b. I., Kronberg-Kippila, C., Ahonen, S., Nevalainen, J., Veijola, R., Pekkanen, J., Ilonen, J., Simell, O., Knip, M., and Virtanen, S. meter. Maternal intake of vitamin D during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-olds. clin.exp.allergy 2009;39(6):875-882. see summary.

Ermis, O., Alpsoy, E., Cetin, L., and Yilmaz, E. Is efficacy of psoralen plus ultraviolet vitiligo therapy enhanced by concurrent topical calcipotriol? a double-blind, placebo-controlled study. br j dermatol 2001;145(3):472-475. see summary.

Escribano, J., Balaguer, A., Pagone, F., Feliu, A., and Roque, I. figures pharmacological interventions for the prevention of complications in idiopathic hypercalciuria. cochrane.database.syst.rev. 2009;(1):cd004754. see summary.

etgen, t., sander, d., bickel, h., and forstl, h. mild cognitive impairment and dementia: the importance of modifiable risk factors. dtsch.arztebl.int 2011;108(44):743-750. see summary.

evans, s. r., nolla, j., hanfelt, j., shabahang, m., nauta, r. j., and shchepotin, i. b. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. clin.cancerres 1998;4(7):1591-1595. see summary.

Ewers, B., Gasbjerg, A., Moelgaard, C., Frederiksen, A. m., and marckmann, p. Vitamin d status in kidney transplant patients: need for intensified routine supplementation. I am j clin nutr 2008;87(2):431-437. see summary.

ezquerra, g. m., queen, m. s., and millet, p. your combination of acitretin and oral calcitriol for the treatment of plaque psoriasis. acta derm.venereol. 2007;87(5):449-450. see summary.

falch, j. a., odegaard, or. R., Finnanger, A. m., and matheson, i. Postmenopausal osteoporosis: no effect of three years of treatment with 1,25-dihydroxycholecalciferol. record med.scan. 1987;221(2):199-204. see summary.

falcini, f., trapani, s., ermini, m. and brandy, m. I Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling. calcif.tissue int 1996;58(3):166-169. see summary.

fan, s. l., almond, m. K. Ball, E. Evans, K., and Cunningham, J. pamidronate therapy as prevention of bone loss after renal transplantation. kidney int 2000;57(2):684-690. see summary.

faulkner, k. A. Cauley, J. a., zmuda, j. m., landsittel, d. p., newman, a. b., studenski, s. a., redfern, m. s., ensrud, k. eg, snitch, h. a., lane, n. e., and nevitt, m. c. Higher concentrations of 1,25-dihydroxyvitamin d3 associated with lower rates of falls in older women living in the community. osteoporosis int 2006;17(9):1318-1328. see summary.

fedirko, v., bostick, r. m., goodman, m., flanders, w. d., and gross, m. d. Blood concentrations of 25-hydroxyvitamin d3 and incident risk of sporadic colorectal adenoma: a combined case-control study. i’m j epidemiology. 2010-1-9;172(5):489-500. see summary.

Fehlings, D., Switzer, L., Agarwal, P., Wong, C., Sochett, E., Stevenson, R., Sonnenberg, L., Smile, S., Young, E., Huber, J., Milo-Manson, G., Kuwait, G. a., and gaebler, d. reporting evidence-based clinical practice guidelines for children with cerebral palsy at risk for osteoporosis: a systematic review. dev.med.child neurol. 2012;54(2):106-116. see summary.

Felson, D. T. Niu J. Clancy M. Alabadi P. Sack B. Guermazi A. Hunter D. J., Amin, S., Rogers, G., and Booth, S. I low vitamin d levels and worsening of knee osteoarthritis: results of two longitudinal studies. rheumatic arthritis. 2007;56(1):129-136. see summary.

fenton, c. and Plosker, G. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris. am j clin dermatol 2004;5(6):463-478. see summary.

ferguson, j. h. and change, to. b. vitamin d supplements for cystic fibrosis cochrane.database.syst.rev. 2009;(4):cd007298. see summary.

ferguson, j. h. and change, to. b. vitamin d supplements for cystic fibrosis cochrane.database.syst.rev. 2012;4:cd007298. see summary.

fernández, j. l., viana, s. l., rock, a. l., ribeiro, m. c., and castro, l. c. Radiographic changes induced by bisphosphonates in two pediatric patients with rheumatic diseases. skeletal radius. 2004;33(12):732-736. see summary.

fischer, e. r. and Harris, D. c. comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism. clin nephrol. 1993;40(4):216-220. see summary.

Fishbane, S., Chittineni, H., Packman, M., Dutka, P., Ali, N. and durie, b. Oral paricalcitol in the treatment of patients with ckd and proteinuria: a randomized trial. i am j kidney disease. 2009;54(4):647-652. see summary.

Fisher, B., Costantino, J. p., wicker, d. L., Redmond, c. K., Kavanah, M., Cronin, W. M. Vogel V. Robidoux A. Dimitrov N. Atkins J. Daly M. Wieand S. Tan-chiu E. Ford L. and Wolmark N. Tamoxifen for breast cancer prevention: report of the National Breast and Bowel Surgical Adjuvant Project p-1 study. j cancer natl inst. 9-16-1998;90(18):1371-1388. see summary.

flicker, l., macinnis, r. j., stein, m. s., scherer, s. c., mead, k. e., nowson, c. A. Thomas, J. Lowndes, C. Hopper, J. L., and Wark, J. d. should older people in residential care get vitamin d to prevent falls? the results of a randomized trial. j am geriatr soc 2005;53(11):1881-1888. see summary.

Fliser, D., Stefanski, A., Franek, E., Fode, P., Gudarzi, A., and Ritz, E. no effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. eur j clin invest 1997;27(7):629-633. see summary.

Fluss, J., Kern, I., de Coulon G., Gonzalez, E., and Chehade, H. Vitamin d deficiency: a neglected treatable cause of motor delay and proximal myopathy. brain development 12-26-2012; see summary.

institute of medicine of the board of food and nutrition. standing committee on the scientific assessment of dietary reference intakes. dietary reference intakes: calcium, phosphorus, magnesium, vitamin d and fluoride. 1997;

form, j. p., bischoff-ferrari, h. A. Willett, W. c., seal, m. j., and curhan, g. c. Vitamin d intake and risk of incident hypertension: results from three large prospective cohort studies. hypertension 2005;46(4):676-682. see summary.

forouhi, n. G. Luan J. Cooper A. Boucher B. j., and wareham, b. J. baseline serum 25-hydroxyvitamin d predicts future glycemic status and insulin resistance: the medical research council prospective study 1990-2000. diabetes 2008;57(10):2619-2625. see summary.

forschner, t., buchholtz, s., and stockfleth, e. Current status of evidence-based literature analysis of vitiligo therapy. j dtsch.dermatol ges. 2007;5(6):467-475. see summary.

fournier a, moriniere p, boudaillez b, maurouard c, westeel pf and achard jm. prevention of radiologically evident hyperparathyroidism in patients on i.v. dialysis 1aoh vitamin d3 (etalpha) in association with mg(oh)2 as the only phosphate binder. nieren- und hochdruckkrankheiten 1993;22:s39-44.

freishtat, r. j., iqbal, s. f., pillai, d. k., klein, c. J., Ryan, L. m., benton, a. s., and teach, s. J. High prevalence of vitamin d deficiency among inner-city African American youth with asthma in Washington, DC. jpediatrician 2010;156(6):948-952. see summary.

freyschuss, b., ljunggren, o., saaf, m., mellstrom, d., and avenell, a. calcium and vitamin d for the prevention of osteoporotic fractures. lancet 12-22-2007;370(9605):2098-2099. see summary.

fronczak, c. m., baron, a. e., persecution, h. P., Ross, C., Brady, H. L., Hoffman, M., Eisenbarth, G. S., Rewers, M., and Norris, J. meter. In utero dietary exposures and risk of islet autoimmunity in children. diabetes care 2003;26(12):3237-3242. see summary.

Fujita, T., Ohue, M., Fujii, Y., Miyauchi, A., and Takagi, Y. reappraisal of the katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (aaaca) on vertebral deformity and fracture. bone miner j metab 2004;22(1):32-38. see summary.

fuleihan geh, nabulsi m and tamim h. Effect of vitamin d replacement on musculoskeletal parameters in school-age children: a randomized controlled trial. jclin endocrinol metab 2006;91(2):406-412.

Gaal, J., Lakos, G., Szodoray, P., Kiss, J., Horvath, I., Horkay, E., Nagy, G., and Szegedi, A. Immunological and clinical effects of alfacalcidol in patients with psoriatic arthropathy: results of an open-label follow-up pilot study. acta derm.venereol. 2009;89(2):140-144. see summary.

gal-moscovici, a. and Sprague, S. meter. use of vitamin d in patients with chronic kidney disease. kidney int 2010;78(2):146-151. see summary.

gallacher, s. J. Mcquillian, C. Harkness, M. Finlay, F. Gallagher, A. p., and dixon, t. prevalence of vitamin d insufficiency in scottish adults with nonvertebral fragility fractures. curr med res opinion. 2005;21(9):1355-1361. see summary.

gallagher, j. c. and Goldgar, D. treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. a randomized controlled study. ann.intern.med. 11-1-1990;113(9):649-655. see summary.

gallagher, j. c. the effects of calcitriol on falls and fractures and physical performance tests. j steroid biochem.mol.biol. 2004;89-90(1-5):497-501. see summary.

gallagher, j. c., hunter, s. e., detter, j. r., and sherman, s. yes Combination therapy with estrogen and calcitriol in the prevention of age-related bone loss. jclin endocrinol metab 2001;86(8):3618-3628. see summary.

gallagher, j. c., rapuri, p. b., and smith, l. meter. An age-related decline in creatinine clearance is associated with an increased number of falls in untreated women, but not in women receiving calcitriol treatment. jclin endocrinol.metab 2007;92(1):51-58. see summary.

gallagher, j. c., rigging, b. L., Recker, R. r. and Goldgar, D. the effect of calcitriol in patients with postmenopausal osteoporosis with special reference to the frequency of fractures. proc.soc exp.biol.med. 1989;191(3):287-292. see summary.

gandrud, l. m., cheung, j. c., daniels, m. w., and bachrach, l. k. low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. j pediatr endocrinol.metab 2003;16(6):887-892. see summary.

garcia-delgado, i., prieto, s., gil-fraguas, l., oaks, e., rufilanchas, j. j., and hawkins, f. treatment with calcitonin, etidronate and calcidiol in bone loss after heart transplantation. calcif tissue int 1997;60(2):155-159. see summary.

garland, c. f., comstock, g. w., garland, f. c., helsing, k. J., Shaw, E. K., and Gorham, E. d. Serum 25-hydroxyvitamin d and colon cancer: eight-year prospective study. Lancet 11-18-1989;2(8673):1176-1178. see summary.

garland, c., shekelle, r. b., barrett-connor, e., criqui, m. h., Rossof, a. h., and Paul, or. Dietary vitamin d and calcium and colorectal cancer risk: a 19-year prospective study in men. lancet. 2-9-1985;1(8424):307-309. see summary.

Gattinara M, Pontikaki I, Gerloni V, and Fantini F. Use of cyclic etidronate in patients with chronic juvenile rheumatic diseases receiving long-term steroid treatment. ann rheumdis 2000;59:743-744.

Gaugris, S., Heaney, R. P., Boonen, S., Kurth, H., Bentkover, J. d., and sen, s. yes Vitamin D insufficiency among postmenopausal women: a systematic review. qjm. 2005;98(9):667-676. see summary.

gears, d. f., hodson, e. m., and craig, j. c. Interventions for bone disease in children with chronic kidney disease. cochrane.database.syst.rev. 2010;(1):cd008327. see summary.

george, p. S., Pearson, E. r., and witham, m. d. Effect of vitamin d supplementation on glycemic control and insulin resistance: a systematic review and meta-analysis. diabetes.med. 2012;29(8):e142-e150. see summary.

geusens, p. and Dequeker, J. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin d3, or intermittent calcium infusion therapy on bone mineral content, bone remodeling, and fracture rate in symptomatic osteoporosis: a double-blind controlled study. bone miner 1986;1(4):347-357. see summary.

giangregorio, l., papaioannou, a., cranney, a., zytaruk, n. and Adachi, J. d. Fragility fractures and the osteoporosis care gap: an international phenomenon. semin.arthritis rheum. 2006;35(5):293-305. see summary.

Giannetti, A., Coppini, M., Bertazzoni, M. G. Califano, A. Altieri, E. Pazzaglia, A. Lega, M. Lombardo, M. Pelfini, C. Veller, Fornasa C., Rabbiosi, G., and Cespa, m. clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream versus etretinate alone in moderate-severe psoriasis. j eur.acad.dermatol.venereol. 1999;13(2):91-95. see summary.

Giannini S., D’Angelo A. Carraro G. Nobile M. Rigotti P. Bonfante L. Marchini F. Zaninotto M. Dalle Carbonare L. , sartori, l., and crepaldi, g. alendronate prevents further bone loss in kidney transplant recipients. j bone miner res 2001;16(11):2111-2117. see summary.

Gilbert, R., Martin, R. M., Beynon, R., Harris, R., Savovic, J., Zuccolo, L., Bekkering, G. e., fraser, w. d., sterling, j. a., and metcalfe, c. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. cancer causes control 2011;22(3):319-340. see summary.

gillespie, l. d., robertson, m. c., gillespie, w. j., lamb, s. e., gates, s., cumming, r. g., and rowe, b. h. Interventions for the prevention of falls in older people living in the community. Cochrane Database System Rev 2009;(2):cd007146. see summary.

gillespie, l. d., robertson, m. c., gillespie, w. J. Sherrington C. Gates S. Clemson L. m., and lamb, s. me. Interventions for the prevention of falls in older people living in the community. cochrane.database.syst.rev. 2012;9:cd007146. see summary.

girolomoni, g., vein, g. a., ayala, f., cannavo, s. p., from, pita o., chimenti, s., and peserico, a. consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. g.ital.dermatol.venereol. 2012;147(6):609-624. see summary.

gissel, t., rejnmark, l., mosekilde, l. and Vestergaard, p. Vitamin D intake and risk of breast cancer: a meta-analysis. j steroid biochem.mol.biol. 2008;111(3-5):195-199. see summary.

Giusti, A., Barone, A., Pioli, G., Sunflowere, G., Razzano, M., Pizzonia, M., Pedrazzoni, M., Palummeri, E., and Bianchi, G. Heterogeneity in serum 25-hydroxy-vitamin d response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin d deficiency. j am geriatr soc 2010;58(8):1489-1495. see summary.

Giusti, A., Barone, A., Razzano, M., Pizzonia, M., Oliveri, M., Palummeri, E., and Pioli, G. High prevalence of secondary hyperparathyroidism due to vitamin D deficiency in hospitalized elderly with and without hip fracture. j endocrinol.invest 2006;29(9):809-813. see summary.

gloth, f. m., iii, alam, w., and hollis, b. vitamin d vs broad-spectrum phototherapy in the treatment of seasonal affective disorder. j nutr health aging 1999;3(1):5-7. see summary.

gloth, f. m., iii, blacksmith, c. e., hollis, b. w., and tobin, j. d. Functional improvement with vitamin d replacement in a cohort of frail older people with vitamin d deficiency. j am geriatric soc 1995;43(11):1269-1271. see summary.

goldberg, p., fleming, m. c., and picardo, e. h. multiple sclerosis: decreased relapse rate by dietary supplementation with calcium, magnesium, and vitamin d. medical hypotheses 1986;21(2):193-200. see summary.

goldman, b. d. Common dermatoses of the male genitalia. recognition of differences in genital rashes and lesions is essential and achievable. postgraduate.med. 9-15-2000;108(4):89-6. see summary.

wow h. ist die karies dermilchzähne durchverabreichung der lebertran gunstig zu beeinflussen? [in German]. vienna klin wochenschr. 1939; 52:35.

Gollnick, H., Altmeyer, P., Kaufmann, R., Ring, J., Christopher, E., Pavel, S., and Ziegler, J. Topical calcipotriol plus oral fumaric acid is more effective and faster-acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. dermatology 2002;205(1):46-53. see summary.

well, he. r., brolin, r. eg, chowdhury, h. a., and shapes, s. a. Gastric and bone bypass surgery: effects of dietary calcium and vitamin d. obes.res 2004;12(1):40-47. see summary.

good man, b. m., iii, artz, n., radford, b., and chen, i. a. prevalence of vitamin d deficiency in adults with sickle cell disease. j natl med assoc 2010;102(4):332-335. see summary.

goodwin, p. J., Ennis, M., Pritchard, K. i., koo, j., and hood, n. Prognostic effects of 25-hydroxyvitamin d levels in early breast cancer. jclin.oncol. 2009-08-10;27(23):3757-3763. see summary.

Gorai I., Chaki O. Taguchi Y. Nakayama M. Osada H. Suzuki N. Katagiri N. Misu Y. and Minaguchi, H. early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-oh-vitamin d3: therapeutic effects of estrogen and/or 1alpha-oh-vitamin d3. calcif tissue int 1999;65(1):16-22. see summary.

degrees, f., brazier, m., kamel, s., duver, s., heurtebize, n., maamer, m., mathieu, m., garabedian, m., sebert, j. l., and fardellone, p. Effects on bone mineral density of calcium and vitamin d supplementation in elderly women with vitamin d deficiency. articular bony spine 2003;70(3):203-208. see summary.

degrees, f., brazier, m., kamel, s., mathieu, m., hurtebize, n., maamer, m., garabedian, m., sebert, j. l., and fardellone, p. Prediction of bone mass density variation by markers of bone remodeling in postmenopausal women with vitamin d insufficiency treated with calcium and vitamin d supplements. jclin endocrinol metab 2003;88(11):5175-5179. see summary.

Grady, D., Halloran, B., Cummings, S., Leveille, S., Wells, L., Black, D., and Byl, N. 1,25-dihydroxyvitamin d3 and muscle strength in the elderly: a randomized controlled trial. jclin endocrinol.metab 1991;73(5):1111-1117. see summary.

great, n. c., breitling, l. p., and brenner, h. vitamin d and cardiovascular disease: systematic review and meta-analysis of prospective studies. prev.med 2010;51(3-4):228-233. see summary.

great, n. c., breitling, l. p., vossen, c. Y., Hahmann, H., Wusten, B., Marz, W., Rothenbacher, D., and Brenner, H. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary artery disease. i am heart j 2010;159(6):1044-1051. see summary.

grant, w. b. a meta-analysis of second cancers after a diagnosis of non-melanoma skin cancer: further evidence that solar ultraviolet-b irradiation reduces the risk of internal cancers. j steroid biochem.mol.biol. 2007;103(3-5):668-674. see summary.

grant, w. b. and garland, c. F. A critical review of studies on vitamin d in relation to colorectal cancer. nutrcancer 2004;48(2):115-123. see summary.

grant, w. b. relationship between the prediagnostic serum level of 25-hydroxyvitamin d and the incidence of breast, colorectal and other cancers. j photochem.photobiol.b 2010-3-11;101(2):130-136. see summary.

grant, w. b., garland, c. f., and gorham, e. d. An estimate of cancer death rate reductions in Europe and the United States with 1000 IU of oral vitamin D per day. recent results cancer res 2007;174:225-234. see summary.

Green, C., Ganpule, M., Harris, D., Kavanagh, G., Kennedy, C., Mallet, R., Rustin, M. and downes, b. Comparative effects of calcipotriol (mc903) solution and placebo (mc903 vehicle) in the treatment of psoriasis of the scalp. br j dermatol 1994;130(4):483-487. see summary.

greenbaum, l. a., benador, n., goldstein, s. L. Walls, A. Melnick, J. Z., Mattingly, S., Amdahl, M., Williams, L. a., and salusky, i. b. Intravenous paricalcitol for the treatment of secondary hyperparathyroidism in children on hemodialysis. i am j kidney disease. 2007;49(6):814-823. see summary.

greenbaum, l. A. Grenda, R. Qiu, P. Restaino, I. Wojtak, A. Paredes, A. Benador, N. Melnick, J. Z., Williams, L. a., and salusky, i. b. Intravenous calcitriol for the treatment of hyperparathyroidism in children on hemodialysis. pediatricr.nephrol 2005;20(5):622-630. see summary.

greenspan, s. L., Bhattacharya, R. k., sereika, s. M., Brufsky, A., and Vogel, V. g. Prevention of bone loss in breast cancer survivors: a randomized, double-blind, placebo-controlled clinical trial. jclin endocrinol.metab 2007;92(1):131-136. see summary.

greenspan, s. L., Nelson, J. b., trump, d. l., and resnick, b. meter. Effect of once weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. ann.intern.med. 3-20-2007;146(6):416-424. see summary.

grieger, j. a., now son, c. a., jarman, h. f., malon, r., and ackland, l. meter. Multivitamin supplementation improves nutritional status and bone quality in elderly care residents. eur.j.clin.nutr. 2009;63(4):558-565. see summary.

grotz, w. h., rump, l. C. Niessen, A. Schmidt-Gayk, H. Reichelt, A. Kirste, G. Olschewski, M. and Schollmeyer, p. J. Treatment of osteopenia and osteoporosis after renal transplantation. transplant 10-27-1998;66(8):1004-1008. see summary.

Grotz, W., Nagel, C., Poeschel, D., Cybulla, M., Petersen, K. G., Uhl, M., Strey, C., Kirste, G., Olschewski, M., Reichelt, A., and Rump, L. c. Effect of Ibandronate on Bone Loss and Kidney Function After Kidney Transplantation. j am soc nephrol 2001;12(7):1530-1537. see summary.

grove, or. and half, b. Osteoporotic Back Pain Relief with Fluoride, Calcium, and Calciferol. record med.scan. 1981;209(6):469-471. see summary.

grozdev, i. s., van voorhees, a. s., gottlieb, a. b., hsu, s., lebwohl, m. eg, I drink, b. f., jr., and korman, b. J. Psoriasis in the Elderly: From the National Psoriasis Foundation Medical Board. j am acad.dermatol. 2011;65(3):537-545. see summary.

Guenther, L., van de Kerkhof, p. C. Snellman, E. Kragballe, K. Chu, A. C., Tegner, E., Garcia-Diez, A., and Springborg, J. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared with calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. br j dermatol 2002;147(2):316-323. see summary.

guillemant, j., le, h. T., Maria, A., Allemandou, A., Peres, G., and Guillemant, S. Wintertime vitamin d deficiency in adolescent males: effect on parathyroid function and response to vitamin d3 supplementation. osteoporosis int 2001;12(10):875-879. see summary.

Gulati, S., Sharma, R. K. Gulati K. Singh U. and Srivastava A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin d supplementation. nephrol.dial.transplantation. 2005;20(8):1598-1603. see summary.

Gupta R. Sharma U. Gupta N. Kalaivani M. Singh U. Guleria R. Jagannathan N. r., and gosvami, r. Effect of cholecalciferol and calcium supplementation on muscle strength and energy metabolism in Asian Indians with vitamin D deficiency: a randomized controlled trial. clin endocrinol (oxf) 2010;73(4):445-451. see summary.

Haas M, Leko-Mohr Z, Roschger P, Kletzmayr J, Schwarz C, Mitterbauer C, Steininger R, Grampp S, Klaushofer K, Delling, G. and Oberbauer, R. Zoledronic acid to prevent bone loss in the first 6 months after kidney transplantation. kidney int 2003;63(3):1130-1136. see summary.

haggerty, l. I Maternal supplementation for the prevention and treatment of vitamin d deficiency in exclusively breastfed infants. breastfeed.med 2011;6:137-144. see summary.

haiyang, zhou and chenggang, xu. Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized controlled trials. clin nephrol. 2009;71(3):276-285. see summary.

halsall, j. a., osborne, j. E. Potter L. Pringle J. h., and hutchinson, p. me. A novel polymorphism in the vitamin D receptor 1a promoter region is associated with altered susceptibility and prognosis in malignant melanoma. br. j cancer 2004-16-8;91(4):765-770. see summary.

hamdy, b. a., kanis, j. a., beneton, m. n., brown, c. b., juttmann, j. R., Jordan, J. G., Josse, S., Meyrier, A., Lins, R. l., and fairey, i. t. Effect of alfacalcidol on the natural course of renal bone disease in mild to moderate renal failure. bmj 11-2-1995;310(6976):358-363. see summary.

hand wrist, h. update of a systematic review of vitamin d for the prevention of osteoporotic fractures. inj.prev. 2009;15(3):213. see summary.

handunnetthi, l., ramagopalan, s. v., and ebers, g. c. multiple sclerosis, vitamin d and hla-drb1*15. neurology 8-6-2010;74(23):1905-1910. see summary.

hansson, t. and ros, b. The effect of fluoride and calcium on spinal bone mineral content: a controlled prospective study (3 years). calcif tissue int 1987;40(6):315-317. see summary.

hargreaves, j. a. and Thompson, G. w. ultraviolet light and dental caries in children. caries res 1989;23(5):389-392. see summary.

harris, s. yes and Dawson Hughes, B. plasma vitamin d and 25ohd responses of young and elderly men to vitamin d3 supplementation. j am coll nutr 2002;21(4):357-362. see summary.

hartman, t. j., albert, p. S., Snyder, K., Slattery, M. L. Caan, B. Paskett, E. Iber, F. Kikendall, J. W. Marshall J. Shike M. Weissfeld J. Brewer B. Schatzkin A. and Lance E. The association of calcium and vitamin D with risk of colorectal adenomas. jnutr 2005;135(2):252-259. see summary.

Hartmann, A., Lurz, C., Hamm, H., Brocker, E. b., and hofmann, u. b. 311nm narrowband uvb versus broadband uvb treatment in combination with topical calcipotriol versus placebo in vitiligo. int j dermatol. 2005;44(9):736-742. see summary.

harwood, r. H., Sahota, O., Gaynor, K., Masud, T., and Hosking, D. J. A randomized controlled comparison of different calcium and vitamin d supplementation regimens in elderly women after hip fracture: the nottingham neck of femur (nonof) study. age aging 2004;33(1):45-51. see summary.

haseen, f., murray, l. j., o’neill, r. f., o’sullivan, j. m., and cantwell, m. meter. a randomized controlled trial to assess the efficacy of a 6-month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy. essays 2010;11:86. see summary.

haugen, m., brantsaeter, a. L., Trogstad, L., Alexander, J., Roth, C., Magnus, P., and Meltzer, H. meter. Vitamin d supplementation and reduced risk of preeclampsia in nulliparous women. epidemiology 2009;20(5):720-726. see summary.

Haworth, c. S., Jones, A. M., Adams, J. eg, selby, p. l., and webb, a. k. randomized double-blind placebo-controlled trial investigating the effect of calcium and vitamin d supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. j cyst.fibros. 2004;3(4):233-236. see summary.

hayashi y, fujita t and inoue t. reduction of vertebral fracture in osteoporosis through the administration of 1a-hydroxy-vitamin d3. jbmm 1992;10:184-188.

healey, j. h., paget, s. A. Williams-Russo, P. Szatrowski, T. P., Schneider R., Spiera H., Mitnick H., Ales K., and Schwartzberg P. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. calcif tissue int 1996;58(2):73-80. see summary.

heaney, r. p. Does inconclusive evidence for vitamin d supplementation to reduce cardiovascular disease risk warrant pessimism? ann.intern med 3-8-2010;153(3):208-209. see summary.

heaney, r. p. Functional indices of vitamin d status and ramifications of vitamin d deficiency. am j clin.nutr 2004;80(6 suppls):1706s-1709s. see summary.

heaney, r. p., arms, l. a., shary, j. r., bell, n. H., Binkley, N., and Hollis, B. w. 25-hydroxylation of vitamin d3: relationship to circulating vitamin d3 under various input conditions. am j clin nutr 2008;87(6):1738-1742. see summary.

heaney, r. p., davies, k. m., chen, t. c., holick, m. f., and barger-lux, m. J. Human serum 25-hydroxycholecalciferol response to prolonged oral dosing with cholecalciferol. I am j clin nutr 2003;77(1):204-210. see summary.

heikkinen, a. m., tuppurainen, m. T., Niskanen L., Komulainen M., Penttila I., and Saarikoski S. Long-term supplementation with vitamin D3 may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. eur j endocrinol. 1997;137(5):495-502. see summary.

robbery, r. S. Zhou W. Wang Z. Liu G. Neuberg D. Su L. Hoovering K. Hollis B. w., lynch, t. j., wain, j. c., giovannucci, e., and christiani, d. c. Circulating 25-hydroxyvitamin d, vdr polymorphisms, and survival in advanced non-small cell lung cancer. jclin.oncol. 12-1-2008;26(34):5596-5602. see summary.

helliwell, p. s., ibrahim, g. H., Karim Z., Sokoll K., and Johnson H. Unexplained musculoskeletal pain in people of South Asian ethnicity referred to a rheumatology clinic – relationship with biochemical osteomalacia, persistence over time, and response to treatment with calcium and vitamin d. clin.exp.rheumatol. 2006;24(4):424-427. see summary.

henderson nk, marshall g, sambrook pn, keogh a, and eisman ja. prevention of bone loss after a heart or lung transplant. j bone miner res 2011;12(suppl):s400.

Henderson, K., Eisman, J., Keogh, A., Macdonald, P., Glanville, A., Spratt, P. and sambrook, p. Protective effect of short-term calcitriol or cyclic etidronate on bone loss after heart or lung transplantation. j bone miner res 2001;16(3):565-571. see summary.

hewison, m. vitamin d and the immune system: new perspectives on an old topic. endocrinol.metab clin north am 2010;39(2):365-79, table. see summary.

highton, a. and suffocate, j. Calcipotriene 0.005% ointment for psoriasis: a safety and efficacy study. calcipotriene study group. j am acad dermatol 1995;32(1):67-72. see summary.

rental math, g. S. Cettomai D. Baynes M. Ratchford J. N. Newsome S. Harrison D. Kerr D. Greenberg B. m., and Calabresi, p. a. Vitamin d status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. mul.scler. 2009;15(6):735-740. see summary.

hodson, e. m., evans, r. a., dunstan, c. R. Hills, E. Wong, S. and., Rosenberg, a. R., and Roy, L. p. treatment of infantile renal osteodystrophy with calcitriol or ergocalciferol. clin nephrol 1985;24(4):192-200. see summary.

hoikka, v., alhava, e. m., savolainen, k., and parviainen, m. osteomalacia in fractures of the proximal femur. acta orthop.scand 1982;53(2):255-260. see summary.

holick mf. vitamin d: the underrated d-lightful hormone that is important for skeletal and cellular health. curr opin endocrinol diabetes 2002;9:87-98.

holick, m. f., biancuzzo, r. m., chen, t. c., klein, e. K. Young A. Bibuld D. Reitz R. Salameh W. Ameri A. and Tannenbaum A. d. vitamin d2 is as effective as vitamin d3 in maintaining circulating concentrations of 25-hydroxyvitamin d. jclin.endocrinol.metab 2008;93(3):677-681. see summary.

Dutch f. coordinated report of the columbia university dental caries research group. j dent res. 1934; 14:303-313.

holm, e. a. and Jemech, G. b. The therapeutic potential of calcipotriol in diseases other than psoriasis. int j dermatol 2002;41(1):38-43. see summary.

holmoy, t., kampman, m. t., and smolders, j. vitamin d in multiple sclerosis: implications for evaluation and treatment. expert.rev.neurotro. 2012;12(9):1101-1112. see summary.

holt, p. R. Arber N. Halmos B. Forde K. Kissileff H. McGlynn K. a., moss, s. f., kurihara, n., fan, k., yang, k., and lipkin, m. colonic epithelial cell proliferation decreases with increasing serum levels of 25-hydroxyvitamin d. cancer epidemiol. biomarkers ant. 2002;11(1):113-119. see summary.

holt, p. r., bresalier, r. s., ma, c. k., liu, k. f., lipkin, m., byrd, j. c., and yang, k. calcium plus vitamin d alters the preneoplastic features of colorectal adenomas and rectal mucosa. cancer 1-15-2006;106(2):287-296. see summary.

holzbeierlein, j. meter. the management of complications of androgen deprivation therapy for prostate cancer. urol.clin.north am 2006;33(2):181-90, vi. see summary.

holzbeierlein, j. m., castle, e., and thrasher, j. b. Complications of androgen deprivation therapy: prevention and treatment. oncology (williston.park) 2004;18(3):303-309. see summary.

homik, j. E. Cranney A. Shea B. Tugwell P. Wells G. Adachi J. d., and suárez-almazor, m. me. a meta-analysis on the use of bisphosphonates in corticosteroid-induced osteoporosis. j rheumatol 1999;26(5):1148-1157. see summary.

Honkanen, R., Alhava, E., Parviainen, M., Talasniemi, S., and Monkkonen, R. the need for and safety of calcium and vitamin d in the elderly. j am geriatric soc 1990;38(8):862-866. see summary.

hopkins, b. and butler, d. outpatient thyroid surgery and the advances that make it possible. curr opin.otolaringol.head neck surgery. 2009;17(2):95-99. see summary.

hosking, d., children, c. E., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., and Yates, A. J. prevention of bone loss with alendronate in postmenopausal women younger than 60 years. early postmenopausal intervention cohort study group. n.engl.jmed 2-19-1998;338(8):485-492. see summary.

hosono, s., matsuo, k., kajiyama, h., hirose, k., suzuki, t., kawase, t., kidokoro, k., nakanishi, t., hamajima, n., kikkawa, f., tajima, k., and tanaka, h. Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. eur j clin nutr 2010;64(4):400-409. see summary.

although, j. p., boyd, r. n., and keating, j. I systematic review of interventions for low bone mineral density in children with cerebral palsy. pediatrics 2010;125(3):e670-e678. see summary.

hovdenak, b. and Haram, K. Influence of mineral and vitamin supplements on pregnancy outcome. eur j obstet.gynecol.reprod.biol. 2012;164(2):127-132. see summary.

hubbell rb, bunting rw. Calcium and phosphorous in saliva in relation to dental caries. j nourish 1932;5:599-605.

huckins, d., felson, d. t., and holick, m. treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin d3: a pilot study. rheumatic arthritis. 1990;33(11):1723-1727. see summary.

hujoel, p. p. vitamin d and dental caries in controlled clinical trials: systematic review and meta-analysis. rev nutrition 2013;71(2):88-97. see summary.

hulshof, m. m., bouwes bavinck, j. N. Bergman W. Masclee A. A. Heickendorff L. Breedveld F. c., and dijkmans, b. a. Double-blind, placebo-controlled study of oral calcitriol for the treatment of systemic and localized scleroderma. j am acad dermatol 2000;43(6):1017-1023. see summary.

hulshof, m. m., pavel, s., breedveld, f. c., dijkmans, b. a., and vermeer, b. J. Oral calcitriol as a new therapeutic modality for generalized morphea. arc dermatol 1994;130(10):1290-1293. see summary.

Humbert, P., Dupond, J. L. Duck P. Laurent R. Rochefort A. Drobacheff C. De Wazieres B. and Aubin F. treatment of scleroderma with oral 1,25-dihydroxyvitamin d3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial. acta derm.venereol. 1993;73(6):449-451. see summary.

huncharek, m., muscat, j., and kupelnick, b. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. nutrcancer 2009;61(1):47-69. see summary.

huncharek, m., muscat, j., and kupelnick, b. Impact of dairy products and dietary calcium on bone mineral content in children: results of a meta-analysis. bone 2008;43(2):312-321. see summary.

Hunter D, Major P, Arden N, Swaminathan R, Andrew T, Macgregor A. J., Sharp, R., Snieder, H., and Spector, T. d. A randomized controlled trial of vitamin d supplementation to prevent postmenopausal bone loss and modify bone metabolism using pairs of identical twins. j bone miner.res 2000;15(11):2276-2283. see summary.

hutchinson, p. e., marks, r., and white, j. The efficacy, safety, and tolerability of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. dermatology 2000;201(2):139-145. see summary.

hyponen, e. and power, c. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. diabetes care 2006;29(10):2244-2246. see summary.

imanishi, and. and nishizawa, and. [activate vitamin d3 or bisphosphonate in glucocorticoid-induced osteoporosis]. clin calcium 2006;16(11):1844-1850. see summary.

Inkovaara, J., Gothoni, G., Haltula, R., Heikinheimo, R., and Tokola, O. Calcium, vitamin d, and anabolic steroids in the treatment of aging bones: long-term, double-blind, placebo-controlled clinical trial. age aging 1983;12(2):124-130. see summary.

inoue, d. [Evidence for the efficacy of active vitamin d3 as an antiosteoporotic drug]. clin calcium 2008;18(10):1469-1475. see summary.

iqbal, s. F. and freishtat, R. J. mechanism of action of vitamin d in the asthmatic lung. j investigag.med. 2011;59(8):1200-1202. see summary.

irlam, j. h., visser, m. m., rollins, n. n., and siegfried, n. Micronutrient supplementation in children and adults with HIV infection. cochrane.database.syst.rev. 2010;(12):cd003650. see summary.

ishida, and. and Kawai, S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: the Yamaguchi osteoporosis prevention study. am.j.med. 10-15-2004;117(8):549-555. see summary.

israeli, r. s., rosenberg, s. j., saltzstein, d. R., Gottesman, J. e., goldstein, h. r., helmet, g. w., tran, d. n., warsi, g. m., and lacerna, l. v. the effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. clin.genitourin.cancer 2007;5(4):271-277. see summary.

israeli, r. S., Ryan, C. W., and Jung, L. I management of bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. jurol. 2008;179(2):414-423. see summary.

itsiopoulos, c., hodge, a., and kaimakamis, m. Can the Mediterranean diet prevent prostate cancer? mol.nutr.food res. 2009;53(2):227-239. see summary.

Iwasaki, T., Takei, K., Nakamura, S., Hosoda, N., Yokota, Y. and ishii, m. Secondary osteoporosis in long-term bedridden patients with cerebral palsy. pediatrician int 2008;50(3):269-275. see summary.

izaks, g. J. Fracture prevention with vitamin d supplementation: considering inconsistent results. bmc. musculoskeletal disorder. 2007;8:26. see summary.

jackson, c., gaugris, s., sen, s. s., and hosking, d. The effect of cholecalciferol (vitamin d3) on fall and fracture risk: a meta-analysis. qjm. 2007;100(4):185-192. see summary.

jagannath, v. a., fedorowicz, z., asokan, g. v., robak, e. w., and whamond, l. vitamin d for the treatment of multiple sclerosis Cochrane database system rev 2010;(12):cd008422. see summary.

jameson ab, cox h. clinical note on vitamin d and dental caries. n z mid j. 1933; 32:41-42.

janssen, h. c., Samson, m. m., and verhaar, h. J. Muscle strength and mobility in geriatric female patients with vitamin d insufficiency: a randomized controlled trial of vitamin d and calcium supplementation. clin aging exp.res 2010;22(1):78-84. see summary.

Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M. and lambrechts, d. Vitamin D deficiency is very common in COPD and correlates with variants in the vitamin D-binding gene. thorax 2010;65(3):215-220. see summary.

javanbakht, m. h., keshavarz, s. a., djalali, m., siassi, f., eshraghian, m. R. Firooz A. Seirafi H. Ehsani A. h., chamari, m., and mirshafiey, a. Randomized controlled trial using vitamin E and D supplementation in atopic dermatitis. j dermatolog.treat. 2011;22(3):144-150. see summary.

jean, g., terrat, j. c., vanel, t., hurot, j. m., lorriaux, c., mayor, b., and chazot, c. Daily oral supplementation of 25-hydroxycholecalciferol for vitamin d deficiency in hemodialysis patients: effects on mineral metabolism and bone markers. nephrol.dial.transplantation. 2008;23(11):3670-3676. see summary.

jean, g., vanel, t., terrat, j. c., and chazot, c. prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin d supplementation. hemodial.int 2010;14(4):486-491. see summary.

jeffcoat, m. The association between osteoporosis and oral bone loss. j periodontol. 2005;76(11 suppls):2125-2132. see summary.

jeffery, j. R., Leslie, W. d., karpinski, m. e., Nickerson, p. w., and haste, d. north. prevalence and treatment of decreased bone density in kidney transplant recipients: a prospective randomized trial of calcitriol versus alendronate. transplant 11-27-2003;76(10):1498-1502. see summary.

jekler, j. and Swanbeck, G. One-minute dithranol therapy in psoriasis: a placebo-controlled matched comparison study. acta derm.venereol. 1992;72(6):449-450. see summary.

Jekovec-vrhovsek, M., Kocijancic, A., and Prezelj, J. Effect of vitamin d and calcium on bone mineral density in children with pc and epilepsy in full-time care. dev.med child neurol. 2000; 42 (6): 403-405. see summary.

Jensen C, Holloway L, Block G, Spiller G, Gildengorin G Long-Term Effects of Nutrient Intervention on Markers of Bone Remodeling and Calciotropic Hormones in Late Postmenopausal Women . am j clin nutr 2002; 75 (6): 1114-1120. see summary.

jensen, g. f., christiansen, c., and transbol, i. treatment of postmenopausal osteoporosis. a controlled therapeutic trial comparing estrogen/gestagen, 1,25-dihydroxy-vitamin d3, and calcium. clin endocrinol (oxf) 1982; 16 (5): 515-524. see summary.

jensen, g. f., meinecke, b., boesen, j., and transbol, i. Does 1.25(oh)2d3 accelerate spinal bone loss? a controlled therapeutic trial in 70-year-old women. clin orthop.relat res 1985;(192):215-221. see summary.

johnson, k. R., J. Jobber, and B. Stonewski. J. prophylactic vitamin d in the elderly. age aging 1980;9(2):121-127. see summary.

jones, c. L., Vieth, R., Spino, M., Ledermann, S., Kooh, S. w., balfe, j., and balfe, j. w. comparisons between oral and intraperitoneal therapy with 1,25-dihydroxyvitamin d3 in children treated with peritoneal dialysis. clin nephrol 1994;42(1):44-49. see summary.

jorde, r. and Figenschau, and. Cholecalciferol supplementation does not improve glycemic control in diabetic subjects with normal serum levels of 25-hydroxyvitamin D. eur j nutr 2009;48(6):349-354. see summary.

Jorde, R., Figenschau, Y., Hutchinson, M., Emmaus, N., and Grimnes, G. high serum concentrations of 25-hydroxyvitamin d are associated with a favorable serum lipid profile. eur.jclin.nutr 2010;64(12):1457-1464. see summary.

Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J. and Waterloo, K. Effects of vitamin d supplementation on symptoms of depression in overweight and obese subjects: double-blind randomized trial. j internal.med. 2008;264(6):599-609. see summary.

jorde, r., sneve, m., torjesen, p. and Figenschau, and. No improvement in cardiovascular risk factors in overweight and obese subjects after vitamin d3 supplementation for 1 year. jintern med 2010;267(5):462-472. see summary.

jorgensen, s. P., Agnholt, J., Glerup, H., Lyhne, S., Villadsen, G. eg, hvas, c. L., Bartels, L. E. Kelsen J. Christensen L. a., and dahlerup, j. F. clinical trial: vitamin d3 treatment in crohn’s disease: a randomized, double-blind, placebo-controlled study. aliment.pharmacol ther. 2010;32(3):377-383. see summary.

judd, s. e., nanese, m. S., Ziegler, T. r., wilson, p. w., and tangpricha, v. Optimal vitamin d status attenuates age-associated increase in systolic blood pressure in white Americans: results from the third national health and nutrition examination survey. am j clin nutr 2008;87(1):136-141. see summary.

jundell i, hanson r sandberg t. stoffwechsel im zahnschmelz und prophylaxe gegen zahncaries [in German]. pediatric record. 1938; 23:141.

juttmann jr and birkenhager jc. treatment of predialysis renal bone disease (rbd) with 1alpha (oh) vitamin d3 and 1,25-(oh) 2 vitamin d3. dutch journal of medicine 1979;22(5):172.

Kalra P. Das V. Agarwal A. Kumar M. Ramesh V. Bhatia E. Gupta S. Singh S. Saxena P. and bhatia, v. Effect of vitamin d supplementation during pregnancy on neonatal mineral homeostasis and anthropometry of the newborn and infant. br.j nutr 2012-9-28;108(6):1052-1058. see summary.

kalyani, r. R. Stein B. Valiyil R. Manno R. Maynard J. w., and crews, d. c. Vitamin d treatment for fall prevention in older adults: systematic review and meta-analysis. j am geriatr soc 2010;58(7):1299-1310. see summary.

Kanaji, A., Higashi, M., Namisato, M., Nishio, M., Ando, ​​K., and Yamada, H. Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fractures in elderly male patients with leprosy. lepr.rev 2006;77(2):147-153. see summary.

Kananen, K., Volin, L., Laitinen, K., Alfthan, H., Ruutu, T. and Valimaki, M. J. prevention of bone loss after allogeneic stem cell transplantation using calcium, vitamin d, and sex hormone replacement with or without pamidronate. jclin endocrinol.metab 2005;90(7):3877-3885. see summary.

kandula, p., dobre, m., schold, j. d., schreiber, m. j., jr., mehrotra, r., and navaneethan, s. d. Vitamin d supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. clin j am soc nephrol. 2011;6(1):50-62. see summary.

kanis, j. a. and McCloskey, E. v. Effect of calcitonin on vertebral and other fractures. qjm. 1999;92(3):143-149. see summary.

kanis, j. A. Stevenson, M. McCloskey, E. V., Davis, S., and Lloyd-Jones, M. Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. health technology assessment. 2007;11(7):iii-xi, 1. see abstract.

karkkainen, m. K., Tuppurainen, M., Salovaara, K., Sandini, L., Rikkonen, T., Sirola, J., Honkanen, R., Arokoski, J., Alhava, E., and Kroger, H. Does daily supplementation with 800 iu of vitamin d and 1000 mg of calcium decrease the risk of falls in ambulatory women aged 65 to 71 years? a 3-year randomized population-based trial (ostpre-fps). maturitas 2010;65(4):359-365. see summary.

karpf, d. b., shapiro, d. R. Seeman, E. Ensrud, K. e., johnston, c. C., Jr., Adami, S., Harris, S. t., santora, a. c., hirsch, l. J., Oppenheimer, L., and Thompson, D. prevention of non-vertebral fractures by alendronate. a meta-analysis. alendronate osteoporosis treatment study groups. jam 9-4-1997;277(14):1159-1164. see summary.

catoh, n. and Kishimoto, S. combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis. eur.j dermatol. 2003;13(4):382-384. see summary.

kaufmann, r., bibby, a. J. Bissonnette, R. Cambazard, F. Chu, A. C. Decroix, J. Douglas, W. S., Lowson, D., Mascaró, J. m., murphy, g. m., and stymne, b. A new formulation of calcipotriol/betamethasone dipropionate (daivobet) is an effective once-daily treatment for psoriasis vulgaris. dermatology 2002;205(4):389-393. see summary.

kawaura a. Inhibitory effect of long-term administration of 1 alpha-hydroxyvitamin d3 in helicobacter pylori infection. jclin biochem nutr 2006;38:103-106.

kesse, e., boutron-ruault, m. c., norat, t., riboli, e., and carnation-chapelon, f. Dietary calcium, phosphorus, vitamin D, dairy products, and the risk of colorectal adenoma and cancer among French women in the e3n-epic prospective study. int j cancer 2005-20-10;117(1):137-144. see summary.

khajehdehi, p. and taheri, s. Effect of oral calcitriol pulse therapy on lipid, calcium, and glucose homeostasis of hemodialysis patients: its safety in combination with oral calcium carbonate. jrennutr 2003;13(2):78-83. see summary.

khajehdehi, p. Effect of vitamins on the lipid profile of patients on regular hemodialysis. scand.j urol.nephrol. 2000;34(1):62-66. see summary.

khoo, b. p., tay, y. k., and goh, c. I calcipotriol ointment versus betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. int j dermatol 1999;38(7):539-541. see summary.

kimball, s. m., ursell, m. r., o’connor, p., and vieth, r. safety of vitamin d3 in adults with multiple sclerosis. am j clin nutr 2007;86(3):645-651. see summary.

Kinney, D. K., Teixeira, P., Hsu, D., Napoleon, S. c., crowley, d. J., Miller, A., Hyman, W., and Huang, E. Relationship of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for vitamin D deficiency and prenatal infections? schizophrenia.bull. 2009;35(3):582-595. see summary.

Kirii, K., Mizoue, T., Iso, H., Takahashi, Y., Kato, M., Inoue, M., Noda, M. and tsugane, s. Calcium, vitamin D, and dairy intake in relation to risk of type 2 diabetes in a Japanese cohort. diabetology 2009;52(12):2542-2550. see summary.

kiss i, mccreary hl, siskin sb and epinette ww. a randomized, double-blind, parallel-group, dose-ranging comparison of the efficacy and safety of calcipotriene solution in the treatment of psoriasis of the scalp. American Academy of Dermatology, 54th Annual Meeting. nineteen ninety six;

Klaus G, Hinder J, Lingens B, Keuth B, Querfield U, and Mehls O. comparison of intermittent and continuous (daily) oral calcitriol for the treatment of renal hyperparathyroidism in children on dialysis vitamin d compounds for people with chronic kidney disease requiring dialysis. pediatric nephrology 1995;9(6):c75.

Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M, Rissanen H, Montonen J. and meet, a. Serum vitamin D and subsequent development of type 2 diabetes. Epidemiology 2008;19(5):666-671. see summary.

Koc, M., Tuglular, S., Arikan, H., Ozener, C., and Akoglu, E. alendronate increases bone mineral density in long-term kidney transplant recipients. transplant.proc. 2002;34(6):2111-2113. see summary.

koeffler, h. p., aslanian, n., and o’kelly, j. vitamin d(2) analog (paricalcitol; zemplar) for the treatment of myelodysplastic syndrome. leuk.res 2005;29(11):1259-1262. see summary.

komulainen, m. H. Kroger H. Tuppurainen M. t., heikkinen, a. m., alhava, e., honkanen, r., and saarikoski, s. hrt and vit d in the prevention of non-vertebral fractures in postmenopausal women; a 5-year randomized trial. mature 11-30-1998;31(1):45-54. see summary.

komulainen, m., kroger, h., tuppurainen, m. t., heikkinen, a. m., alhava, e., honkanen, r., jurvelin, j., and saarikoski, s. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin d3 in early postmenopausal women: a 5-year population-based randomized trial. j clin endocrinol metab 1999;84(2):546-552. see summary.

Kovac, D., Lindic, J., Kandus, A., and Bren, A. F. Prevention of bone loss in renal graft recipients. transplant.proc 2001;33(1-2):1144-1145. see summary.

Kragballe K, Beck Hi, and Søgaard H. improvement of psoriasis by a topical analogue of vitamin d3 (mc 903) in a double-blind study. British Journal of Dermatology 1988; 119 (2): 223-230.

Kragballe, K., Barnes, L., Hamberg, K. J., P. Hutchinson, F. Murphy, S. Moller, T. Ruzicka, and P. van de Kerkhof. c. Calcipotriol cream with or without concurrent topical corticosteroids in psoriasis: tolerability and efficacy. br.j dermatol. 1998;139(4):649-654. see summary.

Kragballe, K., Gjertsen, B. t., de, hoop d., karlsmark, t., van de kerkhof, p. C. Larko O. Nieboer C. Roed-Petersen J. Strand A. and Tikjob G. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in the treatment of psoriasis vulgaris. Lancet 1-26-1991;337(8735):193-196. see summary.

Kragballe, K., Noerrelund, K. L., Lui, H., Ortonne, J. P., Wozel, G., Uurasmaa, T., Fleming, C., Estebaranz, J. l., hanssen, l. i., and person, l. meter. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. br j dermatol 2004;150(6):1167-1173. see summary.

Kragballe, K., Steijlen, P. m., ibsen, h. h., van de Kerkhof, p. C., Esmann, J., Sorensen, L. h., and axelsen, m. b. Efficacy, tolerability, and safety of calcipotriol ointment in keratinization disorders. results of a randomized, double-blind, vehicle-controlled, right/left comparative study. arc dermatol 1995;131(5):556-560. see summary.

Krause R, Buhring M, Hopfenmüller W, Holick M. f., and Sharma, a. meter. ultraviolet b and blood pressure. Lancet 8-29-1998;352(9129):709-710. see summary.

krieg, m. a., jacket, a. f., bremgartner, m., cuttelod, s., thiebaud, d., and burckhardt, p. Effect of vitamin d3 and calcium supplementation on quantitative bone ultrasound in institutionalized older women: a longitudinal study. osteoporos.int 1999;9(6):483-488. see summary.

kriegel, m. a., manson, j. e., and costenbader, k. h. Does vitamin d affect the risk of developing an autoimmune disease?: a systematic review. semin.arthritis rheum. 2011;40(6):512-531. see summary.

kriesel, j. d. and Spruance, J. Calcitriol (1,25-dihydroxy-vitamin D3) co-administered with influenza vaccine does not enhance humoral immunity in human volunteers. vaccine 4-9-1999;17(15-16):1883-1888. see summary.

kukuljan, s., nowson, c. a., low, s. L., Sanders, K., Nicholson, G. c., seibel, m. J., Salmon, J., and Daly, R. meter. Effects of a multicomponent exercise program and calcium-vitamin-d3 fortified milk on bone mineral density in older men: a randomized controlled trial. osteoporos.int 2009;20(7):1241-1251. see summary.

kumaran, m. s., kaur, i., and kumar, b. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. j eur acad dermatol venereol. 2006;20(3):269-273. see summary.

laaksi, i., ruohola, j. P., Mattila, V., Auvinen, A., Ylikomi, T., and Pihlajamaki, H. Vitamin d supplementation for the prevention of acute respiratory tract infection: a randomized, double-blind trial among young Finnish men. j infect.dis. 1-9-2010;202(5):809-814. see summary.

laaksonen, m. A. Knekt P. Rissanen H. Harkanen T. Virtala E. Marniemi J. Aromaa A. Heliovaara M. and Reunanen A. The relative importance of potential modifiable risk factors for type 2 diabetes: a meta-analysis of two cohorts. eur j epidemiol. 2010;25(2):115-124. see summary.

lacroix, a. Z., Kotchen J., Anderson G., Brzyski R., Cauley J. a., cummings, s. R., Gass, M., Johnson, K. C., Ko, M., Larson, J., Manson, J. E., Stefanick, M. L., and Wactawski-wende, J. Calcium plus vitamin d supplementation and mortality in postmenopausal women: the women’s health initiative calcium-vitamin d randomized controlled trial. j gerontol to biol.sci.med.sci. 2009;64(5):559-567. see summary.

lagunova, z., porojnicu, a. c., grant, w. b., bruland, o., and moan, j. me. obesity and increased risk of cancer: does the decrease in the serum level of 25-hydroxyvitamin d with the increase in body mass index explain part of the association? mol. nutr food res 2010;54(8):1127-1133. see summary.

lai, j. K., Lucas, R. m., clementes, m. s., roddam, a. w., and banks, e. Hip fracture risk in relation to vitamin d supplementation and serum 25-hydroxyvitamin d levels: a systematic review and meta-analysis of randomized controlled trials and observational studies. bmc. public health 2010;10:331. see summary.

lakatos p, kiss l, horvath c, takacs i, foldes j, bossanyi a and major t. prevention of corticosteroid-induced osteoporosis with alfacalcidol. lege artis med 1996;6:624-629.

Lakatos, P., Nagy, Z., Kiss, L., Horvath, C., Takacs, I., Foldes, J., Speer, G., and Bossanyi, A. prevention of corticosteroid-induced osteoporosis by alfacalcidol. z reumatol 2000;59 supplement 1:48-52. see summary.

lambrinoudaki, i., chan, d. t., lau, c. s., wong, r. w., young, s. s., and kung, a. w. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. a randomized, double-blind, placebo-controlled study. j rheumatol 2000;27(7):1759-1765. see summary.

lamke, b., sjoberg, h. e., and sylven, m. Bone mineral content in women with colles fracture: effect of calcium supplementation. acta orthop.scan. 1978;49(2):143-146. see summary.

langner a, verjans h, stapor v, mol m, and fraczykowska m. 1 alpha,25-dihydroxyvitamin d-3 (calcitriol) ointment in psoriasis. journal of dermatological treatment 1992;3(4):177-180.

Langner, A., Stapor, W., and Ambroziak, M. Efficacy and tolerability of topical calcitriol 3 microg g(-1) in the treatment of psoriasis: a review of our experience in Poland. br j dermatol 2001;144 suppl 58:11-16. see summary.

lansdowne, a. t. and provost, yes. c. vitamin d3 improves mood in healthy subjects during winter. psychopharmacology (berl) 1998;135(4):319-323. see summary.

larsen er, mosekilde l and foldspang a. Vitamin D and calcium treatment and environmental adjustment in the prevention of falls and osteoporotic fractures among elderly Danish community residents. j bone miner res 2002;17:1137.

larsen, e. r., mosekilde, l., and foldspang, a. Vitamin d and calcium supplementation prevent serious falls in elderly women living in the community: a pragmatic 3-year population-based intervention study. clin aging exp.res 2005;17(2):125-132. see summary.

larsson, s. c., bergkvist, l., and wolk, a. Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. am j clin nutr 2009;89(1):277-282. see summary.

latham, b. k., anderson, c. s., and reid, i. r. Effects of vitamin d supplementation on strength, physical performance, and falls in older people: a systematic review. j am geriatric soc 2003;51(9):1219-1226. see summary.

latham, b. k., anderson, c. S. Lee, A. Bennett, D. A., Moseley, A., and Cameron, I. d. A randomized controlled trial of quadriceps resistance exercise and vitamin d in frail older people: the Frailty Interventions in Older Subjects (Physical Fitness) trial. j am geriatric soc 2003;51(3):291-299. see summary.

lau, e. m., woo, j., lam, v., and hong, a. Milk supplementation of the diet of postmenopausal Chinese women with low calcium intake slows bone loss. j bone miner.res 2001;16(9):1704-1709. see summary.

lau, e. m., woo, j., leung, p. c., swaminathan, r., and leung, d. the effects of calcium supplementation and exercise on bone density in elderly Chinese women. osteoporos.int 1992;2(4):168-173. see summary.

lau, e. m., woo, j., swaminathan, r., macdonald, d., and donnan, s. p. Plasma concentration of 25-hydroxyvitamin d in patients with hip fracture in Hong Kong. gerontology 1989;35(4):198-204. see summary.

law, m., withers, h., morris, j. and Anderson, F. Vitamin d supplementation and the prevention of fractures and falls: results of a randomized trial in older people in residential accommodation. age aging 2006;35(5):482-486. see summary.

lazzeroni, m., gandini, s., puntoni, m., bonanni, b., gennari, a., and decensi, a. the science behind vitamins and natural compounds for breast cancer prevention. get the most out of prevention. mama 2011;20 supplement 3:s36-s41. see summary.

lebret, t., coloby, p., descotes, j. l., droupy, s., geraud, m., and tombal, b. diet and exercise educational toolkit: survey of prostate cancer patients about to receive androgen deprivation therapy. urology 2010;76(6):1434-1439. see summary.

lehtonen-veromaa, m. K., Mottonen, T. t., nuotio, i. o., irjala, k. m., leino, a. e., and viikari, j. yes Vitamin D and peak bone mass achievement among peripubertal Finnish girls: a 3-year prospective study. am j clin nutr 2002;76(6):1446-1453. see summary.

lems wf, jacobs jwg, bijlsma jwj, croone a, houben hhml, and haanen hcm. corticosteroids and bone [thesis]. utrecht (the netherlands): univ. from utrecht. nineteen ninety six;

Leone, G., Pacifico, A., Iacovelli, P., Paro, Vidolin A., and Picardo, M. tacalcitol and narrowband phototherapy in patients with vitiligo. clin exp.dermatol 2006;31(2):200-205. see summary.

Lepore, L., Pennesi, M., Barbi, E., and Pozzi, R. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. clin exp.rheumatol 1991;9 supplement 6:33-35. see summary.

lerchbaum, e. and Obermayer-Pietsch, B. vitamin d and fertility: a systematic review. eur.j endocrinol. 2012;166(5):765-778. see summary.

levis, s. and Theodore, G. summary of the ahrq comparative review of the efficacy of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. j manag.care pharm 2012;18(4 suppl b):s1-15 . see summary.

leytin, v. and Beaudoin, F. I reduce hip fractures in the elderly. clin.interv.aging 2011;6:61-65. see summary.

li, x., liao, l., yan, x., huang, g., lin, j., lei, m., wang, x. and Zhou, Z. Protective effects of 1-alpha-hydroxyvitamin d3 on residual beta-cell function in patients with latent adult-onset autoimmune diabetes (ADA). diabetes metab res rev 2009;25(5):411-416. see summary.

li-ng, m., aloia, j. f. pollock, s. cunha, b. a., mikhail, m., yeh, j., and berbari, n. a randomized controlled trial of vitamin d3 supplementation for the prevention of symptomatic upper respiratory tract infections. epidemiol.infect. 2009;137(10):1396-1404. see summary.

lin, j., zhang, s. m., cook, n. R., Manson, J. eg, read, i. m., and buring, j. me. Calcium and vitamin D intake and colorectal cancer risk in women. i’m j epidemiology. 2005-4-15;161(8):755-764. see summary.

lin, yes. h., lin, y. f., lu, k. c., diang, l. k., chyr, s. h., liao, w. k., and shieh, s. d. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uremic patients with secondary hyperparathyroidism. clin.sci (london) 1994;87(5):533-538. see summary.

Lind, L., Litell, H., Skarfors, E., Wide, L., and Ljunghall, S. reduction of blood pressure by treatment with alfacalcidol. a double-blind, placebo-controlled study in subjects with glucose intolerance. acta med scand 1988;223(3):211-217. see summary.

Lind L. Pollare T. Hvarfner A. Litell H. Sorensen O. h., and ljunghall, s. Long-term treatment with active vitamin D (alfacalcidol) in middle-aged men with glucose intolerance. effects on insulin secretion and sensitivity, glucose tolerance, and blood pressure. diabetesres 1989;11(3):141-147. see summary.

lind, l., wengle, b., and ljunghall, s. Blood pressure is lowered with vitamin D (alfacalcidol) during long-term treatment of patients with intermittent hypercalcemia. a double-blind, placebo-controlled study. acta med scand 1987;222(5):423-427. see summary.

Lind, L., Wengle, B., Litell, H., and Ljunghall, S. No significant metabolic disturbance accompanies the hypotensive effect of active vitamin D. ups.jmed.sci 1991;96(3):199-204. see summary.

Lind, L., Wengle, B., Wide, L., and Ljunghall, S. Blood pressure reduction during long-term treatment with active vitamin D (alfacalcidol) is dependent on plasma renin activity and calcium status. a double-blind, placebo-controlled study. I am hypertensive. 1989;2(1):20-25. see summary.

Lind, L., Wengle, B., Broad, L., Sorensen, O. h., and ljunghall, s. Hypertension in primary hyperparathyroidism: reduction of blood pressure by long-term treatment with vitamin d (alfacalcidol). a double-blind, placebo-controlled study. I am hypertensive. 1988; 1 (4 points 1): 397-402. see summary.

Lippuner, K., Haller, B., Casez, J. p., montandon, a., and jaeger, p. Effect of disodium monofluorophosphate, calcium, and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study. electrolyte miner metab 1996;22(4):207-213. see summary.

lips, p., van ginkel, f. c., jongen, m. J. Rubertus, F. Van der Vijgh, W. j., and netelenbos, j. c. Determinants of vitamin d status in hip fracture patients and elderly control subjects. am j clin nutr 1987;46(6):1005-1010. see summary.

lips, p., wiersinga, a., van ginkel, f. c., jongen, m. j., netelenbos, j. c., hackeng, w. h., delmas, p. d., and van der vijgh, w. J. The effect of vitamin d supplementation on vitamin d status and parathyroid function in elderly subjects. j clin endocrinol metab 1988;67(4):644-650. see summary.

lipworth, l., bender, t. J. Rossi, M. Bosetti, C. Negri, E. Talamini, R. Giacosa, A. Franceschi, S. McLaughlin, J. k., and la, vecchia c. Dietary vitamin d intake and colon and rectal cancers: a case-control study in italy. nutrcancer 2009;61(1):70-75. see summary.

lister rk, woodrow sl, hughes jh, cerio r, norris pg, and griffiths cem. can dithranol have a lasting effect and be more acceptable to patients? Micanol cream – a trial of 171 patients with psoriasis. British Journal of Dermatology 1997; 137 (suppl50): 17.

liu, e., meigs, j. b., pittas, a. eg, economical, c. d., mckeown, b. m., cabin, s. L., and Jacques, p. F. predicted 25-hydroxyvitamin d score and incident type 2 diabetes in the framingham offspring study. am j clin.nutr 2010;91(6):1627-1633. see summary.

liu, y. t., cai, and. f., and shi, j. p. [Meta-analysis on the relationship between the level of 25-hydroxyvitamin D and hypertension]. zhonghua yi xue za zhi 2012-5-15;92(18):1268-1271. see summary.

Ljunghall S. Lind L. Litell H. Skarfors E. Selinus I. Sorensen O. h., and width, l. One-alpha-hydroxycholecalciferol treatment in middle-aged men with glucose intolerance: a prospective randomized double-blind study. acta med scand 1987;222(4):361-367. see summary.

llach, f., keshav, g., goldblat, m. V., Lindberg, J. S., Sadler, R., Delmez, J., Arruda, J., Lau, A., and Slatopolsky, E. suppression of parathyroid hormone secretion in hemodialysis patients by a new vitamin d analog: 19-nor-1,25-dihydroxyvitamin d2. i am j kidney disease. 1998;32(2 Suppl 2):s48-s54. see summary.

lovell, d. J. Glass, D. Ranz, J. Kramer, S. Huang, B. Sierra, R. i., henderson, c. J. Passo M. Graham B. Bowyer S. Higgins G. Rennebohm R. Schikler K. n., and giannini, e. a randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. rheumatic arthritis. 2006;54(7):2235-2242. see summary.

lowenthal, m. north. and Shany, S. osteomalacia in bedouin women of the negev. isr.j med.sci 1994;30(7):520-523. see summary.

good luck, g. p., van de Kerkhof, p. C., Cruysberg, J. r., der kinderen, d. j., and steijlen, p. meter. Topical treatment of sjogren-larsson syndrome with calcipotriol. dermatology 1995;190(4):292-294. see summary.

good luck, g. p., van de Kerkhof, p. c., van dijk, m. r., and steijlen, p. meter. Effect of topical calcipotriol in congenital ichthyosis. br j dermatol 1994;131(4):546-550. see summary.

lufkin, e. eg, Whitaker, m. d., nickelsen, t., argument, r., caplan, r. h., bloomer, r. k., and rigging, b. I treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial. j bone miner.res 1998;13(11):1747-1754. see summary.

Lund, B., Sorensen, O. h., and christensen, a. b. 25-hydroxycholecaliferol and proximal fractures. Lancet 8-16-1975;2(7929):300-302. see summary.

lundin, a. C., Soderkvist P., Eriksson B., Bergman-Jungestrom M., and Wingren S. Association of breast cancer progression with a vitamin d receptor gene polymorphism. south east sweden breast cancer group. rescancer 5-15-1999;59(10):2332-2334. see summary.

lyles, k. w., colon-emeric, c. s., magaziner, j. s., adachi, j. d., pieper, c. F. Mautalen C. Hyldstrup L. Recknor C. Nordsletten L. Moore K. A. Lavecchia C. Zhang J. Mesenbrink P. Hodgson P. K. Abrams, K. Orloff, J. J., Horowitz, Z., Eriksen, E. f., and boonen, s. Zoledronic acid and clinical fractures and mortality after hip fracture. n.engl.jmed 1-1-2007;357(18):1799-1809. see summary.

lions, r. A. Johansen, A. Brophy, S. Newcombe, R. eg, phillips, c. J. Lervy, B. Evans, R., Wareham, K., and Stone, M. d. Fracture prevention among older people living in institutional care: a pragmatic, randomized, double-blind, placebo-controlled trial of vitamin d supplementation. osteoporos.int 2007;18(6):811-818. see summary.

ma, y., zhang, p., wang, f., yang, j., liu, z. and qin, h. Association between vitamin d and colorectal cancer risk: a systematic review of prospective studies. jclin.oncol. 2011-10-1;29(28):3775-3782. see summary.

macdonald, d., lau, e., chan, e. l., mak, t., woo, j., leung, p. c., and swaminathan, r. Intact serum parathyroid hormone levels in elderly Chinese women with hip fracture. calcif.tissue int 1992;51(6):412-414. see summary.

Maclean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., Mcnamara, m., desai, s. B. Zhou A. Chen S. Carter J. Tringale C. Valentine D. Johnsen B. and Grossman J. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. ann.intern.med. 2008-05-2;148(3):197-213. see summary.

magno, c., anastasi, g., marabout, n., gaudio, a., maisano, d., franchina, f., gali, a., frisina, n., and melloni, d. Prevention of bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate. eur.urol. 2005;47(5):575-580. see summary.

mak, j. C. Stuart-Harris, J. Cameron, I. d., and mason, r. yes Oral vitamin d replacement after hip fracture: a comparative review. j am geriatr soc 2010;58(2):382-383. see summary.

mak, r. H. Turner C. Thompson T. Powell H. Haycock G. b., and chantler, c. Suppression of secondary hyperparathyroidism in children with chronic renal failure by high-dose phosphate binders: calcium carbonate versus aluminum hydroxide. br.med.j (clin res ed) 7-9-1985;291(6496):623-627. see summary.

maki, k. c., rubin, m. R., Wong, L. g., mcmanus, j. f., jensen, c. d., and lawless, a. Effects of vitamin d supplementation on 25-hydroxyvitamin d, high-density lipoprotein cholesterol, and other markers of cardiovascular disease risk in subjects with high waist circumference. int j food sci nutr 2011;62(4):318-327. see summary.

mazo, e., gugi, b., brunelle, p., henoq, a., basuyau, j. p., and lemeur, h. Vitamin d supplementation in pregnancy: a controlled trial of two methods. obstetrics gynecology 1986;68(3):300-304. see summary.

Manaseki-Holland, S., Qader, G., Isaq, Masher M., Bruce, J., Zulf, Mughal M., Chandramohan, D., and Walraven, G. effects of vitamin d supplementation in children diagnosed with pneumonia in kabul: a randomized controlled trial. trop.med.int health 2010;15(10):1148-1155. see summary.

manders, m., de groot, l. c., hoefnagels, w. h., dhonukshe-rutten, r. A. Wouters-Wesseling, W. Mulders, A. j., and vanstaveren, w. a. The effect of a nutrient-rich beverage on mental and physical function in institutionalized elderly. j nutr health aging 2009;13(9):760-767. see summary.

mansion, c. A., Gray-Donald, K., and Koski, K. gram. Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. cmaj. 2006-4-25;174(9):1273-1277. see summary.

manson, j. eg, mayne, s. T., and Clinton, S. k. vitamin d and cancer prevention, ready for prime time? n.engl.j med. 4-14-2011;364(15):1385-1387. see summary.

marchetti, a., lapensee, k., and an, p. A pharmacoeconomic analysis of topical therapies for patients with stable mild-to-moderate plaque psoriasis: an American study. clinther 1998;20(4):851-869. see summary.

marik, p. me. and Flemmer, M. Do dietary supplements have beneficial health effects in industrialized countries? what is the evidence? jpen j.parenter.enteral nutr. 2012;36(2):159-168. see summary.

Marjamaki, L., Niinisto, S., Kenward, M. g., uusitalo, l., uusitalo, u., ovaskainen, m. L., Kronberg-Kippila, C., Simell, O., Veijola, R., Ilonen, J., Knip, M., and Virtanen, S. meter. Maternal vitamin d intake during pregnancy and risk of advanced beta-cell autoimmunity and type 1 diabetes in the offspring. diabetology 2010;53(8):1599-1607. see summary.

martin, k. j., gonzalez, e. a., gellens, m., hamm, l. L., Abboud, H., and Lindberg, J. 19-nor-1-alpha-25-dihydroxyvitamin d2 (paricalcitol) safely and effectively lowers intact parathyroid hormone levels in hemodialysis patients. j am soc nephrol. 1998;9(8):1427-1432. see summary.

martineau, a. R., Timms, p. m., bothamley, g. H. Hanifa Y. Islam K. Claxton A. p., package, g. E., Moore-Gillon, J. c., darmalingam, m., davidson, r. n., milburn, h. j., baker, l. v., barker, r. d., wood, n. j., ventón, t. R., Barnes, K. e., mullet, c. j., cousins, a. k., rutterford, c. m., mein, c. a., davies, g. R., Wilkinson, R. J., Nikolaevskyy, V., Drobniewski, F. a., eldridge, s. m., and Griffiths, c. J. High-dose vitamin d(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomized controlled trial. Lancet 1-15-2011;377(9761):242-250. see summary.

martineau, a. R., Wilkinson, R. j., wilkinson, k. a., newton, s. m., kampmann, b., hall, b. m., package, g. e., davidson, r. n., eldridge, s. m., maunsell, z. j., rainbow, s. j., berry, j. l., and griffiths, c. J. a single dose of vitamin d improves immunity to mycobacteria. am j respir.crit care med 7-15-2007;176(2):208-213. see summary.

martinez, c., virgili, n., cuerda, c., chicharro, l., gomez, p., moreno, j. m., alvarez, j., martí, e., matia, p., plume, m. a., garde, c., de, luis d., gonzalo, m., and lobo, g. [Cross-sectional study on the prevalence of metabolic bone disease (mbd) and home parenteral nutrition (hpn) in Spain: data from the nadya group]. hosp.nutricion 2010;25(6):920-924. see summary.

martinez, m. E., Marshall, J. R., R. Sampliner, J. Wilkinson, and D. Alberts. yes calcium, vitamin d and risk of adenoma recurrence (united states). cancer causes control 2002;13(3):213-220. see summary.

Maria, R. K., Rathee, S., and Manrow, M. Effect of calcium and vitamin d supplementation on toxemia of pregnancy. gynecologist obstetric invest 1987;24(1):38-42. see summary.

Maria, R. K., Rathee, S., Dua, V., and Sangwan, K. Effect of vitamin d supplementation during pregnancy on fetal growth. indian j med res 1988;88:488-492. see summary.

Maria, R. k., rathee, s., lata, v., and mudgil, s. effects of vitamin d supplementation in pregnancy. gynecologist obstetric invest 1981;12(3):155-161. see summary.

mason, a. R., Mason, J., Cork, M., Dooley, G., and Edwards, G. Topical treatments for chronic plaque psoriasis. Cochrane Database System Rev 2009;(2):cd005028. see summary.

bricklayer, j., bricklayer, a. r., and cork, m. J. Topical preparations for the treatment of psoriasis: a systematic review. br j dermatol 2002;146(3):351-364. see summary.

mastaglia, s. r., mautalen, c. a., paris, m. s., and oliveri, b. dose of vitamin d2 needed to rapidly increase 25ohd levels in women with osteoporosis. eur.j clin nutr 2006;60(5):681-687. see summary.

matías, p. J. Jorge, C. Ferreira, C. Borges, M. Aires, I. Amaral, T. Gil, C. Cortez, J., and Ferreira, A. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. clin.j am soc.nephrol. 2010;5(5):905-911. see summary.

maxwell, d. R., Benjamin, D. m., donahay, s. l., allen, m. K., Burger, R. j., and luft, f. c. calcitriol in dialysis patients. clin pharmacol.ther 1978;23(5):515-519. see summary.

maxwell, j. D. Ang L. Brooke O. g., and brown, i. r. Vitamin D supplementation improves weight gain and nutritional status in pregnant Asian women. br j obstet gynaecol 1981;88(10):987-991. see summary.

may, h. t., bair, t. l., lappe, d. L., Anderson, J. l., horn, b. D., Carlquist, J. f., and muhlestein, j. b. Association of vitamin d levels with incident depression among a general cardiovascular population. i am heart j 2010;159(6):1037-1043. see summary.

mayne, s. T., Ferrucci, L. m., and cartmel, b. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. annu.rev.nutr. 2012-08-21;32:369-390. see summary.

mayron l, ott jn amontree e et al. light, radiation and dental caries. Incidence of dental caries in schoolchildren as a function of light quality and radiation protection. acad there 2013;1975(10):441-448.

mcalindon, t., lavalley, m., schneider, e., nuite, m., lee, j. and., price, l. l., lo, g., and dawson-hughes, b. Effect of vitamin d supplementation on knee pain progression and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. jama 2013-9-1;309(2):155-162. see summary.

mcbeath ec, verlin wa. Further studies on the role of vitamin d in the nutritional control of dental caries in children. j amdent asoc. 1942; 29:1393-1397.

mcbeath ce, zucker tf. The role of vitamin d in the control of dental caries in children. j nourish 1938; 15:547-564.

mcbeath ec. Experiments on the dietary control of dental caries in children. j dent res. 1932; 12 (723): 747.

mcbeth, j., pye, s. R., O’Neill, T. w., macfarlane, g. J. Chop, A. Bartfai, G. Boonen, S. Bouillon, R. Casanueva, F. Finn, J. d., forti, g., giwercman, a., have, t. s., huhtaniemi, i. t., kula, k., thin, m. E. Pendleton, N. Punab, M. Silman, A. j., vanderschueren, d., and wu, f. c. Musculoskeletal pain is associated with very low vitamin D levels in men: results from the European Aging Male Study. ann.rheum.dis. 2010;69(8):1448-1452. see summary.

mcclung, m. R., Lewiecki, E. m., cohen, s. b., bolognese, m. a., woodson, g. c., moffett, a. h., peacock, m., miller, p. d., lederman, s. n., chestnut, c. H. Lain, D. Kivitz, A. j., holloway, d. L. Zhang C. Peterson M. c., and bekker, p. J. denosumab in postmenopausal women with low bone mineral density. n.engl.jmed 2006-23-2;354(8):821-831. see summary.

mccullough, m. l., flag, e. v., moore, d. f., and kushi, l. h. Vitamin D and calcium intake in relation to endometrial cancer risk: a systematic review of the literature. prev.med. 2008;46(4):298-302. see summary.

mccullough, m. L., Robertson, A. S. Rodriguez, C. Jacobs, E. J. Bye A. Carolyn J. Street E. e., willett, w. c., and thun, m. J. Calcium, vitamin d, dairy products, and risk of colorectal cancer in the cancer prevention study ii nutrition cohort (united states). cancer causes control 2003;14(1):1-12. see summary.

mckeag rh. report on a practical test of the effects of “ostelin”and parathyroids on the teeth of children. Brandon J. 1930;51:281-286.

medical research council. The influence of diet on dental caries in children (final report). london: h.m. stationery off. 1936;

memes, l. m., van der harst, p., van gilst, w. h., and deboer, r. a. biology of vitamin d in heart failure: molecular mechanisms and systematic review. current drug targets. 2011;12(1):29-41. see summary.

meeuwis, k. a., from hullu, j. a., massager, l. f., van de Kerkhof, p. c., and van rossum, m. meter. Genital psoriasis: a systematic review of the literature on this hidden skin disease. acta derm.venereol. 2011;91(1):5-11. see summary.

megid, n. a., hashish, a. f., anwar, m., and sidhom, g. Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. j alternative complement med 2010;16(6):641-645. see summary.

meier, c., woitge, h. W., Witte K., Lemmer B., and Seibel M. J. Oral vitamin d3 and calcium supplementation during winter prevents seasonal bone loss: a prospective, randomized, controlled, open-label trial. j bone miner res 2004;19(8):1221-1230. see summary.

melamed, m. I and Thadhani, R. Yo. vitamin d therapy in chronic kidney disease and end-stage renal disease. clin.j am soc.nephrol. 2012;7(2):358-365. see summary.

melin, a., wilske, j., ringertz, h., and saaf, m. Seasonal variations in serum 25-hydroxyvitamin D and parathyroid hormone levels, but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. j am geriatric soc 2001;49(9):1190-1196. see summary.

melanby m, pattison cl proud jw. The effect of diet on the development and spread of dental caries in children. br med j. 1924; 2:354-355.

melanby m, pattison cl. Some dietary factors that influence the spread of caries in children. Brandon J. 1926;47:1045-1057.

memories, d. E., Eastwood, J. b., talner, l. b., gower, p. E., Curtis, J. R., Phillips, M. eg, carter, g. D. Alaghband-zadeh, J. Roberts, A. p., and de wardener, h. me. Double-blind trial of oral 1,25-dihydroxy vitamin d3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance hemodialysis. br med j (clin res ed) 13-6-1981;282(6280):1919-1924. see summary.

Menczel, J., Foldes, J., Steinberg, R., Leichter, I., Shalita, B., Bdolah-Abram, T., Kadosh, S., Mazor, Z., and Ladkani, D. alfacalcidol (alpha d3) and calcium in osteoporosis. clin orthop.relat res 1994;(300):241-247. see summary.

messenger, w., nielson, c. M., Li, H. Beer, T., Barrett-Connor, E. Stone, K., and Shannon, J. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. nutr metab cardiovasc.dis. 2012;22(10):856-863. see summary.

Messer, G., Degitz, K., Plewig, G., and Rocken, M. Pretreatment of psoriasis with the vitamin d3 derivative tacalcitol increases responsiveness to 311-nm ultraviolet b radiation: results of a right/left controlled study. br.j dermatol. 2001;144(3):628-629. see summary.

meyer, g. and Kopke, S. vitamin d and cataracts information about the damage is missing. bmj 2009;339:b4395. see summary.

miguel, y. L., Whitlock, E. p., lin, j. s., fu, r., o’connor, e. a., and gold, r. Primary care-relevant interventions to prevent falls in older adults: a systematic review of evidence for the us. uu. Preventive Services Task Force. ann.intern med 2010-12-21;153(12):815-825. see summary.

michaelson, m. d., kaufman, d. S. Lee H. McGovern F. j., kantoff, p. w., fallon, m. A. Finkelstein, J. s., and smith, m. r. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. jclin.oncol. 3-20-2007;25(9):1038-1042. see summary.

miheller, p., muzes, g., hritz, i., lakatos, g., pregun, i., lakatos, p. l., herszenyi, l., and tulassay, z. Comparison of the effects of 1,25 dihydroxyvitamin d and 25 hydroxyvitamin d on bone pathology and disease activity in patients with crohn’s disease. inflamm.bowel.dis. 2009;15(11):1656-1662. see summary.

thousand, h. and Davison, J. Nutritional education for the prevention of osteoporosis in men with prostate cancer who start androgen deprivation therapy. clin joncol. nurs. 2012;16(5):497-503. see summary.

miller, p. D. Roux C. Boonen S. Barton I. p., dunlap, l. e., and Burgio, d. me. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. j bone miner.res 2005;20(12):2105-2115. see summary.

mirzaei, s., zajicek, h. K., Knoll, P., Hahn, M., Levi, M., Kohn, H., and Pohl, W. Effect of Rocaltrol on bone mass in patients with lung disease treated with corticosteroids. j asthma 2003;40(3):251-255. see summary.

mitchell, d. the relationship between vitamin d and cancer clin.joncol.nurs. 2011;15(5):557-560. see summary.

mitri, j., muraru, m. d., and pittas, a. gram. vitamin d and type 2 diabetes: a systematic review. eur.j clin.nutr 2011;65(9):1005-1015. see summary.

mitsuhashi, y., kawaguchi, m., hozumi, y., and kondo, s. topical vitamin d3 is effective in treating senile warts possibly by inducing apoptosis. j dermatol 2005;32(6):420-423. see summary.

Mizoue T., Kimura Y. Toyomura K. Nagano J. Kono S. Mibu R. Tanaka M. Kakeji Y. Maehara Y. Okamura, T., Ikejiri, K., Futami, K., Yasunami, Y., Maekawa, T., Takeka, K., Ichimiya, H. and imaizumi, n. calcium, dairy, vitamin d, and colorectal cancer risk: the fukuoka colorectal cancer study. cancer epidemiol. biomarkers ant. 2008;17(10):2800-2807. see summary.

moe, yes. M. Zekonis M. Harezlak J. Ambrosius W. T., Gassensmith, c. m., murphy, c. L., Russell, R. r., and batiuk, t. d. a placebo-controlled trial to evaluate the immunomodulatory effects of paricalcitol. i am j kidney disease. 2001;38(4):792-802. see summary.

molín, l. Topical calcipotriol combined with phototherapy for psoriasis. the results of two randomized trials and a review of the literature. calcipotriol-uvb study group. dermatology 1999;198(4):375-381. see summary.

molin, l., cutler, t. p., helander, i., nyfors, b., and downes, n. Comparative efficacy of calcipotriol (mc903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. a multicenter, randomized, double-blind, parallel-group study. calcipotriol study group. br j dermatol 1997;136(1):89-93. see summary.

monastirli a, zografakis c braun h et al. calcipotriol vs. anthralin in the treatment of chronic plaque psoriasis. zhautk 2000;75:626-629.

Monastirli, A., Georgiou, S., Pasmatzi, E., Sakkis, T., Badavanis, G., Draneas, D., Sagriotis, A., and Tsambaos, D. Short-contact calcipotriol plus dithranol: a new topical combination therapy for chronic plaque psoriasis. skin pharmacol.appl.piel fisiol 2002;15(4):246-251. see summary.

moniz, c., dew, t., and dixon, t. prevalence of vitamin d insufficiency in patients with osteoporotic hip fracture in london. curr med res opinion. 2005;21(12):1891-1894. see summary.

morthi, r. n., kandula, p., and moe, s. meter. Optimal replacement of vitamin d, calcitriol, and vitamin d analogs in chronic kidney disease: to d or not to d: that is the question. curr.opin.nephrol.hypertens. 2011;20(4):354-359. see summary.

marabout, n., gaudio, a., lasco, a., catalano, a., atteritano, m., trifiletti, a., anastasi, g., melloni, d., and frisina, n. Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer. j bone miner.res 2004;19(11):1766-1770. see summary.

morcos, m. m., gabr, a. A., Samuel, S., Kamel, M., El, Baz M., El, Beshry M., and Michail, R. r. administration of vitamin d to tuberculous children and its value. boll.chim.farm. 1998;137(5):157-164. see summary.

moreira-pfrimer, l. d., pedrosa, m. a., teixeira, l., and lazaretti-castro, m. Treatment of vitamin d deficiency increases lower extremity muscle strength in institutionalized older people regardless of regular physical activity: a double-blind randomized controlled trial. ann.nutr metab 2009;54(4):291-300. see summary.

Moriniere, P., Fournier, A., Leflon, A., Herve, M., Sebert, J. L., Gregoire, I., Bataille, P., and Gueris, J. comparison of 1 alpha-oh-vitamin d3 and high-dose calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in maintenance dialysis patients. nephron 1985;39(4):309-315. see summary.

morse, n. I benefits of docosahexaenoic acid, folic acid, vitamin d, and iodine on fetal and infant brain development and function after maternal supplementation during pregnancy and lactation. Nutrients 2012;4(7):799-840. see summary.

Mortensen, L., Kragballe, K., Wegmann, E., Schifter, S., Risteli, J. and charles, p. treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. a randomized, double-blind, placebo-controlled study. acta derm.venereol. 1993;73(4):300-304. see summary.

mosekilde, l., langdahl, b. l., nielsen, l. r., and vestergaard, p. [The usefulness of calcium and vitamin d supplementation after the women’s health initiative trial]. ugeskr.laeger 2007-9-24;169(39):3273-3276. see summary.

mosekilde, l., vestergaard, p., and langdahl, b. Prevention of fractures in postmenopausal women. clin evid.(online.) 2007;2007 see abstract.

motiwala, s. r. and wang, t. J. vitamin d and cardiovascular disease curr.opin.nephrol.hypertens. 2011;20(4):345-353. see summary.

moyad, m. a. promoting general health during androgen deprivation therapy (adt): a quick 10-step review for your patients. urol.oncol. 2005;23(1):56-64. see summary.

moyer, v.a. prevention of falls in older adults living in the community: u.s. preventive services task force recommendation statement. ann.intern.med. 7-8-2012;157(3):197-204. see summary.

muir, yes. w. and montero-odasso, m. Effect of vitamin d supplementation on muscle strength, gait, and balance in older adults: a systematic review and meta-analysis. j am geriatr.soc. 2011;59(12):2291-2300. see summary.

murad, m. h., draco, m. t., mullan, r. J., Mauck, K. f., stuart, l. m., lane, m. a., abu elnour, b. o., erwin, p. j., hazem, a., puhan, m. a., li, t., and montori, v. m. clinical review. Comparative efficacy of drug treatments in preventing fragility fractures: a systematic review and network meta-analysis. j clin.endocrinol.metab 2012;97(6):1871-1880. see summary.

murad, m. h., elamin, k. b., abu elnour, b. o., elamine, m. b., alkatib, a. a., fatourechi, m. m., almandoz, j. p., mullan, r. j., lane, m. A. Liu, H. Erwin, p. j., hensrud, d. d., and montori, v. m. clinical review: the effect of vitamin d on falls: a systematic review and meta-analysis. jclin.endocrinol.metab 2011;96(10):2997-3006. see summary.

murdoch, d. r., slow, s., cameras, s. T., Jennings, L. c., stewart, a. w., priest, p. c., florkowski, c. m., livesey, j. h., camargo, c. a., and scragg, r. Effect of vitamin d3 supplementation on upper respiratory tract infections in healthy adults: the vidaris randomized controlled trial. jama 3-10-2012;308(13):1333-1339. see summary.

murphy, p. k. and wagner, c. I vitamin d and mood disorders among women: an integrative review. j midwifery women’s health 2008;53(5):440-446. see summary.

myers, g. or a college founded on the needs of physicians. md state med.j 1975;24(6):48-49. see summary.

myrup, b., jensen, g. f., and mcnair, p. cardiovascular risk factors during treatment with estrogen-norethindrone and cholecalciferol. archiintern med 1992;152(11):2265-2268. see summary.

nagpal, j., pande, j. n., and bhartia, a. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin d3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. diabetes.med 2009;26(1):19-27. see summary.

naldi, l. and Rzany, B. psoriasis (chronic plaque). clin evid.(online.) 2009;2009 see summary.

name, j. h., moon, j. i., chung, s. s., kim, s. i., park, k. i., song, and. d., kim, k. r., lee, h. c., huh, k., and lim, s. k. trial of pamidronate and calcitriol for the prevention of early bone loss after renal transplantation. transplant.proc. 2000;32(7):1876. see summary.

national osteoporosis foundation. Physician’s guide to prevention and treatment of osteoporosis. 2008;

nellen, j. f., smulders, and. m., jos frissen, p. h., slats, e. h., and silberbusch, j. hypovitaminosis d in immigrant women: slow to be diagnosed. bmj 2-3-1996;312(7030):570-572. see summary.

neubauer, e., neubauer, n., ritz, e., dreikorn, k., and krause, k. h. Bone mineral content after renal transplantation. prospective placebo-controlled study with 1,25-dihydroxy vitamin d3. klin.wochenschr. 1-16-1984;62(2):93-96. see summary.

neuhouser, m. L. Sorensen, B. Hollis, B. W., Ambs, A. Ulrich, C. M., Mctiernan, A., Bernstein, L., Wayne, S., Gilliland, F., Baumgartner, K., Baumgartner, R., and Ballard-Barbash, R. Vitamin d insufficiency in a multiethnic cohort of breast cancer survivors. am j clin nutr 2008;88(1):133-139. see summary.

newton-bishop, j. A. Beswick, S. Randerson-Moor, J. Chang, Y. M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., Kukalizch, K., Whitaker, L., Jackson, S., Gerry, E. Nolan C. Bertram C. Marsden J. Elder D. E., Barrett, J. h., and bishop, d. t. Serum levels of 25-hydroxyvitamin d3 are associated with Breslow thickness at melanoma presentation and survival. jclin.oncol. 2009-11-10;27(32):5439-5444. see summary.

neyens, j. c., van haastregt, j. c., cocks, b. P., Martens, M., van den Heuvel, W. j., dewitte, l. p., and schools, j. meter. Effectiveness and implementation aspects of interventions to prevent falls in older people in long-term care settings: a systematic review of RCTs. j am med.dir.assoc. 2011;12(6):410-425. see summary.

ng, k., meyerhardt, j. A. Wu K. Feskanich D. Hollis B. w., giovannucci, e. l., and fuchs, c. yes Circulating levels of 25-hydroxyvitamin d and survival in patients with colorectal cancer. jclin.oncol. 6-20-2008;26(18):2984-2991. see summary.

nguyen, n. D., Eisman, J. a., and nguyen, t. v. Anti-hip fracture efficacy of bisphosphonates: a Bayesian analysis of clinical trials. j bone miner.res 2006;21(2):340-349. see summary.

Nicholson, I., Dalzell, A. m., and the matary, w. vitamin d as therapy for colitis: a systematic review. j crohns.colitis. 2012;6(4):405-411. see summary.

nielsen, b. O., Skifte, T., Andersson, M., Wohlfahrt, J., Soborg, B., Koch, A., Melbye, M., and Ladefoged, K. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. br j nutr 2010;104(10):1487-1491. see summary.

nilas, l. and Christiansen, c. Treatment with vitamin D or its analogs does not change body weight or blood glucose level in postmenopausal women. int j obes. 1984;8(5):407-411. see summary.

Nishioka, T., Kurayama, H., Yasuda, T., Udagawa, J., Matsumura, C., and Niimi, H. Nasal administration of salmon calcitonin for the prevention of glucocorticoid-induced osteoporosis in children with nephrosis. j pediatrician 1991;118(5):703-707. see summary.

nnoaham, k. me. and clarke, a. Low serum vitamin d levels and tuberculosis: a systematic review and meta-analysis. int j epidemiology. 2008;37(1):113-119. see summary.

no author. Vitamin D supplementation in early childhood and risk of type I (insulin-dependent) diabetes mellitus. the eurodiab substudy 2 study arm. diabetology 1999;42(1):51-54. see summary.

noguera, a., ros, j. b., pavia, c., alcover, e., valls, c., villaronga, m., and gonzalez, e. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. jpediatr endocrinol.metab 2003;16(4):529-536. see summary.

nordal kp, halse j and dahl e. the effect of nasal calcitonin on bone mineral density in kidney transplant recipients. nephrology dialysis transplant 1996;11(6):1212.

nordal, k. p. and Dahl, E. Low-dose calcitriol versus placebo in predialysis chronic renal failure patients. jclin endocrinol.metab 1988;67(5):929-936. see summary.

Nurmatov, U., Devereux, G., and Sheikh, A. Nutrients and foods for primary prevention of asthma and allergy: systematic review and meta-analysis. j.allergy clin.immunol. 2011;127(3):724-733. see summary.

nursyam, e. w., amin, z., and rumende, c. meter. The effect of vitamin d as adjunctive treatment in patients with moderately advanced pulmonary tuberculosis. acta med indones. 2006;38(1):3-5. see summary.

Nuti, R., Martini, G., Valenti, R., Gambera, D., Gennari, L., Salvadori, S., and Avanzati, A. Vitamin d status and bone turnover in women with acute hip fracture. clin orthop.relat res 2004;(422):208-213. see summary.

O’Donnell, S., Moher, D., Thomas, K., Hanley, D. a., and craneney, a. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. jbone miner metab 2008;26(6):531-542. see summary.

Obara, W., Konda, R., Akasaka, S., Nakamura, S., Sugawara, A., and Fujioka, T. Prognostic significance of vitamin d receptor and retinoid receptor x expression in renal cell carcinoma. jurol. 2007;178(4pt 1):1497-1503. see summary.

Obara, W., Suzuki, Y., Kato, K., Tanji, S., Konda, R., and Fujioka, T. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. int j urol. 2007;14(6):483-487. see summary.

oh, k., willett, w. c., wu, k., fuchs, c. s., and giovannucci, e. I calcium and vitamin D intake in relation to the risk of distal colorectal adenoma in women. i’m j epidemiology. 5-15-2007;165(10):1178-1186. see summary.

okada, n. [measures for osteoporosis in the dermatological field-vitamin d3 and bisphosphonates]. clin calcium 2004;14(10):145-149. see summary.

okamoto, r., akagi, t. and Koeffler, p. vitamin d compounds and myelodysplastic syndrome. leuko.lymphoma 2008;49(1):12-13. see summary.

oken, e., ning, y., raffles-shiman, s. L., Rich-Edwards, J. w., olsen, s. f., and gillman, m. w. diet during pregnancy and risk of preeclampsia or gestational hypertension. ann.epidemiol. 2007;17(9):663-668. see summary.

olson, c. v., patel, p. h., and wuermser, l. a. Influence of season, ethnicity, and chronicity on vitamin d deficiency in traumatic spinal cord injury. j spinal cord.med 2010;33(3):202-213. see summary.

olgaard, k. and Lewis, E. use (or misuse) of vitamin d treatment in chronic kidney disease and dialysis patients: a recent meta-analysis on vitamin d compounds in chronic kidney disease [1] and an accompanying editorial comment [2] have already been published to this meta-analysis. we believe that these articles deserve some comments in the interest of ndt readers. nephrol.dial.transplantation. 2008;23(6):1786-1789. see summary.

oliver, d., connelly, j. b., victor, c. R., Shaw, F. E. Whitehead, A. Genc, ​​Y. Vanoli, A. Martin, F. c., and Gosney, m. a. Strategies to prevent falls and fractures in hospitals and nursing homes and the effect of cognitive impairment: a systematic review and meta-analysis. bmj 13-1-2007;334(7584):82. see summary.

oliveri, m. b., palermo, r., mautalen, c., and hubscher, o. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. j rheumatol 1996;23(12):2152-2155. see summary.

ooms, m. e., roos, j. c., bezemer, p. d., van der vijgh, w. j., bouter, l. m., and lips, p. Bone loss prevention by vitamin d supplementation in elderly women: a double-blind randomized trial. jclin endocrinol metab 1995;80(4):1052-1058. see summary.

orange, a. P., Marcoux, D., Svensson, A., prendiville, J., Krafchik, B., Toole, J., Rosenthal, D., de Waard-van der spek fb, Molin, L., and Axelsen, M. . Topical calcipotriol in childhood psoriasis. j am acad dermatol 1997;36(2 pt 1):203-208. see summary.

orimo, h., shiraki, m., hayashi, t., and nakamura, t. reduction of the incidence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (oh)-vitamin d3. bone miner 1987;3(1):47-52. see summary.

Orimo, H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T., and Ogawa, n. Effects of 1 alpha-hydroxyvitamin d3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. calcif tissue int 1994;54(5):370-376. see summary.

ortonne, j. P. Humbert, P. Nicolas, J. f., tsankov, n., tonev, s. D., Janin, A., Czernielewski, J., Lahfa, M. and Dubertret, L. Intraindividual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment in chronic plaque psoriasis located on the face, hairline, retroauricular or flexural areas. br j dermatol 2003;148(2):326-333. see summary.

ortonne, j. P., Kaufmann, R., Lecha, M., and Goodfield, M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomized, double-blind trial. dermatology 2004;209(4):308-313. see summary.

orwoll, e. s., mcclung, m. r., oviatt, s. K., Recker, R. R., and Weigel, R. meter. Histomorphometric effects of treatment with calcium or calcium plus 25-hydroxyvitamin d3 in senile osteoporosis. j bone miners 1989;4(1):81-88. see summary.

orwoll, e. s., oviatt, s. K., McClung, M. r., defaults, l. j., and sacristan, g. the rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. ann.intern.med. 1-1-1990;112(1):29-34. see summary.

orwoll, e., riddle, m., and prince, m. Effects of vitamin d on insulin and glucagon secretion in non-insulin dependent diabetes mellitus. am j clin nutr 1994;59(5):1083-1087. see summary.

ott jn. light; photosynthesis, the oculoendocrine system and dental caries. j am soc prev dent. 1975; 5:10-15.

ott, yes. meter. and chestnut, c. h., iii. calcitriol treatment is not effective in postmenopausal osteoporosis. ann.intern.med. 2-15-1989;110(4):267-274. see summary.

oudshoorn, c., mattace-raso, f. u., van, der, v, colin, e. m., and van der cammen, t. J. Higher serum levels of vitamin D3 are associated with better performance on cognitive tests in patients with Alzheimer’s disease. dement.geriatr cogn disord 2008;25(6):539-543. see summary.

paik, j. m., curhan, g. c., and taylor, e. north. Calcium intake and risk of primary hyperparathyroidism in women: a prospective cohort study. bmj 2012;345:e6390. see summary.

palmer, s. c., mcgregor, d. o., and strippoli, g. F. Interventions for the prevention of bone disease in renal transplant recipients. cochrane.database.syst.rev. 2007;(3):cd005015. see summary.

palmer, s. c., mcgregor, d. O., Craig, J. c., elder, g., macaskill, p., and strippoli, g. F. vitamin d compounds for people with chronic kidney disease not requiring dialysis. cochrane.database.syst.rev. 2009;(4):cd008175. see summary.

palmer, s. c., mcgregor, d. O., Craig, J. c., elder, g., macaskill, p., and strippoli, g. F. vitamin d compounds for people with chronic kidney disease requiring dialysis. cochrane.database.syst.rev. 2009;(4):cd005633. see summary.

palmer, s. c., mcgregor, d. O., Macaskill, P., Craig, J. c., old man, g. j., and strippoli, g. F. meta-analysis: vitamin d compounds in chronic kidney disease. ann. intern med 12-18-2007;147(12):840-853. see summary.

palmer, s. c., strippoly, g. f., and mcgregor, d. o Interventions for the prevention of bone diseases in kidney transplant recipients: a systematic review of randomized controlled trials. i am j kidney disease. 2005;45(4):638-649. see summary.

Palmer, S., McGregor, D. o., and strippoli, g. F. Interventions for the prevention of bone disease in renal transplant recipients. cochrane.database.syst.rev. 2005;(2):cd005015. see summary.

skillet, w. h., wang, c. y., li, l. a., kao, l. s., and yes, s. h. No significant effect of calcium and vitamin d supplementation on blood pressure and calcium metabolism in Chinese elderly. chin j physiol 1993;36(2):85-94. see summary.

Panichi, V., Andreini, B., de, Pietro S., Migliori, M., Taccola, D., Giovanni, L., Ferdeghini, M. and Palla, R. Oral calcitriol therapy for the prevention of secondary hyperparathyroidism in patients with predialysis renal failure. clin nephrol. 1998;49(4):245-250. see summary.

panju, a. H. Breunis, H. Cheung, A. M., Leach, M., Fleshner, N., Warde, P., Duff-Canning, S., Krahn, M., Naglie, G., Tannock, I., Tomlinson, G., and Alibhai, S. meter. Management of decreased bone mineral density in men starting androgen deprivation therapy for prostate cancer. bju.int 2009;103(6):753-757. see summary.

papapoulos, s. e., how much, s. a., liberman, u. a., hochberg, m. c., and thompson, d. me. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. osteoporosis int 2005;16(5):468-474. see summary.

dad, k. A. Guenther, L. Boyden, B. Larsen, F. eg, harvima, r. j., guilhou, j. J., Kaufmann, R., Rogers, S., van de Kerkhof, p. c., hanssen, l. I., Tegner, E., Burg, G., Talbot, D., and Chu, A. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. j am acad dermatol 2003;48(1):48-54. see summary.

dad, h. m., gordon, c. m., saslowsky, t. m., zholudev, a., horror, b., shih, m. c., and great, r. J. Vitamin d status in children and young adults with inflammatory bowel disease. pediatrics 2006;118(5):1950-1961. see summary.

parekh, d., sarathi, v., shivane, v. k., bandgar, t. r., Meno, p. s., and shah, n. yes pilot study to assess the effect of short-term improvement in vitamin d status on glucose tolerance in patients with type 2 diabetes mellitus. endocr.pract. 2010;16(4):600-608. see summary.

park, s. and., murphy, s. p., wilkens, l. r., nomura, a. m., henderson, b. e., and kolonel, l. north. Calcium and vitamin D intake and colorectal cancer risk: the multiethnic cohort study. i’m j epidemiology. 4-1-2007;165(7):784-793. see summary.

park, y., leitzmann, m. f., climb, a. f., hollenbeck, a., and schatzkin, a. dairy foods, calcium, and cancer risk in the nih-aarp health and diet study. arch intern.med. 2009-2-23;169(4):391-401. see summary.

Parker J. Hashmi O. Dutton D. Mavrodaris A. Strangers S. Kandala N. B., Clarke, A., and Frank, O. h. vitamin d levels and cardiometabolic disorders: systematic review and meta-analysis. maturitas 2010;65(3):225-236. see summary.

parsad, d., saini, r., and nagpal, r. calcipotriol in vitiligo: a preliminary study. dermatol pediatrician 1999;16(4):317-320. see summary.

parsad, d., saini, r., and verma, n. combination of puvasol and topical calcipotriol in vitiligo. dermatology 1998;197(2):167-170. see summary.

Patel, P., Poretsky, L. and liao, e. Lack of effect of subtherapeutic vitamin d treatment on glycemic and lipid parameters in type 2 diabetes: a prospective randomized pilot trial. j diabetes 2010;2(1):36-40. see summary.

Patel R, Collins D, Bullock S, Swaminathan R, Blake G. m., and fogelman, i. The effect of season and vitamin d supplementation on bone mineral density in healthy women: a double-blind crossover study. osteoporosis int 2001;12(4):319-325. see summary.

Pooled patient-level analysis of 68,500 patients from seven major vitamin d fracture trials in the united states and europe. bmw 2010;340:b5463. see summary.

paul, g., brehm, j. m., alcorn, j. f., holguín, f., aujla, s. j., and celedon, j. c. vitamin d and asthma am j respir.crit care med. 15-1-2012;185(2):124-132. see summary.

Peacock, M., Liu, G., Carey, M., McClintock, R., Ambrosius, W., Hui, S., and Johnston, C. c. Effect of dietary calcium or vitamin d3 25oh supplementation on bone loss at the hip in men and women older than 60 years. j clin endocrinol metab 2000;85(9):3011-3019. see summary.

peichl, p., rintelen, b., kumpan, w. and broll, h. Increased axial and appendicular cortical and trabecular bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy. gynecol.endocrinol. 1999;13(1):7-14. see summary.

pereira, i. a., speck, l. m., cross, b. a., brenol, c. v., fronza, l. s., bertolo, m. b., freitas, m. v., silva, n. a., louzada-junior, p., giorgi, r. d., lime, r. a., and pinheiro, gda r. consensus of the brazilian society of rheumatology of 2012 on the management of comorbidities in patients with rheumatoid arthritis. rev.bras.reumatol. 2012;52(4):474-495. see summary.

pereira, r. m., carvalho, j. f., paula, a. p., zerbini, c., domitiano, d. S., Gonçalves, H., Danowski, J. s., marquis net, j. f., mendonca, l. m., bezerra, m. c., terreri, m. T., Imamura, M., Weingrill, P., Plapler, P. G., Radominski, S., Tourinho, T., Szejnfeld, V. l., and andrada, n. c. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. rev.bras.reumatol. 2012;52(4):580-593. see summary.

Pérez, A., Chen, T. C., Turner, A., Raab, R., Bhawan, J., Poche, P., and Holick, M. F. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis. br j dermatol 1996;134(2):238-246. see summary.

petchey, w. G., Johnson, D. w., and isbel, n. meter. Shining d’ light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin d. nephrology.(carlton.) 2011;16(4):351-367. see summary.

petitpain d, budak a, desmarteau j, durkalski v, and byrne tk. Preoperative vitamin d status in potential bariatric surgery patients. bariatric nursing surgery patient care 2010;5(3):255-260.

pfeifer, m. and Minne, H. w. [The role of vitamin d in the treatment of osteoporosis in the elderly]. med klin.(munich) 2006;101 supplement 1:15-19. see summary.

pfeifer, m., begerow, b., minne, h. w., nachtigall, d., and hansen, c. Effects of short-term vitamin d(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. jclin endocrinol metab 2001;86(4):1633-1637. see summary.

pfeifer, m., begerow, b., minne, h. W., Suppan, K., Fahrleitner-Pammer, A., and Dobnig, H. Effects of long-term vitamin d and calcium supplementation on falls and muscle function parameters in older people living in the community. osteoporos.int 2009;20(2):315-322. see summary.

pieper, a. K., Haffner, D., Hoppe, B., Dittrich, K., Offner, G., Bonzel, K. E., John, U., Frund, S., Klaus, G., Stubinger, A., Duker, G., and Querfeld, U. a randomized crossover trial comparing sevelamer with calcium acetate in children with ckd. i am j kidney disease. 2006;47(4):625-635. see summary.

pierrot-deseilligny, c. Clinical implications of a possible role of vitamin D in multiple sclerosis. j neurol. 2009;256(9):1468-1479. see summary.

Pilz, S., Dobnig, H., Fischer, J. E. Wellnitz B. Seelhorst U. Boehm B. o., and marz, w. low vitamin d levels predict stroke in patients referred for coronary angiography. stroke 2008;39(9):2611-2613. see summary.

Pilz, S., Tomaschitz, A., Ritz, E., and Pieber, T. r. Vitamin D status and arterial hypertension: a systematic review. nat.rev cardiol 2009;6(10):621-630. see summary.

Pironi, L., Maghetti, A., Zolezzi, C., Ruggeri, E., Incasa, E., Gnudi, S., Pizzoferrato, A., Barbara, L. and miglioli, m. Bone turnover in patients with home parenteral nutrition: a longitudinal observation using biochemical markers. clin.nutr 1996;15(4):157-163. see summary.

pisaniello, d., parmeggiani, d., piatto, a., avenia, n., d’ajello, m., monacelli, m., calzolari, f., sanguinetti, a., parmeggiani, u., and sperlongan, e.g. What therapy to prevent post-thyroidectomy hypocalcaemia? g.chir 2005;26(10):357-361. see summary.

Pitocco D. Crino A. Di Stasio E. Manfrini S. Guglielmi C. Spera S. Anguissola G. b. visalli, n. suraci, c. matteoli, m. c., patera, i. p., horse, m. g., bizzarri, c., and pozzilli, p. the effects of calcitriol and nicotinamide on residual pancreatic beta cell function in patients with recent-onset type 1 diabetes (imdiab xi). diabetes.med 2006;23(8):920-923. see summary.

Pitt, P., Li, F., Todd, P., Webber, D., Pack, S., and Moniz, C. a double-blind, placebo-controlled study to determine the effects of intermittent cyclic etidronate on bone mineral density in patients on long-term oral corticosteroid therapy. thorax 1998;53(5):351-356. see summary.

pitas, a. G. Chung M. Trikalinos T. Mitri J. Brendel M. Patel K. Lichtenstein A. h., lau, j., and balk, e. meter. systematic review: vitamin d and cardiometabolic outcomes. ann.intern med 3-2-2010;152(5):307-314. see summary.

pitas, a. G., Dawson-Hughes, B., Li, T., Van Dam, R. m., willett, w. C., Manson, J. e., and hu, f. b. Vitamin d and calcium intake in relation to type 2 diabetes in women. diabetes care 2006;29(3):650-656. see summary.

pitas, a. g., harris, s. s., rigid, p. c., and dawson-hughes, b. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. diabetes care 2007;30(4):980-986. see summary.

pitas, a. g., sun, q., manson, j. e., dawson-hughes, b., and hu, f. b. Plasma 25-hydroxyvitamin d concentration and risk of incident type 2 diabetes in women. diabetes care 2010;33(9):2021-2023. see summary.

piura e, chapman jw lipton a et al. serum 1-oh vitamin d and prognosis of postmenopausal patients with breast cancer: ncic-ctg ma 14 trial [abstract 534]. jclin oncol 2013;27:15.

plotnikoff, g. a. and Quigley, J. meter. prevalence of severe hypovitaminosis d in patients with persistent and nonspecific musculoskeletal pain. mayonnaise clin.proc. 2003;78(12):1463-1470. see summary.

plotnikoff, g. a. Does inconclusive evidence for vitamin d supplementation to reduce cardiovascular disease risk warrant pessimism? ann. intern med 3-8-2010;153(3):208-210. see summary.

poole, k. e., loveridge, n., barker, p. J., Halsall, D. J., Rose, C., Reeve, J., and Warburton, E. a. vitamin d depletion in acute stroke. stroke 2006;37(1):243-245. see summary.

popescu m, morris j and hillman l. calcium and vitamin d supplementation in children cf. pediatric pulmonology 1998;26(suppl17):359.

Praygod, G., Range, N., Faurholt-Jepsen, D., Jeremiah, K., Faurholt-Jepsen, M., Aabye, M. g., jensen, l., jensen, a. v., growth, h. m., magnussen, p., changalucha, j., andersen, a. b., and friis, h. Daily multiple micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-negative but HIV-uninfected patients in Mwanza, Tanzania. j nutr 2011-1-4;141(4):685-691. see summary.

prince, r. l., devine, a., dhaliwal, s. s., and dick, i. meter. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year double-blind, placebo-controlled trial in elderly women. arch intern.med. 2006-4-24;166(8):869-875. see summary.

Prince, R., Devine, A., Dick, I., Criddle, A., Kerr, D., Kent, N., Price, R. and Randell, A. the effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. j bone miners 1995;10(7):1068-1075. see summary.

przedlacki, j., manelius, j. and Huttunen, K. Bone mineral density assessed by dual-energy x-ray absorptiometry after one year of calcitriol treatment initiated in the predialysis phase of chronic renal failure. nephron 1995;69(4):433-437. see summary.

Psimenou E, Konstantinidou E, Giapraka N, Marinaki S, Kostakis A, and Stathakis CP. Randomized controlled study of calcitonin and etidronate in the treatment of osteoporosis in renal transplant patients. xix international congress of the transplant society 2002;

pun, k. K., Wong, F. h., wang, c., lau, p., ho, p. w., play on words, w. k., chow, s. p., cheng, c. L., Leong, J. c., and young, r. t. Vitamin D status among patients with fractured femoral neck in Hong Kong. Bone 1990;11(5):365-368. see summary.

ragi-eis, s., zerbini, c. a., provence, j. r., grey, l. h., from gregorio, l. h., Russian, l. a., silva, n. a., borges, j. l., de souza, a. c., castro, m. L., and Lewiecki, E. meter. Is it ethical to use placebos in osteoporosis trials? j clin densitom. 2006;9(3):274-280. see summary.

rajpathak, s. n. xue x. wassertheil-smoller s. van horn l. robinson j. G., Liu, S., Allison, M., Martin, L. w., ho, g. y., and rohan, t. me. 5-year effect of calcium plus vitamin d supplementation on change in circulating lipids: results from the women’s health initiative. I am j clin nutr 2010;91(4):894-899. see summary.

ramsay, c. a., schwartz, b. E., D. Lowson, K. Papp, A. Bolduc, and M. Gilbert. calcipotriol cream combined with twice weekly broadband uvb phototherapy: a safe, effective and uvb-sparing antipsoriatic combination treatment. the canadian calcipotriol and uvb study group. dermatology 2000;200(1):17-24. see summary.

ranganathan, l. north. and ramaratnam, s. vitamins for epilepsy cochrane.database.syst.rev 2005;(2):cd004304. see summary.

range, n., andersen, a. b., magnussen, p., mugomela, a., and friis, h. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. trop.med int health 2005;10(9):826-832. see summary.

Rashidi, B., Haghollahi, F., Shariat, M., and Zayerii, F. the effects of calcium-vitamin d and metformin in polycystic ovary syndrome: a pilot study. taiwan.j obstet.gynecol. 2009;48(2):142-147. see summary.

ravn, p., clemmesen, b., riis, b. j., and christiansen, c. The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for the prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study. Bone 1996;19(5):527-533. see summary.

recker, r. R. Hampers, S. Davies, K. m., heaney, r. p., stegman, m. R., Lappe, J. m., and kimmel, d. b. correction of nutritional calcium deficiency prevents spinal fractures in elderly women. j bone miner res 1996;11(12):1961-1966. see summary.

recker, r. R., Kendler, D., Recknor, C. P., Rooney, T. W., Lewiecki, E. m., utian, w. h., cauley, j. a. lorraine, j. qu, y. kulkarni, p. m., gaich, c. L., Wong, M., Pluffe, L., Jr., and Stock, J. I Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass. Bone 2007;40(4):843-851. see summary.

reddy, vanga s., well, m., howard, p. a., and vacek, j. I role of vitamin d in cardiovascular health. am j cardiol 9-15-2010;106(6):798-805. see summary.

Reed, A., Haugen, M., Pachman, L. m., and langman, c. b. 25-hydroxyvitamin d therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. jpediatrician 1991;119(4):657-660. see summary.

log, j. Y. Kuntz, D. Verdickt, W. Wouters, M. Guillevin, L. Menkes, C. J., and Nielsen, K. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. osteoporos.int 1999;9(1):75-81. see summary.

rehman, p. k. subclinical rickets and recurrent infection. jtrop.pediatr 1994;40(1):58. see summary.

reid, i. r., ames, r. w., evans, m. c., bet, g. d., and sharpe, s. J. Effect of calcium supplementation on bone loss in postmenopausal women. n.engl.j med. 2-18-1993;328(7):460-464. see summary.

reid, i. r., ames, r. w., evans, m. c., bet, g. d., and sharpe, s. J. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. i’m j med. 1995;98(4):331-335. see summary.

reid, i. R., Bolland, M. J., Avenell, A., and Grey, A. cardiovascular effects of calcium supplementation. osteoporos.int 2011;22(6):1649-1658. see summary.

reid, i. r., brown, j. P. Burckhardt P. Horowitz Z. Richardson P. Trechsel U. Widmer A. Devogelaer J. p., kaufman, j. m., jaeger, p., body, j. j., brandi, m. L. Broell J. Di Micco R. Genazzani A. R., Felsenberg, D., Happ, J., Hooper, M. J. Ittner J. Leb G. Mallmin H. Murray T. Ortolani S. Rubinacci A. Saaf M. Samsioe G. Verbruggen L. and meunier, pp. J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. n.engl.jmed 2002-28-2;346(9):653-661. see summary.

reid, i. R. Mason, B. Horne, A. Ames, R. Reid, H. e., bava, u., bolland, m. j., and bet, g. d. Randomized controlled trial of calcium in healthy older women. i’m j med. 2006;119(9):777-785. see summary.

reid, i. r., watts, d. j., evans, m. c., bet, g. D., Stapleton, J. p., and Cornwall, j. Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis. jclin endocrinol.metab 1994;79(6):1595-1599. see summary.

kings, j. P. von Muhlen D. Miller E. r., iii, michos, e. d., and appeal, l. J. Vitamin d status and cardiometabolic risk factors in the united states adolescent population. pediatrics 2009;124(3):e371-e379. see summary.

Rejnmark L, Avenell A, Masud T, Anderson F, Meyer H. eg, sanders, k. M., Salovaara, K., Cooper, C., Smith, H. e., jacobs, e. T., Torgerson, D., Jackson, R. D., Manson, J. E. Brixen K. Mosekilde L. Robbins J. a., francis, r. m., and abrahamsen, b. Vitamin d with calcium reduces mortality: pooled patient-level analysis of 70,528 patients from eight major vitamin d trials. jclin.endocrinol.metab 2012;97(8):2670-2681. see summary.

rendina, d., de, filippo g., and strazzullo, p. Should vitamin d status be assessed in patients with congestive heart failure? nutr metab cardiovasc.dis. 2010;20(9):627-632. see summary.

Reyes, Garcia R., Jodar, Gimeno E., Garcia, Martin A., Romero, Muñoz M., Gomez Saez, J. m., luque, fernandez, i, varsavsky, m., guadalix, churches s., cano, rodriguez, i, ballesteros pomar, m. D., Vidal, Casariego A., Rozas, Moreno P., Cortes, Berdonces M., Fernandez, Garcia D., Calleja, Canelas A., Palma, Moya M., Martinez Diaz-Guerra, G., Jimenez Moleon, J. j., and muñoz, torres m. clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional conditions. bone metabolism working group of the Spanish society of endocrinology]. endocrinol.nutr 2012;59(3):174-196. see summary.

rhee, h. V., Coebergh, J. w., and vries, e. d. sunlight, vitamin d, and cancer prevention: a systematic review of epidemiological studies. eur j anterior cancer. 8-26-2009; see summary.

Richy, F., Dukas, L., and Schacht, E. Differential effects of hormone d analogs and native vitamin d on fall risk: a comparative meta-analysis. calcif.tissue int 2008;82(2):102-107. see summary.

Richy, F., Ethgen, O., Bruyere, O., and Reginster, J. Y. Efficacy of alfacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. osteoporosis int 2004;15(4):301-310. see summary.

Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., and Reginster, J. Y. Vitamin d analogs versus native vitamin d in the prevention of osteoporosis-related bone loss and fractures: a comparative meta-analysis. calcif.tissue int 2005;76(3):176-186. see summary.

ris, b. J., Thomsen, K., and Christiansen, C. Does 24r,25(oh)2-vitamin d3 prevent postmenopausal bone loss? calcif tissue int 1986;39(3):128-132. see summary.

edge, j. h., choe, and. b., and young, j. Yo. Positive effect of using calcipotriol ointment with narrowband ultraviolet b phototherapy in patients with psoriasis. photodermatol.photoimmunol.photomed. 2002;18(3):131-134. see summary.

edge, j. h., park, j. and., choe, and. b., and young, j. Yo. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy. i am j clin.dermatol. 2003;4(7):507-510. see summary.

ring, j., kowalzick, l., christopher, e., schill, w. B. Schopf E. Stander M. Wolff H. h., and altmeyer, p. Calcitriol ointment 3 microg g-1 in combination with ultraviolet b phototherapy for the treatment of plaque psoriasis: results of a comparative study. br.j dermatol. 2001;144(3):495-499. see summary.

ring, j. d. and Schacht, E. potential of alfacalcidol to reduce the increased risk of falls and fractures. rheumatol.int 2009;29(10):1177-1185. see summary.

ring, j. d. questions about the superiority of alfacalcidol over plain vitamin d in the treatment of glucocorticoid-induced osteoporosis. rheumatol.int 2004;24(6):370. see summary.

ring, j. D., Coster, A., Meng, T., Schacht, E., and Umbach, R. treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin d/calcium. calcif.tissue int 1999;65(4):337-340. see summary.

ring, j. D., A. Dorst, H. Faber, K. Ibach, and J. Preuss. bolus injection of ibandronate every 3 months offers favorable tolerability and a sustained efficacy advantage over 2 years in established corticosteroid-induced osteoporosis. rheumatology.(oxford) 2003;42(6):743-749. see summary.

ring, j. D., Farahmand P., Faber H., and Dorst A. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. rheumatol.int 2009;29(3):311-315. see summary.

Ritz, E., Kuster, S., Schmidt-Gayk, H., Stein, G., Scholz, C., Kraatz, G., and Heidland, A. low-dose calcitriol prevents the increase in 1.84-ipth without affecting serum calcium and phosphate in patients with moderate renal insufficiency (multicenter prospective placebo-controlled trial). nephrol.dial.transplantation. 1995;10(12):2228-2234. see summary.

rix, m., eskildsen, p., and olgaard, k. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. nephrol.dial.transplantation. 2004;19(4):870-876. see summary.

rodriguez-martin, m., garcia, bustinduy m., saez, rodriguez m., and noda, cabrera a. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and exposure to sunlight in the treatment of non-segmental vitiligo in adults. br.j dermatol. 2009;160(2):409-414. see summary.

rodriguez-rodriguez, e., navia-lomban, b., lopez-sobaler, a. m., and ortega, r. meter. Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren. eur j clin nutr 2010;64(5):461-467. see summary.

roh, j. me and park, c. Yo. Routine oral calcium and vitamin d supplementation for prevention of hypocalcaemia after total thyroidectomy. amjsurg 2006;192(5):675-678. see summary.

pink, c. J. Morrison A. Zhou H. Storm D. Hunter S. J., K. Musgrave, T. Chen, W. Wei, and M. Holick. F. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calcium-tropic hormones. bone miner 1994;25(2):83-92. see summary.

ross, e. A. Tian J. Abboud H. Hippensteel R. Melnick J. Z., Pradhan, R. S., Williams, L. a., hamm, l. l., and sprague, s. meter. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. i am j nephrol. 2008;28(1):97-106. see summary.

roudebush, p., polzin, d. J., Adams, L. eg, towel, t. l., and forrester, s. d. An evidence-based review of therapies for canine chronic kidney disease. j little anim pract. 2010;51(5):244-252. see summary.

rovner, a. j., stagnation, v. A., Schall, J. i., leonard, m. b., and zemel, b. yes Vitamin d insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. am j clin nutr 2007;86(6):1694-1699. see summary.

Rudge, S., Hailwood, S., Horne, A., Lucas, J., Wu, F., and Cundy, T. Effects of once-weekly oral alendronate on bone in children receiving glucocorticoids. rheumatology.(oxford) 2005;44(6):813-818. see summary.

ruiz-irastorza, g., gordo, s., olivares, n., egurbide, m. v., and aguirre, c. Changes in vitamin d levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. arthritis care res (hoboken.) 2010;62(8):1160-1165. see summary.

ruiz-irastorza, g., ramos-casals, m., brito-zeron, p., and khamashta, m. a. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. ann.rheum.dis. 2010;69(1):20-28. see summary.

ruzicka, t. and lorenz, b. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks of calcipotriol treatment in the topical therapy of psoriasis vulgaris: a randomized, double-blind, multicenter study. br j dermatol 1998;138(2):254-258. see summary.

ryan, c. W. Huo D. Demers L. m., beer, t. m., and lacerna, l. v. Zoledronic acid started during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. jurol. 2006;176(3):972-978. see summary.

ryan, l. m., brandoli, c., freishtat, r. j., wright, j. l., tosi, l., and chamberlain, j. meter. prevalence of vitamin d insufficiency in african american children with forearm fractures: a preliminary study. j pediatric orthop. 2010;30(2):106-109. see summary.

ryan, p. and Dixon, T. prevalence of vitamin d insufficiency in patients attending a metabolic bone clinic in medway. curr med res opinion. 2006;22(1):211-216. see summary.

saab, g., young, d. O. Gincherman, Y. Giles, K., Norwood, K., and Coyne, D. w. prevalence of vitamin d deficiency and the safety and efficacy of monthly ergocalciferol in hemodialysis patients. nephron clin.pract. 2007;105(3):c132-c138. see summary.

saadati n, rajabian r. the effect of bisphosphonates in the prevention of glucocorticoid-induced osteoporosis. iranian red crescent medical journal 2008;10:8-11.

saag, k. g., emkey, r., schnitzer, t. j., brown, j. P. Hawkins F. Goemaere S. Thamsborg G. Liberman U. a., delmas, p. d., malice, m. p., czachur, m., and daifotis, a. gram. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. glucocorticoid-induced osteoporosis intervention study group. n.engl.j med. 7-30-1998;339(5):292-299. see summary.

sabherwal, s., bravis, v., and devendra, d. Effect of oral vitamin d and calcium replacement on glycemic control in South Asian patients with type 2 diabetes. Practice int j clin. 2010;64(8):1084-1089. see summary.

sahin, m. o., canda, a. E., Yorukoglu, K., Mungan, M. u., sade, m., and kirkali, z. 1,25 Dihydroxyvitamin D(3) Receptor Expression in Superficial Transitional Cell Carcinoma of the Bladder: A Possible Prognostic Factor? eur.urol. 2005;47(1):52-57. see summary.

Sahu, M., Das, V., Aggarwal, A., Rawat, V., Saxena, P., and Bhatia, V. Vitamin D replacement in pregnant women in rural North India: a pilot study. eur.jclin.nutr 2009;63(9):1157-1159. see summary.

sai, a. J., Gallagher, J. c., and fang, x. Effect of hormone therapy and calcitriol on serum lipid profile in older postmenopausal women: association with estrogen receptor-alpha genotypes. menopause. 2011;18(10):1101-1112. see summary.

sakuma, m., endo, n., oinuma, t., hayami, t., endo, e., yazawa, t., watanabe, k., and watanabe, s. vitamin d and intact pth status in patients with hip fracture. osteoporosis int 2006;17(11):1608-1614. see summary.

salmhofer, w., maier, h., soyer, h. p., honigsmann, h., and hodl, s. double-blind, placebo-controlled, randomized, right-to-left study comparing calcipotriol monotherapy with a combination treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. acta derm.venereol.suppl (stockh) 2000;(211):5-8. see summary.

Salovaara, K., Tuppurainen, M., Karkkainen, M., Rikkonen, T., Sandini, L., Sirola, J., Honkanen, R., Alhava, E. and Kroger, H. Effect of vitamin d(3) and calcium on fracture risk in women aged 65 to 71 years: a 3-year population-based, randomized, controlled trial: the ostpre-fps. j bone miner.res 2010;25(7):1487-1495. see summary.

salusky, i. B., J. Foley, P. Nelson, and W. Goodman. gram. Aluminum accumulation during aluminum hydroxide treatment and dialysis in children and young adults with chronic kidney disease. n.engl.j med. 21-2-1991;324(8):527-531. see summary.

salusky, i. b., good man, w. G. Sahney S. Wales B. Perilloux A. Wang H. J., Elashoff, R. m., and juppner, h. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during active vitamin D sterol therapy. j am soc nephrol 2005;16(8):2501-2508. see summary.

salusky, i. b., kuizon, b. d., belin, t. R., Ramirez, J. a., gales, b., segre, g. v., and goodman, w. gram. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. kidney int 1998;54(3):907-914. see summary.

sambrook pn. what treatments are effective in preventing and treating glucocorticoid-induced bone loss: commentary on the american college of rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. arthritis rheum 1997;40:1550-1551.

sambrook, p. N. Kotowicz M. Nash P. Styles c. B. Naganathan, V. Henderson-Briffa, K. N., Eisman, J. A., and Nicholson, G. c. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin d plus calcium, and alendronate plus calcium. j bone miner.res 2003;18(5):919-924. see summary.

Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N. and Eisman, J. prevention of osteoporosis by corticosteroids. a comparison of calcium, calcitriol and calcitonin. n.engl.j med. 6-17-1993;328(24):1747-1752. see summary.

sambrook, p., henderson, b. K., Keogh, A., Macdonald, P., Glanville, A., Spratt, P., Bergin, P., Ebeling, P., and Eisman, J. effect of calcitriol on bone loss after heart or lung transplantation. j bone miner res 2000;15(9):1818-1824. see summary.

sanabria, a., dominguez, l. c., vega, v., osorio, c., and duarte, d. Cost-effectiveness analysis regarding postoperative administration of vitamin d and calcium after thyroidectomy to prevent hypocalcaemia. rev.salud publica (bogotá) 2011;13(5):804-813. see summary.

sanabria, a., dominguez, l. c., vega, v., osorio, c., and duarte, d. Routine postoperative vitamin D and calcium administration after total thyroidectomy: a meta-analysis. surgery int j. 2011;9(1):46-51. see summary.

sanders, k. m., stuart, a. L., Merriman, E. n., read, m. L., Kotowicz, M. A. Young, D. Taylor, R. Blair-Holt, I. Mander, A. G., and Nicholson, G. c. trials and tribulations of recruiting 2000 older women in a clinical trial investigating falls and fractures: vital study d. bmc.med.res method. 2009;9:78. see summary.

sanders, k. m., stuart, a. L., Williamson, E. j., simpson, j. a., kotowicz, m. A. Young, D., and Nicholson, G. c. Annual high doses of oral vitamin D and falls and fractures in older women: a randomized controlled trial. jam 5-12-2010;303(18):1815-1822. see summary.

sandhu, m. yes and marry him, you. b. the role of vitamin d in asthma. ann.allergy asthma immunol. 2010;105(3):191-199. see summary.

Saraceno, R., Andreassi, L., Ayala, F., Bongiorno, M. R., Giannetti, A., Lisi, P., Martini, P., Peris, K., Pesrico, A., and Chimenti, S. Efficacy, safety, and quality of life of calcipotriol/betamethasone dipropionate (dovobet) versus calcipotriol (daivonex) in the treatment of psoriasis vulgaris: a multicenter, randomized clinical trial. j dermatolog.treat. 2007;18(6):361-365. see summary.

sato, y., honda, y. and iwamoto, j. Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial. bone 2006;39(5):1080-1086. [withdrawn]. see summary.

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Alendronate and vitamin d2 for the prevention of hip fracture in parkinson’s disease: a randomized controlled trial. mov disord 2006;21(7):924-929. [withdrawn]. see summary.

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Improvement of osteoporosis and hypovitaminosis d by sunlight exposure in elderly women hospitalized with alzheimer’s disease: a randomized controlled trial. j bone miner.res 2005;20(8):1327-1333. [withdrawn]. see summary.

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Low-dose vitamin d prevents muscle atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. cerebrovasc.dis. 2005;20(3):187-192. [withdrawn]. see summary.

sato, y., kanoko, t., satoh, k. and iwamoto, j. Prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer’s disease: a randomized controlled trial. internal arch med 8-8-2005;165(15):1737-1742. [withdrawn]. see summary.

Sato, Y., Kanoko, T., Yasuda, H., Satoh, K. and iwamoto, j. Beneficial effect of etidronate therapy in immobilized hip fracture patients. am j phys.med rehabil 2004;83(4):298-303. [withdrawn]. see summary.

Sato, Y., Kuno, H., Asoh, T., Honda, Y., and Oizumi, K. Effect of immobilization on vitamin d status and bone mass in chronically hospitalized disabled stroke patients. age aging 1999;28(3):265-269. [withdrawn]. see summary.

Sato, Y., Manabe, S., Kuno, H., and Oizumi, K. Improvement of osteopenia and hypovitaminosis d by 1 alpha-hydroxyvitamin d3 in elderly patients with parkinson’s disease. j neurol.neurosurg.psychiatry 1999;66(1):64-68. [withdrawn]. see summary.

Sato, Y., Maruoka, H., and Oizumi, K. improvement of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin d3 and calcium supplementation. stroke 1997;28(4):736-739. [withdrawn]. see summary.

sawka, a. m., papaioannou, a., adachi, j. D. Gafni, A. Hanley, D. a., and thabane, l. Does alendronate reduce fracture risk in men? a meta-analysis incorporating previous knowledge on antifracture efficacy in women. bmc. musculoskeletal disorder. 2005;6:39. see summary.

scarpa c, kokelj f, plozzer c, lavani g and torsello p. Efficacy and tolerability of once-daily tacalcitol in the treatment of psoriasis vulgaris (Italian multicenter, double-blind, randomized, placebo-controlled study). giornale italiano di dermatologiae venereologia 1997;132(5):335-338.

escarpment c. Tacalcitol ointment is an effective and well-tolerated treatment for psoriasis. journal of the european academy of dermatology & venereology 1996;6(2):142-146.

schaadt op and bohr hh. Alfacalcidol in prednisone treatment: a controlled study of the effect on bone mineral content in the lumbar spine, femoral neck, and diaphysis. calcif tissue int 1986;39(suppl):a58.

schaafsma, a., muskiet, f. a. storm, h. hofstede, g. j., pakan, i., and van, der, v. Vitamin d(3) and vitamin K(1) supplementation in Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin d and carboxylated osteocalcin. eur j clin nutr 2000;54(8):626-631. see summary.

schaafsma, a., van doormaal, j. j., musket, f. a., hofstede, g. j., pakan, i., and van, der, v. Positive effects of a chicken eggshell powder-enriched vitamin-mineral supplement on femoral neck bone mineral density in healthy late postmenopausal Dutch women. br.j nutr 2002;87(3):267-275. see summary.

schachter hm, clifford tj, cranney a, barrowman nj, and moher d. Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of the evidence for efficacy and safety Ottawa, Ontario, Canada: Canadian Coordinating Office for Health Technology Assessment. 2005;

scher, h. i. jia x. chi k. de wit r. berry w. R. Albers P. Henick B. Waterhouse D. Ruether D. j., rosen, p. J., Meluch, A. A., Nordquist, L. t., venner, p. m., heidenreich, a., chu, l., and heller, g. Phase III randomized open-label trial of high-dose docetaxel plus calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. jclin.oncol. 6-1-2011;29(16):2191-2198. see summary.

schmitt, c. P., Ardissino, G., Testa, S., Claris-appiani, A., and Mehls, O. growth in children with chronic renal failure with intermittent versus daily calcitriol. pediatricr.nephrol 2003;18(5):440-444. see summary.

schnatz, p. F. the 2010 american menopause society position statement: updates on detection, prevention, and management of postmenopausal osteoporosis. conn.med. 2011;75(8):485-487. see summary.

schoenthal l, brodsky rh. dietary control and etiology of dental caries. i am j dis child. 1933; 46:91-104.

Schoindre, Y., Terrier, B., Kahn, J. E. Saadoun, D. Souberbielle, J. C. Benveniste O. Amoura Z. Piette J. c., cacoub, p., and costodoat-chalumeau, b. [vitamin d and autoimmunity. second part: clinical aspects]. rev.med.interne 2012;33(2):87-93. see summary.

scholl, t. or y chen, x. Vitamin d intake during pregnancy: association with maternal characteristics and infant birth weight. early hum.dev. 2009;85(4):231-234. see summary.

schwarz, s. and Leweling, H. multiple sclerosis and nutrition. mul.scler. 2005;11(1):24-32. see summary.

scragg, r., khaw, k. T., and Murphy, S. Effect of oral vitamin d3 supplementation in winter on cardiovascular risk factors in older adults. eur j clin nutr 1995;49(9):640-646. see summary.

seeman, e., crans, g. g. ten-perez, a. pinette, k. v., and delmas, p. d. Vertebral fracture efficacy of raloxifene: a meta-analysis. osteoporosis int 2006;17(2):313-316. see summary.

sorry, you. a., semaeo, e. J. Stettler N. Piccoli D. a., stagnation, v. a., and zemel, b. yes Vitamin D status in children, adolescents, and young adults with Crohn’s disease. am j clin nutr 2002;76(5):1077-1081. see summary.

Seubwai, W., Wongkham, C., Puapairoj, A., Khuntikeo, N., and Wongkham, S. Vitamin D receptor overexpression indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. cancer 6-15-2007;109(12):2497-2505. see summary.

shahar, d. R. Schwarzfuchs, D. Fraser, D. Vardi, H. Thiery, J., Fiedler, G. m., bluher, m., stumvoll, m., stampfer, m. J., and Shai, I. dairy calcium intake, serum vitamin d, and successful weight loss. I am j clin nutr 2010;92(5):1017-1022. see summary.

sharma rk, jeloka t, gupta a, gupta s, gulati s and sharma ap. Role of alendronate in post-kidney transplant osteoporosis: a randomized study. indian journal of nephrology 2002;12(4):236-237.

shaw, n. j., boivin, c. m., and crab, n. J. Intravenous pamidronate in juvenile osteoporosis. archdis.child 2000;83(2):143-145. see summary.

shaw, n. vitamin d and bone health in children bmj 2011;342:d192. see summary.

Shea, B., Wells, G., Cranney, A., Zytaruk, N., Robinson, V., Griffith, L., Ortiz, Z., Peterson, J., Adachi, J., Tugwell, p., and guyatt, g. Meta-analysis of therapies for postmenopausal osteoporosis. vii. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. endocr.rev. 2002;23(4):552-559. see summary.

Shikari, M., Kushida, K., Yamazaki, K., Nagai, T., Inoue, T., and Orimo, H. Effects of 2-year treatment of osteoporosis with 1 alpha-hydroxy vitamin d3 on bone mineral density and fracture incidence: a prospective double-blind placebo-controlled study. endocr.j 1996;43(2):211-220. see summary.

shiraki, m. [Physician-Initiated Clinical Trial for Evidence in the Treatment of Osteoporosis: Joint Protocol (Japanese Osteoporosis Intervention Trial)]. nihon rinsho 2011;69(7):1281-1286. see summary.

shiraki, m. and Orimo, H. [The effect of estrogens and sex steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis: a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-ohd3) on senile osteoporosis]. nippon naibunpi gakkai zasshi 1991-2-20;67(2):84-95. see summary.

Shiraki, M., Orimo, H., Ito, H., Akiguchi, I., Nakao, J., Takahashi, R. and Ishizuka, S. long-term treatment of postmenopausal osteoporosis with active vitamin d3, 1-alpha-hydroxycholecalciferol (1alpha-ohd3), and 1,24 dihydroxycholecalciferol (1,24(oh)2d3). endocrinol jpn. 1985;32(2):305-315. see summary.

sidbury, r., sullivan, a. f., thadhani, r. i., and Camargo, c. a., jr. Randomized controlled trial of vitamin d supplementation for winter-related atopic dermatitis in boston: a pilot study. br.j dermatol. 2008;159(1):245-247. see summary.

Sinclair, D., Abba, K., Grobler, L., and Sudarsanam, T. d. nutritional supplements for people being treated for active tuberculosis. cochrane.database.syst.rev. 2011;(11):cd006086. see summary.

slattery, m. l., neuhausen, s. L., Hoffman, M., Caan, B., Curtin, K., Ma, K. n., and Samowitz, w. dietary calcium, vitamin d, vdr genotypes, and colorectal cancer. int j cancer 9-20-2004;111(5):750-756. see summary.

smedshaug gb, pedersen ji and meyer he. Can vitamin d supplementation improve grip strength in elderly nursing home residents? a double-blind controlled trial. scand j food nutr 2007;51:74-78.

Smith, H., Anderson, F., Raphael, H., Maslin, P., Crozier, S., and Cooper, C. Effect of annual intramuscular vitamin d on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trial. rheumatology.(oxford) 2007;46(12):1852-1857. see summary.

blacksmith, m. r. Diagnosis and management of treatment-related osteoporosis in men with carcinoma of the prostate. cancer 2-1-2003; 97 (3 supplements): 789-795. see summary.

blacksmith, m. r. osteoporosis and other adverse changes in body composition during androgen deprivation therapy for prostate cancer. cancer metastasis rev. 2002;21(2):159-166. see summary.

blacksmith, m. r. osteoporosis during androgen deprivation therapy for prostate cancer. urology 2002;60(3):79-85.

blacksmith, m. R., Eastham, J., Gleason, D. m., shasha, d., tchekmedyian, s., and zinner, n. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for non-metastatic prostate cancer. jurol. 2003;169(6):2008-2012. see summary.

blacksmith, m. R., Egerdie, B., Hernandez, Toriz N., Feldman, R., Tammela, T. L. Saad, F. Heracek, J. Szwedowski, M. Ke, C. Kupic, A. Leder, B. z., and gosl, c. denosumab in men receiving androgen deprivation therapy for prostate cancer. n.engl.j med. 2009-8-20;361(8):745-755. see summary.

blacksmith, m. r., fallon, m. A., Lee, H., and Finkelstein, J. yes Raloxifene for preventing gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. j clin.endocrinol.metab 2004;89(8):3841-3846. see summary.

snijder, m. b., go to school, n. m., pluijm, s. m., van dam, r. m., visser, m., and lips, p. Vitamin d status in relation to 1-year risk of recurrent falls in older men and women. j clin.endocrinol.metab 2006;91(8):2980-2985. see summary.

snyman, j. R. de Sommers K. Steinmann M. a., and lizamore, d. J. Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis. eur jclin pharmacol. 1997;52(4):277-280. see summary.

sowers, m. R., Wallace, R. b., and lemke, j. h. The association of vitamin d and calcium intake with blood pressure among women. am j clin nutr 1985;42(1):135-142. see summary.

Staberg, B., Roed-Petersen, J., and Menne, T. Efficacy of topical treatment in psoriasis with mc903, a new analog of vitamin d. acta derm.venereol. 1989;69(2):147-150. see summary.

stein, e. M., Ortiz, D., Jin, Z., McMahon, D. J., and Shane, E. Fracture prevention after solid organ transplantation: a meta-analysis. j clin.endocrinol.metab 2011;96(11):3457-3465. see summary.

stempfle, h. U. Werner C. Echtler S. Wehr U. Rambeck W. A. Siebert, U. Uberfuhr, P. Angrymann, C. E., Theisen, K., and Gartner, R. Prevention of osteoporosis after heart transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. transplant 8-27-1999;68(4):523-530. see summary.

stempfle, h. U. Werner C. Siebert U. Assum T. Wehr U. Rambeck W. A. Meiser, B., Theisen, K., and Gartner, R. The role of tacrolimus (fk506)-based immunosuppression on bone mineral density and bone turnover after heart transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. transplant 2-27-2002;73(4):547-552. see summary.

stene, l. c. and Joner, G. Cod liver oil use during the first year of life is associated with a lower risk of childhood-onset type 1 diabetes: a large population-based case-control study. am j clin nutr 2003;78(6):1128-1134. see summary.

stene, l. C., Ulriksen, J., Magnus, P., and Joner, G. Cod liver oil use during pregnancy was associated with a lower risk of type I diabetes in the offspring. diabetology 2000;43(9):1093-1098. see summary.

stevenson, m., jones, m. L. de nigris E. Brewer N. Davis S. and Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene, and teriparatide for the prevention and treatment of postmenopausal osteoporosis. health.technology.assessment 2005;9(22):1-160. see summary.

stewart, r. and hirani, v. Relationship between vitamin d levels and depressive symptoms in older residents of a nationally surveyed population. psychosom med 2010;72(7):608-612. see summary.

sticherling, m., augustin, m., boehncke, w. H., Christophers, E., Domm, S., Gollnick, H., Reich, K., and Mrowietz, U. Psoriasis therapy in childhood and adolescence – a consensus of German experts. j dtsch.dermatol.ges. 2011;9(10):815-823. see summary.

stockton, k. A. Mengersen K. Paratz J. D., Kandiah, D., and Bennell, K. I effect of vitamin d supplementation on muscle strength: a systematic review and meta-analysis. osteoporos.int 2011;22(3):859-871. see summary.

stolzenberg-solomon, r. Z., Hayes, R. b., horst, r. L., Anderson, K. e., hollis, b. w., and silverman, d. t. Serum vitamin D and pancreatic cancer risk in the prostate, lung, colon, and ovarian screening trial. rescancer 2-15-2009;69(4):1439-1447. see summary.

strasky, m. and Rysava, L. nutrition as prevention and treatment of osteoporosis. physiol res 2009;58 supplement 1:s7-s11. see summary.

Straube, S., Derry, S., Moore, R. a., and mcquay, h. J. vitamin d for the treatment of chronic painful conditions in adults. Cochrane Database System Rev 2010;(1):cd007771. see summary.

straube, s., moore, r. A., Derry, S., Hallier, E., and Mcquay, H. J. vitamin d and chronic pain in immigrant and ethnic minority patients: investigation of relationship and comparison with native western populations. int j endocrinol. 2010;2010:753075. see summary.

stream lp, beaudet jp. Inhibition of dental caries by ingestion of fluoridevitamin tablets. ny state j med. 1945;45:2183.

sudarsanam, t. D. John, J. Kang, G. Mahendri, V. Gerrior, J. Franciosa, M. Gopal, S. John, K. r., straw, c. a., and muliyil, j. Pilot randomized trial of nutritional supplements in patients with tuberculosis and hiv-tuberculosis co-infection receiving short-course, directly observed chemotherapy for tuberculosis. trop.med.int health 2011;16(6):699-706. see summary.

sudden, j. a., davies, j. i., conam, m. d., morris, a. d., and struthers, a. d. vitamin d improves endothelial function in patients with type 2 diabetes mellitus and low vitamin d levels. diabetes.med 2008;25(3):320-325. see summary.

sutherland, e. R. Goleva, E. Jackson, L. p., stevens, a. d., and leung, d. Y. Vitamin d levels, lung function, and steroid response in adult asthma. am j respir. crit care med 4-1-2010;181(7):699-704. see summary.

Swanenburg, J., de Bruin, E. D., Stauffacher, M., Mulder, T., and Uebelhart, D. Effects of exercise and nutrition on postural balance and risk of falls in older people with decreased bone mineral density: a randomized controlled trial pilot study. clin rehabilitation 2007;21(6):523-534. see summary.

tai, k., need, a. G., Horowitz, M., and Chapman, I. meter. glucose tolerance and vitamin d: effects of treatment of vitamin d deficiency. nutrition 2008;24(10):950-956. see summary.

Takeda, S., Kaneoka, H., and Saito, T. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol. rheumatol mod. 2008;18(3):271-276. see summary.

Talalaj, M., Gradowska, L., Marcinowska-suchowierska, E., Durlik, M., Gaciong, Z. and lao, m. Efficacy of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin d3 and calcium in kidney transplant patients. transplant.proc. 1996;28(6):3485-3487. see summary.

Tamez, S., Norizoe, C., Ochiai, K., Takahashi, D., Shimojima, A., Tsutsumi, Y., Yanaihara, N., Tanaka, T., Okamoto, A. and urashima, m. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. br.j cancer 12-15-2009;101(12):1957-1960. see summary.

tanaka, h. [Nutrition and bone health during childhood]. clin calcium 2008;18(10):1504-1509. see summary.

spike, b. m., eslick, g. D., C. Nowson, C. Smith, and A. Bensoussan. Use of calcium or calcium in combination with vitamin d supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 8-25-2007;370(9588):657-666. see summary.

tartaglia, f., giuliani, a., sgueglia, m., biancari, f., juvonen, t. and bell, f. p. Randomized study of oral administration of calcitriol to prevent symptomatic hypocalcaemia after total thyroidectomy. amjsurg 2005;190(3):424-429. see summary.

Tauchmanova, L., de, Simone G., Musella, T., Orio, F., Ricci, P., Nappi, C., Lombardi, G., Colao, A., Rotoli, B., and seller, c. Effects of various antiresorptive therapies on bone mineral density in young hypogonadal women after allogeneic stem cell transplantation. bone marrow transplant. 2006;37(1):81-88. see summary.

Tauchmanova, L., Guerra, E., Pivonello, R., de Martino, M. c., from Leo m., Caggiano, f., Lombardi, g., and Colao, a. Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing’s syndrome. j endocrinol.invest 2009;32(5):390-394. see summary.

Taxel, P., Dowsett, R., Richter, L., Fall, P., Klepinger, A. and Albertsen, p. Risedronate prevents early bone loss and increases bone turnover in the first 6 months of luteinizing hormone-releasing hormone agonist therapy for prostate cancer. bju.int 2010;106(10):1473-1476. see summary.

tenconi, m. t., devoti, g., comelli, m., pinon, m., capocchiano, a., calcaterra, v., and pretti, g. Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study. diabetes record. 2007;44(1):14-19. see summary.

tenford, a. s., sayres, l. c., sainani, k. L., and Fredericson, M. Evaluating the relationship of calcium and vitamin d in the prevention of stress fracture injuries in the young athlete: a review of the literature. pm.r. 2010;2(10):945-949. see summary.

tentori, f., albert, j. m., young, e. w., blayney, m. j., robinson, b. m., pisoni, r. L., Akiba, T., Greenwood, R. n., kimata, n., levin, n. w., piera, l. m., saran, r., wolfe, r. a., and port, f. k. Survival advantage for hemodialysis patients taking vitamin d is questioned: findings from the dialysis outcomes study and practice patterns. nephrol.dial.transplantation. 2009;24(3):963-972. see summary.

thacher td, ighogboja si and fischer pr. Rickets without vitamin D deficiency in Nigerian children. ambulatory child health 1997;3(1):56-64.

thatcher, t. d., fischer, p. r., pettifor, j. m., lawson, j. o., isichei, c. o., and chan, g. meter. Case-control study of factors associated with nutritional rickets in Nigerian children. jpediatrician 2000;137(3):367-373. see summary.

thatcher, t. d., fischer, p. r., strand, m. a., and pettifor, j. meter. Nutritional rickets worldwide: causes and future directions. ann.trop.paediatr. 2006;26(1):1-16. see summary.

tham, yes. n., mon, k. c., and cheong, w. k. a comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. br j dermatol 1994;131(5):673-677. see summary.

columbia university school of dental and oral surgery. report to the community fund. new york: commonwealth fund 1934;

theodoratou, e., farrington, s. M. Tenesa, A. McNeill, G. Cetnarskyj R., Barnetson R. a., porteous, m. eg, Dunlop, m. G., and Campbell, H. Modifying the inverse association between dietary vitamin d intake and colorectal cancer risk by a foki variant supports a chemoprotective action of vitamin d intake mediated by vdr binding. int j cancer 2008-1-11;123(9):2170-2179. see summary.

Thiebaud, D., Burckhardt, P., Costanza, M., Sloutskis, D., Gilliard, D., Quinodoz, F., Jacquet, A. f., and burnand, b. Importance of albumin, 25(oh)-vitamin D and igfbp-3 as risk factors in elderly women and men with hip fracture. osteoporosis int 1997;7(5):457-462. see summary.

Thomas, g. n., scragg, r., jiang, c. q., chan, w., marz, w., pilz, s., kim, h. C. Tomlinson B. Bosch J. Lam T. h., cheung, b. m., and cheng, k. k. hyperglycemia and vitamin d: a systematic overview. curr.diabetes rev. 2012;8(1):18-31. see summary.

Thomsen, K., Nilas, L., and Christiansen, C. Dietary calcium intake and blood pressure in normotensive subjects. record med.scan. 1987;222(1):51-56. see summary.

thomsen, k., riis, b., and christiansen, c. Effect of estrogen/gestagen therapy and 24r,25-dihydroxyvitamin d3 on bone formation in postmenopausal women. j bone miners 1986;1(6):503-507. see summary.

thorne-lyman, a. and fawzi, w. w. Vitamin d during pregnancy and maternal, neonatal, and child health outcomes: a systematic review and meta-analysis. paediatr.perinat.epidemiol 2012;26 supplement 1:75-90. see summary.

Thornton, J., Ashcroft, D., O’Neill, T., Elliott, R., Adams, J., Roberts, C., Rooney, M., and Symmons, D. a systematic review of the effectiveness of strategies to reduce fracture risk in children with juvenile idiopathic arthritis with additional data on long-term fracture risk and cost of disease management. health technology assessment. 2008;12(3):iii-xiv, 1. see abstract.

thys-jacobs, s., donovan, d., papadopoulos, a., sarrel, p., and bilezikian, j. p. Vitamin D and calcium dysregulation in polycystic ovary syndrome. Steroids 1999;64(6):430-435. see summary.

tilyard, m. w., spears, g. f., thomson, j., and dovey, s. treatment of postmenopausal osteoporosis with calcitriol or calcium. n.engl.j med. 6-2-1992;326(6):357-362. see summary.

tisdall ff. the effect of nutrition on primary teeth. child development 1937;8:102-104.

tiwari, a. elocalcitol, a vitamin d3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder, and male infertility. drugs 2009;12(6):381-393. see summary.

Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner S. m., and rump, l. c. high-dose cholecalciferol to correct vitamin d deficiency in hemodialysis patients. nephrol.dial.transplantation. 2008;23(12):4016-4020. see summary.

tomb, b. a holistic approach to androgen deprivation therapy: treating cancer without harming the patient. urol.int 2009;83(4):373-378. see summary.

toner, c. d., davis, c. d., and milner, j. a. the conundrum of vitamin d and cancer: aiming for a moving target. j am diet assoc 2010;110(10):1492-1500. see summary.

torgerson, d. J. and bell-syer, s. me. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. jam 6-13-2001;285(22):2891-2897. see summary.

torgerson, d. J. and bell-syer, s. me. Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomized trials. bmc.musculoskelet.disord 2001;2:7. see summary.

torregrosa, j. v., bover, j., cannata, andia j., lorenzo, v., de francisco, a. L., Martinez, I., Rodriguez, Portillo M., Arenas, L., Gonzalez, Parra E., Caravaca, F., Martin-Malo, A., Fernandez, Giraldez E., and Torres, A. Recommendations of the Spanish Society of Nephrology for the control of mineral and bone disorders in patients with chronic kidney disease (s.e.n.-m.b.d.). nephrology. 2011;31 supplement 1:3-32. see summary.

torregrosa, j. V. Moreno, A. Gutierrez, A. Vidal, S., and Oppenheimer, F. alendronate for the treatment of renal transplant patients with osteoporosis. transplant.proc. 2003;35(4):1393-1395. see summary.

torres, a., garcia, s., gomez, a., gonzalez, a., barrios, y., concepcion, m. T., Hernandez, D., Garcia, J. j., Czech, m. d., lorenzo, v., and out, e. intermittent calcitriol and calcium therapy reduces bone loss after renal transplantation. kidney int 2004;65(2):705-712. see summary.

Tougaard, L., Sorensen, E., Brochner-Mortesen, J., Christensen, M. s., rodbro, p., and sorensen, a. w. controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure. lancet 5-15-1976;1(7968):1044-1047. see summary.

touvier, m., chan, d. s., lau, r., aune, d., scallop, r., greenwood, d. C., Kampman, E., Riboli, E., Hercberg, S., and Norat, T. Meta-analysis of vitamin d intake, 25-hydroxyvitamin d status, vitamin d receptor polymorphisms, and colorectal cancer risk. cancer epidemiol. biomarkers ant. 2011;20(5):1003-1016. see summary.

trager, j. d. what is your diagnosis well-defined vulvar erythema in two girls. j pediatr.adolesc.gynecol. 2005;18(1):43-46. see summary.

tremor, a. and Gilbert, J. a. dairy products, insulin resistance syndrome and type 2 diabetes. j am coll nutr 2009;28 supplement 1:91s-102s. see summary.

tretli, s., hernes, e., berg, j. p., hestvik, u. e., and robsahm, t. me. Association between serum 25(oh)d and death from prostate cancer. br.j cancer 2009-10-2;100(3):450-454. see summary.

Tripkovic, L., Lambert, H., Hart, K., Smith, C. P., Bucca, G., Penson, S., Chope, G., Hypponen, E., Berry, J., Vieth, R., and Lanham-new, S. Comparison of vitamin d2 and vitamin d3 supplementation to elevate serum 25-hydroxyvitamin d status: a systematic review and meta-analysis. am j clin.nutr 2012;95(6):1357-1364. see summary.

tsugawa, s. [Vitamin d and osteoporosis: current topics of epidemiological studies]. rinsho byori 2010;58(3):244-253. see summary.

tuppurainen, m., heikkinen, a. m., penttila, i., and saarikoski, s. does vitamin d3 have negative effects on serum lipid levels? a follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin d3. maturitas 1995;22(1):55-61. see summary.

Ugur, A., Guvener, N., Isiklar, I., Karakayali, H., and Erdal, R. Efficacy of preventive treatment of osteoporosis after renal transplantation. transplant.proc. 2000;32(3):556-557. see summary.

urrutia, r. p. and Thorp, J. meter. vitamin d in pregnancy: current concepts. curr.opin.obstet.gynecol. 2012;24(2):57-64. see summary.

Ushiroyama, T., Ikeda, A., Sakai, M., Higashiyama, T., and Ueki, M. Effects of combined use of calcitonin and 1 alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term, continuous administration of low-dose calcitonin. mature 2001-12-14;40(3):229-238. see summary.

Vacca, A., Cormier, C., Piras, M., Mathieu, A., Kahan, A., and Allanore, Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. j rheumatic 2009;36(9):1924-1929. see summary.

vallecillo, g., ten, a., carbonell, j., and gonzalez, macias j. [Treatment of osteoporosis with calcium and vitamin d. systematic review]. med.clin (barc.) 10-6-2000;115(2):46-51. see summary.

van beresteyn, e. c., schaafsma, g., and de, waard h. Oral calcium and blood pressure: a controlled intervention trial. am j clin nutr 1986;44(6):883-888. see summary.

van Cleemput, J., Daenen, W., Geusens, P., Dequeker, P., van de Werf, F. and Vanhaecke, J. prevention of bone loss in heart transplant recipients. a comparison of bisphosphonates and vitamin d. transplant 5-27-1996;61(10):1495-1499. see summary.

van de Kerkhof, p. c., cambazard, f., hutchinson, p. E. Haneke, E. Wong, E. Souteyrand, P. Damstra, R. J. Combemale, P. Neumann, M. h., chalmers, r. J., Olsen, L. and revuz, j. the effect of adding calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. br.j dermatol. 1998;138(1):84-89. see summary.

van de Kerkhof, p. C. Green, C. Hamburg, K. j., hutchinson, p. E., Jensen, J. K. Kidson, P. Kragballe, K. Larsen, F. g., munro, c. s., and tillman, d. meter. Safety and efficacy of high-dose combination treatment with calcipotriol ointment and solution in patients with psoriasis. dermatology 2002;204(3):214-221. see summary.

van de Kerkhof, p. c., van, bokhoven m., zultak, m., and czarnetzki, b. meter. a double-blind study of topical 1 alpha,25-dihydroxyvitamin d3 in psoriasis. br j dermatol 1989;120(5):661-664. see summary.

van de Kerkhof, p. c., wasel, n., kragballe, k., cambazard, f., and murray, s. a two-component product containing calcipotriol and betamethasone dipropionate provides rapid and effective treatment of psoriasis vulgaris regardless of baseline disease severity. dermatology 2005;210(4):294-299. see summary.

van de Kerkhof, p. C. Werfel, T. Hausten, U. f., luger, t., czarnetzki, b. m., niemann, r., and planitz-stenzel, v. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicenter, placebo-controlled, double-blind efficacy and safety study. br j dermatol 1996;135(5):758-765. see summary.

van de Kerkhof, P., de, Peuter R., Ryttov, J. and Jansen, J. p. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. curr.med.res opinion. 2011;27(1):225-238. see summary.

van der putten, g. J. Vanobbergen J. de Visschere L. Schols J. and de Baat C. Association of some specific nutritional deficiencies with periodontal disease in older people: a systematic review of the literature. nutrition 2009;25(7-8):717-722. see summary.

van dijk f, ham thio hb neumann. non-oncological and non-infectious diseases of the penis (penile lesions). eau-ebu update series 2006;4:13-19.

vargas, a. J. and Thompson, p. a. Diet and nutritional factors on colorectal cancer risk. practice nutr.clin. 2012;27(5):613-623. see summary.

vecchio, m., navaneethan, s. d., johnson, d. W. Lucisano, G. Graziano, G. Saglimbene, V. Ruospo, M. Querques, M. Jannini, E. a., and strippoli, g. F. Interventions for the treatment of sexual dysfunction in patients with chronic kidney disease. Cochrane Database System Rev 2010;(12):cd007747. see summary.

veien, n. K., Bjerke, J. R., Rossmann-Ringdahl, I., and Jakobsen, H. b. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. a double-blind trial. br j dermatol 1997;137(4):581-586. see summary.

verreault, r., semba, r. d., volpato, s., ferrucci, l., fried, l. p., and guralnik, j. meter. low serum vitamin d does not predict new disability or loss of muscle strength in older women. j am geriatric soc 2002;50(5):912-917. see summary.

vestergaard, p., mosekilde, l., and langdahl, b. Prevention of fractures in postmenopausal women. clin.evid.(online.) 2011;2011 see abstract.

Viapiana, O., Gatti, D., Rossini, M., Idolazzi, L., Fracassi, E., and Adami, S. [Vitamin D and fractures: a systematic review]. rheumatism. 2007;59(1):15-19. see summary.

vieth, r., chan, p. c., and macfarlane, g. d. efficacy and safety of vitamin d3 intake exceeding the lowest level of observed adverse effects. I am j clin nutr 2001;73(2):288-294. see summary.

vieth, r., kimball, s., hu, a., and walfish, p. gram. Randomized comparison of the effects of adequate vitamin d3 intake versus 100 mcg (4000 iu) per day on biochemical responses and well-being in patients. nut j 7-19-2004;3:8. see summary.

viljakainen, h. t., natri, a. m., karkkainen, m., huttunen, m. M. Palssa, A. Jakobsen, J. Cashman, K. d., molgaard, c., and lamberg-allardt, c. A positive dose-response effect of vitamin d supplementation on increased site-specific bone minerals in adolescent girls: a 1-year double-blind randomized placebo-controlled intervention. j bone miner res 2006;21(6):836-844. see summary.

vogel, v. G., Costantino, J. p., wicker, d. L., Cronin, W. m., cecchini, r. S., Atkins, J. n., bever, t. B. Fehrenbacher, L. Pajon, E. R., Jr., Wade, J. L. III, Robidoux, A. Margolese, R. G., James, J., Lippman, S. m., runowicz, c. d., ganz, p. a., kings, s. E., McCaskill-Stevens, W., Ford, L. g., jordan, v. c., and wolmark, b. Effects of tamoxifen versus raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the nsabp study of tamoxifen and raloxifene (star) p-2 trial. jam 6-21-2006;295(23):2727-2741. see summary.

von hurst, p. R., Stonehouse, W., and Coad, J. Vitamin d supplementation reduces insulin resistance in south asian women living in new zealand who are insulin resistant and vitamin d deficient: a randomized placebo-controlled trial. br j nutr 2010;103(4):549-555. see summary.

von, j. knorring, p. slatis, t. weber. h., and Helen, t. Serum levels of 25-hydroxyvitamin d, 24,25-dihydroxyvitamin d, and parathyroid hormone in patients with femoral neck fracture in southern finland. clin endocrinol.(oxf) 1982;17(2):189-194. see summary.

vondracek, s. F. and with a hood, d. w. Combination vitamin d therapy in stage 5 chronic kidney disease. ann.pharmacother. 2011;45(7-8):1011-1015. see summary.

wagner, d., sidhom, g., whiting, s. J., Rousseau, D., and Vieth, R. Bioavailability of vitamin D from fortified cheeses and supplements is equivalent in adults. j nutr 2008;138(7):1365-1371. see summary.

wang, h., xia, n., yang, y., and peng, d. q. influence of vitamin d supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. lipids health dis. 2012;11:42. see summary.

wang, l., manson, j. e., song, y., and sesso, h. d. systematic review: vitamin d and calcium supplements in the prevention of cardiovascular events. ann.intern.med. 3-2-2010;152(5):315-323. see summary.

Wang, L. Song, Y. Manson, J. E. Pilz S. Marz W. Michaelsson K. Lundqvist A. Jassal S. K. Barrett-Connor E. Zhang C. Eaton C. b., may, h. T., Anderson, J. l., and sesso, h. d. Circulating 25-hydroxy-vitamin d and cardiovascular disease risk: a meta-analysis of prospective studies. circ.cardiovasc.qual.results. 2012;5(6):819-829. see summary.

war, b. d., lindsley, c. b., robinson, f. g., and lukert, b. p. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. j rheumatol. 1994;21(3):530-535. see summary.

warning, a. me. and Arnspiger, S. a. diffuse musculoskeletal pain is not associated with low vitamin d levels or improved by vitamin d treatment. jclin rheumatol 2008;14(1):12-16. see summary.

wasserman, p. and Rubin, D. yes Highly prevalent vitamin d deficiency and insufficiency in an urban cohort of hiv-infected men under care. aids patient.care stds. 2010;24(4):223-227. see summary.

watson, a. r., kooh, s. w., tam, c. s., reilly, b. j., balfe, j. w., and vieth, r. Renal osteodystrophy in children in capd: a prospective trial of 1-alpha-hydroxycholecalciferol therapy. urol nephro child. 1988;9(4):220-227. see summary.

watson, p. me. and McDonald, B. w. The association of maternal diet and dietary supplement intake in pregnant New Zealand women with infant birth weight. eur.jclin.nutr 2010;64(2):184-193. see summary.

wei, m. y. Garland, c. f., gorham, e. d., mohr, s. b., and giovannucci, e. vitamin d and prevention of colorectal adenoma: a meta-analysis. cancer epidemiol. biomarkers ant. 2008;17(11):2958-2969. see summary.

wengard, k. k. Nursing implications of bone loss associated with androgen deprivation therapy. urol.nurs. 2006;26(4):261-269. see summary.

weingarten, m. A., Zalmanovici, A., and Yaphe, J. Calcium dietary supplements to prevent colorectal cancer and adenomatous polyps. Cochrane Database System Rev 2008;(1):cd003548. see summary.

weingarten, m. A., Zalmanovici, A., and Yaphe, J. Calcium dietary supplements to prevent colorectal cancer and adenomatous polyps. cochrane.database.syst.rev. 2005;(3):cd003548. see summary.

weisberg, p., scanlon, k. s., li, r., and cogswell, m. me. Nutritional rickets among children in the united states: review of cases reported between 1986 and 2003. am j clin nutr 2004;80(6 suppl):1697s-1705s. see summary.

wejse, c., gomes, v. f., rabna, p., gustafson, p., aaby, p., lisse, i. m., andersen, p. L., Glerup, H., and Sodemann, M. Vitamin d as adjunctive therapy for tuberculosis: a double-blind, randomized, placebo-controlled trial. am j respir.crit care med 5-1-2009;179(9):843-850. see summary.

Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O’Connell D, and craneney, a. Meta-analysis of therapies for postmenopausal osteoporosis. v. Meta-analysis of the efficacy of hormone replacement therapy in the treatment and prevention of osteoporosis in postmenopausal women. endocr.rev. 2002;23(4):529-539. see summary.

wesa km, cronin a segal nh et al. serum 25-hydroxy vitamin d (vit d) and survival in colorectal cancer (crc): a retrospective analysis [abstract3615]. jclin oncol 2010;28:289.

White, S., Sell, R., Thaci, D., Haverkamp, ​​C., Naeyaert, J. M., Foster, R., Martinez Escribano, J. a., cambazard, f., and bibby, a. Use of calcipotriene cream (dovonex cream) after acute treatment of psoriasis vulgaris with the two-compound calcipotriene/betamethasone dipropionate product (taclonex): a parallel-group randomized clinical trial. am j clin dermatol 2006;7(3):177-184. see summary.

wilkins, c. h., birch, s. J., Sheline, Y. i., and morris, j. c. Vitamin D deficiency is associated with poorer cognitive performance and lower bone density in older African Americans. j natl med assoc 2009;101(4):349-354. see summary.

williams, h., powell, i. j., earth, s. j., sakr, w. a., hughes, m. r., patel, b. p., heilbrun, l. k., and everson, r. b. Vitamin d receptor gene polymorphisms and disease-free survival after radical prostatectomy. prostate 11-1-2004;61(3):267-275. see summary.

wimalawansa, s. J. a four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. am j med 1998;104(3):219-226. see summary.

winger chuk, d. m., lesaux, j., rice, g. P., Kremenchutzky, M., and Ebers, G. c. a pilot study of oral calcitriol (1,25-dihydroxyvitamin d3) for relapsing-remitting multiple sclerosis. j neurol.neurosurg.psychiatry 2005;76(9):1294-1296. see summary.

winzenberg, t. m., powell, s., shaw, k. a., and jones, g. vitamin d supplements to improve bone mineral density in children. Cochrane Database System Rev 2010;(10):cd006944. see summary.

Winzenberg, T., Powell, S., Shaw, K. a., and jones, g. Effects of vitamin d supplementation on bone density in healthy children: systematic review and meta-analysis. bmj 2011;342:c7254. see summary.

wise, k. M., Broeders, N., Moreno-Reyes, R., Gervy, C., Stallenberg, B., and Abramowicz, D. A controlled study of vitamin d3 to prevent bone loss in kidney transplant patients receiving low doses of steroids. transplant 1-15-2005;79(1):108-115. see summary.

conam, m. D., Crighton, L. j., gillespie, b. d., struthers, a. d., and mcmurdo, m. me. The effects of vitamin d supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. circ.heart fail. 2010;3(2):195-201. see summary.

conam, m. d., pigeon, f. J., Dryburgh, M., Sugden, J. a., morris, a. d., and struthers, a. d. the effect of different doses of vitamin d(3) on markers of vascular health in patients with type 2 diabetes: a randomized controlled trial. diabetology 2010;53(10):2112-2119. see summary.

conam, m. d., nadir, m. a., and struthers, a. d. effect of vitamin d on blood pressure: a systematic review and meta-analysis. j hypertensive. 2009;27(10):1948-1954. see summary.

conam, m. d., price, r. j., struthers, a. d., donnan, p. t., messow, c. m., ford, i., and mcmurdo, m. me. Cholecalciferol treatment to lower blood pressure in older patients with isolated systolic hypertension: the vitdish randomized controlled trial. jama intern.med. 12-8-2013; see summary.

witteveen, j. e., van, thiel s., romijn, j. a., and hamdy, b. a. Hungry bone syndrome: still a challenge in the postoperative management of primary hyperparathyroidism: a systematic review of the literature. eur j endocrinol 2013;168(3):r45-r53. see summary.

wondale, y., shiferaw, f., and lulseged, s. a systematic review of nutritional rickets in ethiopia: status and prospects. ethiop.med j 2005;43(3):203-210. see summary.

wong, yes. yes and well, c. I double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodulare. arc dermatol 2000;136(6):807-808. see summary.

wong, t. s., lau, v. m., lim, w., and fung, g. a survey of vitamin d level in people with learning disabilities in long-stay hospital wards in hong kong. j intellect.disabil. 2006;10(1):47-59. see summary.

wu, a. h., paganini-hill, a., ross, r. k., and henderson, b. me. Alcohol, physical activity, and other risk factors for colorectal cancer: a prospective study. br.j cancer 1987;55(6):687-694. see summary.

wu, yes. h., ho, s. c., and zhong, l. effects of vitamin d supplementation on blood pressure. south med j 2010;103(8):729-737. see summary.

xu, y., shibata, a., mcneal, j. E., Stamey, T. a., feldman, d., and peehl, d. meter. Vitamin d receptor start codon polymorphism (foki) and prostate cancer progression. epidemiological biomarkers of cancer ant. 2003;12(1):23-27. see summary.

yagmurdur, m. c., attacked, f. b. uslu n. ekici y. verdi h. ozdemir b. h., moray, g., and haberal, m. Clinical importance of vitamin d receptor gene polymorphism in invasive ductal carcinoma. internal surgery 2009;94(4):304-309. see summary.

yamada, h. [Long-term effect of 1 alpha-hydroxyvitamin d, calcium, and thiazide administration on glucocorticoid-induced osteoporosis]. nippon naibunpi gakkai zasshi 6-20-1989;65(6):603-614. see summary.

Yamauchi, Y., Tsunematsu, T., Konda, S., Hoshino, T., Itokawa, Y., and Hoshizaki, H. [A double-blind trial of alfacalcidol in patients with rheumatoid arthritis (RA)]. Ryumachi 1989;29(1):11-24. see summary.

yamshchikov, a. v., desaí, n. S., Blumberg, H. m., ziegler, t. r., and tangpricha, v. vitamin d for the treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. endocr.pract. 2009;15(5):438-449. see summary.

yanuskiewicz a. the role of vitamin d in the prevention of breast cancer. internet j nutr wellness 2010;8(2):15.

Yeksan, M., Turk, S., Polat, M., Cigli, A., and Erdogan, Y. Effects of 1.25(oh)2d3 treatment on lipid levels in uremic hemodialysis patients. int j artif. organs 1992;15(12):704-707. see summary.

yin, l., grandi, n., raum, e., haug, u., arndt, v., and brenner, h. Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk. aliment.pharmacol.ther 7-1-2009;30(2):113-125. see summary.

yin, l., grandi, n., raum, e., haug, u., arndt, v., and brenner, h. meta-analysis: serum vitamin d and risk of breast cancer. eur j cancer 2010;46(12):2196-2205. see summary.

Yoshida, Y., Sato, N., Furumura, M., and Nakayama, J. treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed radiofrequency in combination with topical application of vitamin d3 ointment. j dermatol 2007;34(4):227-230. see summary.

yosipovitch, g., hoon, t. s., and leok, g. c. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatology patients. dermatol arch. 2001;137(4):477-481. see summary.

yu, c. K., Sykes, L., Sethi, M., Teoh, T. g., and robinson, s. vitamin d deficiency and supplements during pregnancy clin.endocrinol.(oxf) 2009;70(5):685-690. see summary.

Zeghoud, f., ben-mekhbi, h., djeghri, n., and garabedian, m. Vitamin d prophylaxis during childhood: comparison of the long-term effects of three intermittent doses (15, 5, or 2.5 mg) on ​​25-hydroxyvitamin d concentrations. am j clin nutr 1994;60(3):393-396. see summary.

Zhou, G., Stoitzfus, J., and Swan, B. a. optimization of vitamin d status to reduce colorectal cancer risk: a review of the evidence. clin joncol. nurs. 2009;13(4):e3-e17. see summary.

zhou, w., heist, r. S. Liu, G. Peeking, K. Neuberg, D. s., hollis, b. w., wain, j. c., lynch, t. j., giovannucci, e., his, l. and Christiani, D. c. circulating levels of 25-hydroxyvitamin d predict survival in patients with early-stage non-small cell lung cancer. jclin.oncol. 2007-10-2;25(5):479-485. see summary.

zhou, w., heist, r. S., Liu, G., Neuberg, D. S. Peeking, K. His, L. Wain, J. c., lynch, t. j., giovannucci, e., and christiani, d. c. Vitamin d receptor polymorphisms and survival in patients with early-stage non-small cell lung cancer. epidemiological biomarkers of cancer ant. 2006;15(11):2239-2245. see summary.

Zhu, K., Austin, N., Devine, A., Bruce, D., and Prince, R. I a randomized controlled trial of the effects of vitamin d on muscle strength and mobility in older women with vitamin d insufficiency. j am geriatr.soc. 2010;58(11):2063-2068. see summary.

Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P. and Andrew, P. an investigator-blinded comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment versus calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque psoriasis. j eur acad dermatol venereol. 2007;21(4):466-472. see summary.

zipitis, c. yes and Akobeng, A. k. Vitamin d supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. archdis.child 2008;93(6):512-517. see summary.

zisman, a. L., Ghantous W., Schinleber P., Roberts L., and Sprague S. meter. Parathyroid hormone inhibition: a dose equivalence study of paricalcitol and doxercalciferol. i am j nephrol. 2005;25(6):591-595. see summary.

Zittermann, A., Frisch, S., Berthold, H. K., Getting, C., Kuhn, J., Kleesiek, K., Stehle, P., Koertke, H., and Koerfer, R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. am j clin nutr 2009;89(5):1321-1327. see summary.

Zittermann, A., Gummert, J. f., and borgermann, j. the role of vitamin d in dyslipidemia and cardiovascular disease. curr.pharm des 2011;17(9):933-942. see summary.

Zittermann, A., Gummert, J. f., and borgermann, j. vitamin d deficiency and mortality. curr opin. clin nutr metab care 2009;12(6):634-639. see summary.

Zold, E., Szodoray, P., Nakken, B., Barath, S., Kappelmayer, J., Csathy, L., Hajas, A., Sipka, S., Gyimesi, E., Gaal, J., Barta, Z., Hallay, J., Szegedi, G., and Bodolay, E. alfacalcidol treatment restores derailed immune regulation in patients with undifferentiated connective tissue disease. autoimmune.rev. 2011;10(3):155-162. see summary.

aarskog d, aksnes l, lehmann v. low 1,25-dihydroxyvitamin d in heparin-induced osteopenia (letter). Lancet 1980;2:650-1. see summary.

abud m. vitamin d supplementation and sleep: a systematic review and meta-analysis of intervention studies. nutrients 2022;14(5):1076. see summary.

abdeen haa, rodriguez-sanz d, ewidea m, al-hamaky dma, mohamed mae, elerian ae. Efficacy of vitamin d supplementation in addition to aerobic exercise training in obese women with perceived myalgia: a single-blind randomized controlled clinical trial. nutrients 2021;13(6):1819. see summary.

abuelazm m, muhammad s, gamal m, et al. The effect of vitamin d supplementation on symptom severity and quality of life in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. nutrients 2022;14(13):2618. see summary.

acharya p, safarova ms, dahlia t, et al. Effects of vitamin d supplementation and 25-hydroxyvitamin d levels on atrial fibrillation risk. am j cardiol 2022;173:56-63. see summary.

adachi jd, bensen wg, bianchi f, et al. Vitamin d and calcium in the prevention of corticosteroid-induced osteoporosis: a 3-year follow-up. j rheumatol 1996;23:995-1000. see summary.

adler aj, berlyne gm. Duodenal absorption of aluminum in the rat: effect of vitamin D. am j physiol 1985;249:g209-13. see summary.

ahmed b, nasir k, mehmood a, et al. Effect of physical activity and vitamin d compared to vitamin d alone on muscle strength, back flexibility, and aerobic activity in patients with chronic kidney disease: a comparative study from pakistan. asia pac j clin nutr 2021;30(4):566-572. see summary.

ahmed mohamed a, salah ahmed em, abdel-aziz rta, et al. The impact of active vitamin d administration on clinical outcomes of acne vulgaris. j dermatological treatment. 2020:1-6. see summary.

ahmed w, khan n, glueck cj, et al. Low serum levels of 25(OH) vitamin D (<32 ng/mL) are associated with reversible myalgia-myositis in patients treated with statins. translation 2009;153:11-6. see summary.

albert cm, cook nr, pester j, et al. Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial. never. 2021;325(11):1061-1073. see summary.

alcala-diaz jf, limia-perez l, gomez-huelgas r, et al. Calcifediol treatment and hospital mortality from covid-19: a cohort study. nutrients 2021;13(6):1760. see summary.

aloia jf, talwar sa, abadejo s, yeh j. a randomized controlled trial of vitamin d3 supplementation in african american women. archiintern med 2005;165:1618-23. see summary.

amrein k, schnedl c, holl a, et al. Effect of high-dose vitamin d3 on length of hospital stay in critically ill patients with vitamin d deficiency: the vitdal-icu randomized clinical trial. never. 2014;312(15):1520-30. doi: 10.1001/jama.2014.13204. errata in: jama. 2014 November 12; 312 (18): 1932. see abstract.

angelidi am, belanger mj, lorinsky mk, et al. Vitamin d status is associated with hospital mortality and mechanical ventilation: a cohort of patients hospitalized for covid-19. mayonnaise clin proc. 2021 Apr;96(4):875-886. see summary.

angellotti e, d’alessio d, dawson-hughes b, et al. Vitamin d supplementation in patients with type 2 diabetes: study of vitamin d for established type 2 diabetes (ddm2). j endocr soc. 2018 February 26; 2(4): 310-21. see summary.

annweiler c, beaudenon m, gautier j, et al. High-dose versus standard-dose vitamin d supplementation in older adults with covid-19 (covit-trial): a multicenter, open-label, randomized, controlled superiority trial. plos med 2022;19(5):e1003999. see summary.

annweiler g, corvaisier m, gautier j, et al. Vitamin d supplementation was associated with better survival in hospitalized frail elderly covid-19 patients: the quasi-experimental geria-covid study. nutrients 2020;12(11):3377. see summary.

arms la, hollis bw, heaney rp. vitamin d2 is much less effective than vitamin d3 in humans. jclin endocrinol metab 2004;89:5387-91. see summary.

arnas lag, heaney rp, hollis bw. vitamin d2 is much less effective than vitamin d3 in humans (abstract or22-2). the 86th annual meeting of the endocrine society, june 16-19, new orleans, la.

Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine Ms, Cheng S, Valcour A, Swales H, Taylor B, Carney E, Guanaga D, Young Jr, Karol C, Torre M, Azzahir A, Strachan SM , o’neill dc, wolf m, harrell f, newton-cheh c, wang tj. Vitamin d therapy in people with prehypertension or hypertension: the daytime trial. circulation. January 20, 2015; 131 (3): 254-62. see summary.

stream-diaz ja, julve j, vlacho b, et al. Previous vitamin d supplementation and morbidity and mortality outcomes in people hospitalized for covid-19: a cross-sectional study. facing public health 2021;9:758347. see summary.

asbaghi ​​o, khosroshahi mz, kashkooli s, abbasnezhad a. Effect of calcium and vitamin D co supplementation on insulin, insulin sensitivity, and glycemia: a systematic review and meta-analysis of randomized clinical trials. horm metab res. 2019;51(5):288-295. see summary.

aschauer r, unterberger s, zöhrer pa, et al. Effects of vitamin d3 supplementation and resistance training on 25-hydroxyvitamin d status and functional performance of older adults: a randomized placebo-controlled trial. nutrients 2021;14(1):86. see summary.

Ashcroft, D. m., po, a. L., Williams, H. c., and griffiths, c. me. Systematic review of the comparative efficacy and tolerability of calcipotriol in the treatment of chronic plaque psoriasis. bmw 2000;320(7240):963-967. see summary.

autier p, gandini s. Vitamin d supplementation and total mortality: a meta-analysis of randomized controlled trials. archiintern med 2007;167:1730-7. see summary.

baeksgaard l, andersen kp, hyldstrup l. Calcium and vitamin d supplementation increases spinal bmd in healthy postmenopausal women. osteoporosis int 1998;8:255-60. see summary.

bahrami a, avan a, sadeghinia hr, et al. High-dose vitamin D supplementation may improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. gynecol endocrinol. 2018;34(8):659-663. see summary.

Baker K, Zhang Y Q, Goggins J, et al. Hypovitaminosis d and its association with muscle strength, pain, and physical function in knee osteoarthritis (OA). meeting of the american college of rheumatology; San Antonio, Texas, October 16-21, 2004. Abstract 1755.

bakhshaee m, sharifian m, esmatinia f, rasoulian b, mohebbi m. therapeutic effect of vitamin d supplementation in allergic rhinitis. ear, nose and throat euro arch. 2019 Oct;276(10):2797-2801. see summary.

bakshi s, mahajan r, karim a, de d, handa s, saikia b. Oral vitamin D versus acitretin in non-syndromic congenital ichthyosis: double-blind randomized controlled trial. jdtsch dermatol ges 2022;20(3):297-304. see summary.

balachandar r, pullakhandam r, kulkarni b, sachdev hs. Relative efficacy of vitamin d2 and vitamin d3 in improving vitamin d status: systematic review and meta-analysis. nutrients 2021;13(10):3328. see summary.

bar-or d, yoel g. calcium and calciferol antagonize the effect of verapamil in atrial fibrillation. br med j 1981;282:1585-6. see summary.

barbagallo m, veronese n, di prazza a, et al. Effect of calcifediol on physical performance and muscle strength parameters: a systematic review and meta-analysis. nutrients 2022;14(9):1860. see summary.

barbarawi m, kheiri b, zayed y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83,000 people in 21 randomized clinical trials: a meta-analysis. never cardol. 2019. see abstract.

barbour la, kick sd, steiner jf, et al. a prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. am j obstetgynecol 1994;170:862-9. see summary.

barham a, mohammad b, hasoun l, et al. the combination of omega-3; fatty acids with high doses of vitamin d₃ raising a1c levels: a randomized clinical trial in people with vitamin d deficiency. int j clin pract 2021;75(11):e14779. see summary.

baron ja, beach m, mandel js, et al. Calcium supplements for the prevention of colorectal adenomas. calcium polyp prevention study group. n engl j med 1999;340:101-7. see summary.

baron ja, tosteson td, wargovich mj, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. j natl cancer institute 1995;87:1303-7. see summary.

bartl i, ondru&scaron;ová m, ku&zcaron;ma m, et al. Cholecalciferol treatment leads to an increase in selected semen parameters in young infertile males: results of a 6-month intervention study. physiol res 2021;70(supplement 1):s99-s107. see summary.

beasley r, weatherall m. vitamin d and asthma: a case to answer. lancet respir med 2017. [epub ahead of print]. see summary.

Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, Petermans J, Reginster JY, Bruyère O. The effects of vitamin d on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. j clin endocrinol metab. 2014 Nov;99(11):4336-45. see summary.

becker gl. the case against mineral oil. am j digestive dis 1952;19:344-8. see summary.

bell rd, pak cy, zerwekh j, et al. Effect of phenytoin on bone and mineral density in ambulatory epileptic children. brain development 1994;16:382-5.

Bello HJ, Caballero-García A, Pérez-Valdecantos D, Roche E, Noriega DC, Córdova-Martínez A. effects of vitamin d on post-exercise muscle recovery. a systematic review and a meta-analysis. nutrients 2021;13(11):4013. see summary.

ben-eltriki m, hopefl r, wright jm, deb s. Association between vitamin d status and risk of developing severe covid-19 infection: a meta-analysis of observational studies. j am coll nutr 2021. see summary.

bengoa jm, bolt mj, rosenberg ih. hepatic inhibition of vitamin d 25-hydroxylase by cimetidine and isoniazid. j lab clin med 1984;104;546-52. see summary.

bernstein cn, seeger ll, anton pa, et al. a randomized, placebo-controlled trial of calcium supplementation for decreased bone density in patients with inflammatory bowel disease using corticosteroids: a pilot study. aliment pharmacol ther 1996;10:777-86. see summary.

bertone-johnson er, hankinson se, bendich a, et al. calcium and vitamin d intake and risk of incident premenstrual syndrome. archiintern med 2005;165:1246-52. see summary.

bischoff ha, stahelin hb, dick w, et al. Effects of vitamin d and calcium supplementation on falls: a randomized controlled trial. j bone miner res 2003;18:343-51.. see abstract.

bischoff-ferrari ha, borchers m, gudat f, et al. Vitamin D receptor expression in human muscle tissue decreases with age. j bone miner res 2004;19:265-9. . see summary.

bischoff-ferrari ha, dawson-hughes b, orav ej, et al. Monthly high-dose vitamin d treatment for prevention of functional decline: a randomized clinical trial. jama intern med. 2016;176(2):175-83. see summary.

bischoff-ferrari ha, dawson-hughes b, willett wc, et al. effect of vitamin d on falls: a meta-analysis. jama 2004;291:1999-2006.. see abstract.

bischoff-ferrari ha, dietrich t, ​​orav ej, et al. Higher concentrations of 25-hydroxyvitamin D are associated with better lower extremity function in active and inactive people older than 60 years. i am j clin nutr 2004;80:752-8. see summary.

bischoff-ferrari ha, orav eg, dawson-hughes b. Effect of cholecalciferol plus calcium on falls in ambulatory older men and women: a 3-year randomized controlled trial. archiintern med 2006;166:424-30. see summary.

bischoff-ferrari ha, vellas b, rizzoli ret al. Effect of vitamin d supplementation, omega-3 fatty acid supplementation, or a strength training exercise program on clinical outcomes in older adults: the do-health randomized clinical trial. never. 2020;324(18):1855-1868. see summary.

bischoff-ferrari ha, willett wc, wong jb, et al. Fracture prevention with vitamin d supplementation: a meta-analysis of randomized controlled trials. jama 2005;293:2257-64. see summary.

bjelakovic g, gluud ll, nikolova d, et al. Vitamin d supplementation for prevention of mortality in adults. database system cochrane rev. 2014;1:cd007470. see summary.

black pn, scragg r. Relationship between serum 25-hydroxyvitamin d and lung function in the third national health and nutrition examination survey. chest 2005;128:3792-8. see summary.

bolland mj, gray a, gamble gd, reid ir. The effect of vitamin d supplementation on skeletal, vascular, or cancer outcomes: a trial-sequential meta-analysis. diabetes endocrinol lancet 2014 April; 2(4): 307-20. see summary.

bolland mj, gray a, gamble gd, reid ir. Vitamin d supplementation and falls: a trial sequential meta-analysis. diabetes endocrinol lancet 2014 July; 2 (7): 573-80. see summary.

boonen s, body jj, boutsen y, et al. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a Belgian bone club consensus document. osteoporosis int 2005;16:239-54. see summary.

boonen s, lips p, bouillon r, et al. Additional calcium requirement to reduce hip fracture risk with vitamin d supplementation: evidence from a comparative meta-analysis of randomized controlled trials. jclin endocrinol metab 2007;92:1415-23. see summary.

borsche l, glauner b, von mendel j. covid-19 mortality risk is inversely correlated with vitamin d3 status, and a near-zero mortality rate could theoretically be achieved with 50 ng/mL 25(oh)d3: results of a systematic review and a meta-analysis. nutrients 2021;13(10):3596. see summary.

boxer rs, hoit bd, schmotzer bj, stefano gt, gomes a, negrea l. the effect of vitamin d on aldosterone and health status in patients with heart failure. card failure j. 2014 May;20(5):334-42. see summary.

boxer rs, kenny am, schmotzer bj, vest m, fiutem jj, pina il. a randomized controlled trial of high-dose vitamin d3 in patients with heart failure. heart failure jack 2013 Feb;1(1):84-90. see summary.

bozzetto s, carraro s, giordano g, et al. asthma, allergy and respiratory infections: the vitamin d hypothesis. allergy 2012;67:10-7. see summary.

brehm jm, schuemann b, fuhlbrigge al, et al.; research group of the childhood asthma control program. Serum vitamin d levels and severe asthma exacerbations in the childhood asthma control program study. j allergy clin immunol 2010;126(1):52-8.e5. see summary.

brenner h, holleczek b, sch&ouml;ttker b. Vitamin d insufficiency and deficiency and respiratory disease mortality in a cohort of older adults: potential to limit the number of deaths during and after the covid-19 pandemic. nutrients 2020;12(8)e2488; doi:10.3390/nu12082488. see summary.

brodie mj, boobis ar, hillyard cj, et al. Effect of rifampin and isoniazid on vitamin d metabolism. clin pharmacol ther 1982;32:525-30. see summary.

broe ke, chen tc, weinberg j, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized multiple-dose study. j am geriatric soc 2007;55:234-9. see summary.

brustad n, eliasen au, stokholm j, bønnelykke k, bisgaard h, chawes bl. High-dose vitamin d supplementation during pregnancy and asthma in offspring at age 6 years. never. 2019;321(10):1003-1005. see summary.

brustad n, yousef s, estokholm j, bønnelykke k, bisgaard h, chawes bl. Safety of high-dose vitamin d supplementation among children aged 0 to 6 years: a systematic review and meta-analysis. network never open 2022;5(4):e227410. see summary.

buckley lm, leib es, cartularoks, et al. Calcium and vitamin d3 supplementation prevent spinal bone loss secondary to low-dose corticosteroids in patients with rheumatoid arthritis. a randomized, double-blind, placebo-controlled trial. ann intern med 1996;125:961-8. see summary.

burt la, billington eo, rose ms, raymond da, hanley da, boyd sk. Effect of high-dose vitamin d supplementation on volumetric bone density and bone strength: a randomized clinical trial. never. 2019;322(8):736-745. see summary.

caan b, neuhouser m, aragaki a, et al. calcium supplements plus vitamin d and the risk of postmenopausal weight gain. archiintern med 2007;167:893-902. see summary.

cai y, wanigatunga aa, mitchell cm, et al. The effects of vitamin d supplementation on frailty in older adults at risk of falls. bmc geriatr 2022;22(1):312. see summary.

campi i, gennari l, merlotti d, et al. vitamin d and covid-19 severity and related mortality: a prospective study in italy. bmc infect dis 2021;21(1):566. see summary.

canadian cancer society announces recommendation for vitamin d. Canadian Cancer Society Press Release, June 8, 2007. Available at: www.cancer.ca (Accessed June 13, 2007).

cangussu lm, nahas-neto j, orsatti cl, et al. Effect of isolated vitamin d supplementation on fall rate and postural balance in postmenopausal women who experience falls: a randomized, double-blind, placebo-controlled trial. menopause. 2016;23(3):267-74. see summary.

cannata-andía jb, diaz-sottolano a, fernández p, et al. A single oral bolus of 100,000 iu of cholecalciferol at hospital admission did not improve outcomes in covid-19 disease: the covid-vit-d-a international multicenter randomized clinical trial. bmc med 2022;20(1):83. see summary.

castro m, king ts, kunselman sj, et al.; asmanet of the national heart, lung, and blood institute. Effect of vitamin d3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin d levels: the lifetime randomized clinical trial. jama 2014;311(20):2083-91. see summary.

cauley ja, chlebowski rt, wactawski-wende j, et al. Calcium plus vitamin d supplementation and health outcomes five years after the active intervention ended: the women’s health initiative. j women’s health (larchmt). 2013;22(11):915-29. see summary.

cava rc, javier an. vitamin d deficiency [editorial]. n engl j med 2007;357:1981. see summary.

cereda e, bogliolo l, lobascio f, et al. Vitamin d supplementation and outcomes in patients with coronavirus disease 2019 (covid-19) from the lombardy, italy outbreak area. nutrition. 2021;82:111055. see summary.

Chandler PD, Chen Wy, Ajala On, et al. Effect of vitamin d3 supplementation on the development of advanced cancer: a secondary analysis of the vital randomized clinical trial. never open network 2020;3(11):e2025850. see summary.

chapuy mc, arlot me, duboeuf f, et al. vitamin d3 and calcium to prevent hip fractures in older women. n engl j med 1992;327:1637-42. see summary.

chapuy mc, arlot me, duboeuf f, et al. vitamin d3 and calcium to prevent hip fractures in older women. n engl j med 1992;327:1637-42.. see abstract.

chapuy mc, pamphile r, paris e, et al. Combined calcium and vitamin d3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and risk of hip fracture: the decalios ii study. osteoporos int 2002;13:257-64.. see abstract.

chen j, mei k, xie l, et al. Low vitamin d levels do not exacerbate risk or death from covid-19, and vitamin d supplementation does not improve outcomes in hospitalized patients with covid-19: a meta-analysis and grading of cohort studies and RCTs. nutrj 2021;20(1):89. see summary.

cheng sh, chen kh, chen c, chu wc, kang yn. The optimal vitamin d strategy for sarcopenia: a network meta-analysis of randomized controlled trials. nutrients 2021;13(10):3589. see summary.

chlebowski rt, johnson kc, kooperberg c, et al. calcium plus vitamin d supplements and breast cancer risk. j natl cancer inst 2007;100:1581-91. see summary.

cho e, smith-warner sa, spiegelman d, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. j natl cancer inst 2004;96:1015-22. see summary.

cho h, myung sk, cho he. Efficacy of vitamin d supplementation in the treatment of acute respiratory infection: a meta-analysis for randomized controlled trials. nutrients 2022;14(6):1144. see summary.

cho he, myung sk, cho h. Efficacy of vitamin d supplementation in the prevention of acute respiratory infection: a meta-analysis for randomized controlled trials. nutrients 2022;14(4):818. see summary.

chong rih, yaow cyl, loh cyl, et al. Vitamin d supplementation for irritable bowel syndrome: a systematic review and meta-analysis. j gastroenterol hepatol 2022;37(6):993-1003. see summary.

Chowdhury R, ​​Kunutsor S, Vitezova A, et al. Vitamin d and risk of cause-specific death: systematic review and meta-analysis of randomized intervention and observational cohort studies. bmj. 2014;348:g1903. see summary.

christensen n, søndergaard j, fisker n, christesen ht. Infant respiratory tract infections or wheezing and maternal vitamin d in pregnancy: a systematic review. pediatrician infect disease j. 2017;36(4):384-391.see abstract.

cimetidine inhibits hepatic hydroxylation of vitamin d. nut rev 1985;43:184-5. see summary.

clarke bl, wynne ag, wilson dm, fitzpatrick la. Osteomalacia associated with adult fanconi syndrome: clinical and diagnostic features. clin endocrinol (oxf) 1995;43:479-90. see summary.

close gl, leckey j, patterson m, et al. the effects of vitamin d(3) supplementation on serum total 25[oh]d concentration and physical performance: a randomized dose-response study. br j sports med. 2013;47(11):692-6. see summary.

coburn jw. An update on vitamin d in relation to nephrology practice: 2003. Kidney Int Supl 2003; 64(87):s125-30. see summary.

collins n, maher j, cole m, et al. A prospective study to assess the dose of vitamin d required to correct low levels of 25-hydroxyvitamin d, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. qjmed 1991;78:113-22. see summary.

compston je, horton lw. Oral 25-hydroxyvitamin d3 in the treatment of osteomalacia associated with ileal resection and cholestyramine therapy. gastroenterology 1978;74:900-2. see summary.

compston heh, thompson rp. Intestinal absorption of 25-hydroxyvitamin d and osteomalacia in primary biliary cirrhosis. Lancet 1977;1:721-4. see summary.

cox ka, dunn ma. Aluminum toxicity alters calbindin-d28k protein regulation and mRNA expression in chicken intestine. j nutr 2001;131:2007-13. see summary.

crowe m, wollner l, griffiths ra. hypercalcemia after vitamin d and thiazide therapy in the elderly. practitioner 1984;228:312-3. see summary.

cueto-manzano am, konel s, freemont aj, et al. Effect of 1,25-dihydroxyvitamin d3 and calcium carbonate on bone loss associated with long-term renal transplantation. am j kidney dis 2000;35:227-36. see summary.

dahlman tc. Osteoporotic fractures and recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing heparin thromboprophylaxis. am j obstet gynecol 1993;168:1265-70. see summary.

davidson mh, hauptman j, digirolamo m, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. jama 1999;281:235-42. see summary.

davoudi a, najafi n, aarabi m, et al. lack of association between vitamin d insufficiency and clinical outcomes in patients with covid-19 infection. bmc infect dis 2021;21(1):450. see summary.

dawson-hughes b, harris ss, krall ea, dallal ge. Effect of calcium and vitamin d supplementation on bone density in men and women aged 65 years and older. n engl j med 1997;337:670-6. see summary.

dawson-hughes b, harris ss, krall ea, dallal ge. Effect of calcium and vitamin d supplementation on bone density in men and women aged 65 years and older. n engl j med 1997;337:670-6. see summary.

dawson-hughes b, harris ss< palermo nj, ceglia l, rasmussen h. Meal conditions affect the absorption of supplemental vitamin D3 but not the plasma 25-hydroxyvitamin D response to supplementation. j miner bone res. 2013 August; 28 (8): 1778-83. see summary.

dawson-hughes b, heaney rp, holick mf, et al. estimates of optimal vitamin d status. osteoporosis int 2005;16:713-6. see summary.

de niet s, trémège m, coffiner m, et al. Positive effects of vitamin d supplementation in patients hospitalized for covid-19: a randomized, double-blind, placebo-controlled trial. nutrients 2022;14(15):3048. see summary.

demontis r, leflon a, fournier a, et al. 1 alpha(oh) vitamin d3 increases plasma aluminum in hemodialysis patients taking ai(oh)3. clin nephrol 1986;26:146-9. see summary.

demontis r, reissi d, noel c, et al. indirect clinical evidence that vitamin 1alphaoh d₃ Increases intestinal absorption of aluminum. clin nephrol 1989;31:123-7. see summary.

devine a, wilson sg, dick im, prince rl. Effects of vitamin d metabolites on intestinal absorption and bone turnover in elderly women. am j clin nutr 2002;75:283-8.. see abstract.

dhesi jk, bearne lm, moniz c, et al. Neuromuscular and psychomotor function in elderly who fall and the relationship with vitamin d status. j bone miner res 2002;17:891-7. . see summary.

diamond th, ho kw, rohl pg, meerkin m. Annual intramuscular injection of a megadose of cholecalciferol for the treatment of vitamin d deficiency: efficacy and safety data. med juust 2005;183:10-2. see summary.

dietary reference intakes for calcium and vitamin d. Institute of Medicine, November 30, 2010. Available at: https://www.iom.edu/~/media/files/report%20files/2010/dietary-reference-intakes-for-calcium-and-vitamin-d / vitamin%20d%20y%20calcium%202010%20report%20brief.pdf.

Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin d3 and periodontal disease in the US population. am j clin nutr 2004;80:108-13. see summary.

dimeglio la, white ke, econs mj. phosphate metabolism disorders. endocrinol metab clin north am 2000;29:591-609. see summary.

dobnig h, pilz s, scharnagl h, et al. Independent association of low serum levels of 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d with all-cause and cardiovascular mortality. archiintern med 2008;168:1340-49. see summary.

doi y, tsujita m, hamano t, et al. The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: a randomized controlled study. am j transplant 2021;21(9):3043-3054. see summary.

donneyong mm, hornung ca, taylor kc, et al. Heart failure risk among postmenopausal women: a secondary analysis of the women’s health initiative vitamin d plus calcium randomized trial. circ heart fail. 2015 Jan;8(1):49-56. see summary.

dukas l, bischoff ha, lindpaintner ls, et al. alfacalcidol reduces the number of falls in an elderly population living in the community with a minimum calcium intake of more than 500 mg per day. j am geriatr soc 2004;52:230-6.. see abstract.

duplessis ca, harris eb, watenpaugh de, horn wg. vitamin d supplements in submarines underway aviat space environment med 2005;76:569-75. see summary.

ebeling pr, wark jd, yeung s, et al. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double-blind, double-placebo study. j clin endocrinol metab 2001;86:4098-103.. see abstract.

eid a, khoja s, alghamdi s, et al. Vitamin D supplementation improves the severity of generalized anxiety disorder (GAD). metab brain dys. 2019;34(6):1781-1786. see summary.

el amrousy d, abdelhai d, shawky d. Vitamin d and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. eur j pediatr 2021. see summary.

engelsen o, brustad m, aksnes l, lund e. Daily duration of vitamin D synthesis in human skin in relation to latitude, total ozone, altitude, land cover, aerosols, and cloud thickness. photochem photobiol 2005;81:1287-90. see summary.

fairbairn ka, ceelen ijm, skeaff cm, cameron cm, perry tl. Vitamin D3 supplementation does not improve sprint performance in professional rugby players: a randomized, placebo-controlled, double-blind intervention study. int j sport nutr exerc metab 2018;28(1):1-9. see summary.

fang f, ni k, cai y, shang j, zhang x, xiong c. effect of vitamin d supplementation in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. complement ther clin pract 2017;26:53-60. see summary.

federal registration. vol. 81, no. 103. May 27, 2016. rules and regulations. U.S. food and drug administration. https://www.gpo.gov/fdsys/pkg/fr-2016-05-27/pdf/2016-11867.pdf [accessed: 11/30/2018]

food and drug administration, hhs. food labelling: health claims; calcium and osteoporosis, and calcium, vitamin d and osteoporosis. fed log end rule. 2008;73(189):56477-87. see summary.

board of food and nutrition, institute of medicine. dietary reference intakes for calcium, phosphorus, magnesium, vitamin d, and fluoride. Washington, DC: National Academy Press, 1999. Available at: https://books.nap.edu/books/0309063507/html/index.html.

ford ja, maclennan gs, avenell a, bolland m, gray a, witham m; record test group. cardiovascular disease and vitamin d supplementation: analysis of trials, systematic review, and meta-analysis. i am j clin nutr. 2014 September; 100 (3): 746-55. see summary.

forno e, bacharier lb, phipatanakul w, et al. effect of vitamin d₃ Supplementation in severe asthma exacerbations in children with asthma and low vitamin d levels: the vdka randomized clinical trial. never. 2020;324(8):752-760. see summary.

franco as, freitas tq, bernardo wm, pereira rmr. Vitamin d supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis. medicine (baltimore) 2017;96(23):e7024. see summary.

frier bm, scott rd. osteomalacia and arthropathy associated with prolonged abuse of purgatives. br j clin pract 1977;31:17-9. see summary.

fuq, shi mf, chen y. Clinical effect of alfacalcidol in children with henoch-schönlein purpura: a prospective randomized controlled trial. zhongguo dang dai er ke za zhi 2021;23(8):797-801. see summary.

fukumoto s, matsumoto t, tanaka y, et al. Renal magnesium loss in a patient with short bowel syndrome and magnesium deficiency: effect of treatment with 1alpha-hydroxyvitamin d3. j clin endocrinol metab 1987;65:1301-4. see summary.

gallagher jc, jindal ps, smith lm. Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. j miner bone res. 2014;29(5):1081-7. see summary.

gallo d, mortara l, veronesi g, et al. Additional effect of combined selenium and vitamin d supplementation in early control of hyperthyroidism in Graves’ disease during methimazole treatment. frontal endocrinol (lausanne) 2022;13:886451. see summary.

Ganmaa D, Uyanga B, Zhou X, Gantsetseg G, et al. vitamin d supplements for prevention of tuberculosis infection and disease. n english j med 2020;383(4):359-368. see summary.

garcía-carrasco m, mendoza-pinto c, soto-santillán rp, et al. vitamin d in systemic lupus erythematosus with and without lupus nephritis. rev med inst mex insurance soc 2020;58(4):394-399. see summary.

garcia-serna am, morales e. Neurodevelopmental effects of prenatal vitamin d in humans: systematic review and meta-analysis. molar psychiatry. 2020 Oct;25(10):2468-2481. see summary.

garland cf, gorham ed, mohr sb, et al. vitamin d and breast cancer prevention: pooled analysis. j steroid biochem mol biol 2007;103:708-11. see summary.

gaughran f, stringer d, wojewodka g, et al. Effect of vitamin d supplementation on outcomes in people with early psychosis: the dfend randomized clinical trial. never open network 2021;4(12):e2140858. see summary.

gesensway d. vitamin D. ann int med 2000;133:318. see summary.

ginde aa, brower rg, caterino jm, et al. Early high dose vitamin d3 for critically ill patients with vitamin d deficiency. n english j med 2019;381(26):2529-2540. see summary.

ginde aa, mansbach jm, camargo ca jr. Association between serum 25-hydroxyvitamin d level and upper respiratory tract infection in the third national health and nutrition examination survey. archiintern med 2009;169:384-90. see summary.

giovannucci e, liu y, rimm eb, et al. prospective study of predictors of vitamin d status and cancer incidence and mortality in men. j natl cancer inst 2006;98:451-9. see summary.

gkekas nk, anagnostis p, paraschou v, et al. The effect of vitamin d plus protein supplementation on sarcopenia: a systematic review and meta-analysis of randomized controlled trials. mature. 2021 March; 145: 56-63. see summary.

gon&ccedil;alves mdr, miranda neto m, cavalcante igm, et al. 200,000 iu of vitamin d does not lower resting blood pressure and inhibit post-exercise hypotension in older women: a pilot study. an acad bras cienc. 2020;92(1):e20190227. see summary.

good will am, szoeke c. a systematic review and meta-analysis of the effect of low vitamin d on cognition. j am geriatric soc. 2017;65(10):2161-2168. see summary.

gorham ed, garland cf, garland fc, et al. Optimal vitamin d status for colorectal cancer prevention. a quantitative meta-analysis. am j prev med 2007;32:210-6. see summary.

gou x, pan l, tang f, gao h, xiao d. The association between vitamin d status and tuberculosis in children: a meta-analysis. Medicine (Baltimore). 2018;97(35):e12179. see summary.

gough h, goggin t, bissessar a, et al. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure, and diet on vitamin D and calcium metabolism in outpatients with epilepsy. fourth j med 1986;59:569-77. see summary.

graafmans wc, ooms me, hofstee hm, et al. falls in the elderly: a prospective study of risk factors and risk profiles. am j epidemiolo 1996;143:1129-36. . see summary.

grau mv, baron ja, sandler rs, et al. vitamin d, calcium supplementation, and colorectal adenomas: results of a randomized trial. j natl cancer inst 2003;95:1765-71. see summary.

grimnes g, kubiak j, jorde r. Four-month vitamin d supplementation to individuals with vitamin d insufficiency does not improve muscle strength: a randomized controlled trial. plus one. 2019;14(12):e0225600. see summary.

gross md. Vitamin d and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs. j nutr 2005;135:326-31. see summary.

guo x, liu c, huang y. Efficacy and safety of adjuvant vitamin d therapy for ulcerative colitis: a meta-analysis. calculate mathematical methods med 2022;2022:6836942. see summary.

guo xf, wang c, yang t, et al. the effects of fish oil plus vitamin d₃ intervention in nonalcoholic fatty liver disease: a randomized controlled trial. eur j nutr 2022;61(4):1931-1942. see summary.

hahn j, cook nr, alexander ek, et al. Marine vitamin d and omega-3 fatty acid supplementation and incident autoimmune disease: vital randomized controlled trial. bmj 2022;376:e066452. see summary.

hanley da, davison ks. vitamin d insufficiency in north america. j nutr 2005;135:332-7. see summary.

hardwick ll, jones mr, brautbar n, lee dbn. Magnesium absorption: mechanisms and influence of vitamin D, calcium, and phosphate. jnutr 1991;121:13-23. see summary.

harrisss. vitamin d in the prevention of type i diabetes. j nutr 2005;135:323-5. see summary.

harvey nc, d’angelo s, paccou j, et al. Calcium and vitamin d supplementation are not associated with the risk of incident ischemic cardiac events or death: findings from the uk biobank cohort. j miner bone res. January 4, 2018. [epub ahead of print] view abstract.

Hasamoh Y, Thadanipon K, Juntongjin P. Association between vitamin d level and acne, and correlation with disease severity: a meta-analysis. dermatology 2021. see abstract.

hastie ce, mackay df, ho f, et al. vitamin d concentrations and covid-19 infection in the uk biobank. metabolic diabetes syndrome. 2020;14(4):561-565. see summary.

havers fp, detrick b, cardoso sw, et al. The change in vitamin D levels occurs early after initiation of antiretroviral therapy and is dependent on the treatment regimen in resource-limited settings. plus one. 2014 Apr 21;9(4):e95164. see summary.

he is, hao x. The effect of vitamin d3 on blood pressure in people with vitamin d deficiency: a system review and meta-analysis. Medicine (Baltimore). 2019;98(19):e15284. see summary.

heaney rp, dowell ms, hale ca, blessed a. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. j am coll nutr 2003;22:142-6.. see abstract.

Heaton KW, Lever JV, Barnard D. osteomalacia associated with cholestyramine therapy for post-ileectomy diarrhea. gastroenterology 1972;62:642-6. see summary.

herr c, greulich t, ​​koczulla r, et al. The role of vitamin d in lung disease: COPD, asthma, infection, and cancer. breathing res 2011;12:31. see summary.

hibbs am, ross k, kerns la, et al. Effect of vitamin d supplementation on recurrent wheezing in black infants who were born preterm: the d-wheeze randomized clinical trial. jama 2018;319(20):2086-94. see summary.

hoikka v, alhava em, karjalainen p, et al. carbamazepine and bone mineral metabolism. acta neurol scan 1984;70:77-80. see summary.

holick mf, siris es, binkley n, et al. Prevalence of vitamin d insufficiency among postmenopausal North American women receiving therapy for osteoporosis. jclin endocrinol metab 2005;90:3215-24. see summary.

holick mf. sunlight and vitamin d: both good for cardiovascular health. j gene intern med 2002;17:733-5. . see summary.

holick mf. vitamin d: a millennium perspective. j cell biochem 2003;88:296-307. see summary.

holick mf. vitamin d: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. am j clin nutr 2004;79:362-71.. see abstract.

holick mf. sunlight “d”lemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001;357:4-6. see summary.

holick mf. sunlight and vitamin d for bone health and the prevention of autoimmune diseases, cancers and cardiovascular diseases. am j clin nutr 2004;80(6 suppls):1678s-88s. see summary.

holick mf. vitamin d deficiency n engl j med 2007;357:266-81. see summary.

hollis bw. Circulating levels of 25-hydroxyvitamin d indicative of vitamin d sufficiency: implications for establishing a new effective recommendation for dietary intake of vitamin d. j nutr 2005;135:317-22. see summary.

hollis, b. W., Johnson, D., Hulsey, T. c., ebeling, m., and wagner, c. I vitamin d supplementation during pregnancy: double-blind randomized clinical trial of safety and efficacy. j bone miner.res 2011;26(10):2341-2357. see summary.

homik j, suárez-almazor me, shea b, et al. calcium and vitamin d for corticosteroid-induced osteoporosis. Cochrane Database System Rev 2000;(2):cd000952. see summary.

hoogwerf bj, hibbard dm, hunninghake db. Effects of long-term cholestyramine administration on vitamin d and parathormone levels in middle-aged men with hypercholesterolemia. j lab clin med 1992;119:407-11. see summary.

hosseini b, el abd a, shower me fm. Effects of vitamin d supplementation on covid-19 related outcomes: a systematic review and meta-analysis. nutrients 2022;14(10):2134. see summary.

hosseinzadeh-shamsi-anar m, mozaffari-khosravi h, salami ma, hadinedoushan h, mozayan mr. The efficacy and safety of high-dose vitamin d in mothers with gestational diabetes mellitus: a randomized controlled clinical trial. iran j med sci. 2012;37(3):159-65. see summary.

houghton la, vieth r. the case against ergocalciferol (vitamin d2) as a vitamin supplement. i am j clin nutr 2006;84:694-7. see summary.

hsia j, heiss g, ren h, et al. calcium/vitamin d supplements and cardiovascular events. circulation 2007;115;846-54. see summary.

hu c, fan y, wu s, zou y, qu x. Vitamin d supplementation for the treatment of migraine: a meta-analysis of randomized controlled studies. am j emerg med 2021;50:784-788. see summary.

hu z, chen j, sun x, wang l, wang a. Efficacy of vitamin d supplementation on glycemic control in patients with type 2 diabetes: a meta-analysis of intervention studies. Medicine (Baltimore). 2019;98(14):e14970. see summary.

huang h, lu l, chen y, zeng y, xu c. The efficacy of vitamin d supplementation for irritable bowel syndrome: a systematic review with meta-analysis. nutrj 2022;21(1):24. see summary.

huang s, fu j, zhao r, et al. The effect of combined supplementation with vitamin d and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabetes. ann palliat med 2021;10(5):5652-5658. see summary.

hypponen e, laara e, reunanen a, et al. Vitamin d intake and risk of type 1 diabetes: a birth cohort study. Lancet 2001;358:1500-3. see summary.

islam ma, khandker ss, alam ss, kotyla p, hassan r. Vitamin d status in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. autoimmune rev. 2019 Nov;18(11):102392. see summary.

jackson rd, lacroix az, gass m. calcium supplements plus vitamin d and the risk of fractures. n engl j med 2006;354:669-83. see summary.

jagannath va, filippini g, di pietrantonj c, et al. vitamin d for the treatment of multiple sclerosis database system cochrane rev. 2018;9:cd008422. see summary.

jalali-chimeh f, gholamrezaei a, vafa m, et al. Effect of vitamin d therapy on sexual function in women with sexual dysfunction and vitamin d deficiency: a randomized, double-blind, placebo-controlled clinical trial. jurol. 2019;201(5):987-993. see summary.

james e, dobson r, kuhle j, baker d, giovannoni g, ramagopalan sv. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. mult scle. 2013;19(12):1571-9. see summary.

jamilian m, samimi m, ebrahimi fa, et al. the effects of co-supplementation with vitamin d and omega-3 fatty acids on glycemic control and lipid concentrations in patients with gestational diabetes. jclin lipidol. 2017;11(2):459-468. see summary.

janssen hc, samson mm, verhaar hj. vitamin d deficiency, muscle function and falls in older people. am j clin nutr 2002;75:611-5.. see abstract.

jarrett p, camargo ca jr, coomarasamy c, scragg r. A randomized, double-blind, placebo-controlled trial of the effect of monthly vitamin d supplementation in mild psoriasis. j dermatological treatment 2018;29(4):324-8. see summary.

jenkins dja, spence jd, giovannucci el, et al. vitamin and mineral supplements for the prevention and treatment of cvd. j am coll cardiol 2018;71(22):2570-84. see summary.

jeong sh, read su, kim js. prevention of recurrent benign paroxysmal positional vertigo with vitamin d supplementation: a meta-analysis. j neurol. 2020. doi: 10.1007/s00415-020-09952-8. see summary.

johansson h, spadola g, tosti g, et al. Vitamin D supplementation and disease-free survival in stage II melanoma: a randomized placebo-controlled trial. nutrients 2021;13(6):1931. see summary.

john em, schwartz gg, koo j, et al. Sun exposure, vitamin d receptor gene polymorphisms, and risk of advanced prostate cancer. beef cancer 2005; 65:5470-9. see summary.

jolliffe da, camargo ca jr, sluyter jd, et al. Vitamin d supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of pooled data from randomized controlled trials. diabetes endocrinol lancet 2021 May;9(5):276-292. see summary.

jolliffe da, greenberg l, hooper rl, et al. Vitamin d supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. lancet respir med 2017. [epub ahead of print]. see summary.

jones g. pharmacokinetics of vitamin d toxicity. i am j clin nutr. 2008 Aug;88(2):582s-586s. see summary.

jorde r, bonaa kh. calcium from dairy products, vitamin d intake, and blood pressure: the tromso study. I am j clin nutr 2000;71:1530-5. see summary.

juraschek sp, miller rd er, wanigatunga aa, et al. Effects of vitamin d supplementation on orthostatic hypotension: robust trial results. am j hypertension 2021. see abstract.

kang jh, vyas cm, okereke oi, et al. effect of vitamin d on cognitive decline: results of two ancillary studies of the vital randomized trial. scientific representative 2021;11(1):23253. see summary.

karonova tl, golovatyuk ka, kudryavtsev iv, et al. Effect of cholecalciferol supplementation on clinical features and inflammatory markers in hospitalized covid-19 patients: a single-center, open-label, randomized study. nutrients 2022;14(13):2602. see summary.

kenny am, biskup b, robbins b, et al. Effects of vitamin d supplementation on strength, physical function, and health perception in older men living in the community. j am geriatric soc 2003;51:1762-7. see summary.

keshavarzi z, janghorban r, alipour s, tahmasebi s, jokar a. The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer. supportive care cancer. 2019 Apr;27(4):1325-1334. see summary.

keumn, giovannucci e. Vitamin D supplementation and cancer incidence and mortality: a meta-analysis. br j cancer. 2014 August 26; 111 (5): 976-80. see summary.

keum n, lee dh, greenwood dc, manson je, giovannucci e. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ana Oncol. 2019;30(5):733-743. see summary.

khajehei m, abdali k, parsanezhad me, tabatabaee hr. Effect of treatment with dydrogesterone or calcium plus vitamin d on the severity of premenstrual syndrome. int j gynecology obstet 2009;105:158-61. see summary.

knodel lc, talbert rl. Adverse effects of lipid-lowering drugs. med toxicol 1987;2:10-32. see summary.

kolasinski sl, neogi t, hochberg mc, et al. 2019 american college of rheumatology/arthritis foundation guideline for the treatment of osteoarthritis of the hand, hip, and knee. rheumatoid arthritis. 2020 Feb;72(2):220-33. see summary.

kong sh, jang hn, kim jh, kim sw, shin cs. Effect of vitamin d supplementation on the risk of fractures and falls according to dose and interval: a meta-analysis. endocrinol metab (seoul) 2022;37(2):344-358. see summary.

koutkia p, chen tc, holick mf. vitamin d intoxication associated with an over-the-counter supplement. n engl j med 2001;345:66-7. see summary.

kovacs cs, jones g, yendt er. Primary hyperparathyroidism masked by vitamin D deficiency induced by antituberculous therapy. clin endocrinol (oxf) 1994;41:831-8. see summary.

krall ea, wehler c, garcia ri, et al. calcium and vitamin d supplements reduce tooth loss in the elderly. am j med 2001;111:452-6.. see abstract.

kucukay mb, alanli r. Effect of vitamin d replacement on platelet count. j coll doctors surg pak 2021;31(9):1064-1068. see summary.

kyriakidou-himonas m, aloia jf, yeh jk. Vitamin d supplementation in postmenopausal black women. j clin endocrinol metab 1999;84:3988-90. see summary.

l’abbe mr, whiting sj, hanley da. the canadian health claim for calcium, vitamin d and osteoporosis. j am coll nutr 2004;23:303-8. . see summary.

lappe j, watson p, travers-gustafson d, recker r, garland c, gorham e, baggerly k, mcdonnell sl. Effect of vitamin d and calcium supplementation on cancer incidence in older women: a randomized clinical trial. never. 2017 March 28; 317(12): 1234-1243. see summary.

lappe jm, travers-gustafson d, davies km, et al. Vitamin D and Calcium Supplements Reduce Cancer Risk: Results of a Randomized Trial. i am j clin nutr 2007;85:1586-91. see summary.

larsen er, mosekilde l, foldspang a. Vitamin d and calcium supplementation prevent osteoporotic fractures in elderly community dwelling residents: a 3-year pragmatic population-based intervention study. j bone miner res 2004;19:370-8. see summary.

leboff ms, chou sh, ratliff ka, et al. Supplemental vitamin d and incident fractures in older and middle-aged adults. n english j med 2022;387(4):299-309. see summary.

leboff ms, greenspan sl, insogna kl, et al. The physician’s guide to the prevention and treatment of osteoporosis. international osteoporosis. 2022. Available at: https://link.springer.com/content/pdf/10.1007/s00198-021-05900-y.pdf

lee p, greenfield jr, campbell lv. vitamin d insufficiency: a new mechanism of statin-induced myalgia? clin endocrinol published online Oct 16, 2008: doi: 10.1111/j.1365-2265.2008.03448.x. see summary.

lehouck a, mathieu c, carremans c, et al. High-dose vitamin d to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. ann intern med 2012;156(2):105-14. see summary.

lerchbaum e, trummer c, theiler-schwetz v, et al. Effects of vitamin d supplementation on androgens in men with low testosterone levels: a randomized controlled trial. eur j nutr. 2019;58(8):3135-3146. see summary.

levis s, gomez a, jimenez c, et al. Vitamin D deficiency and seasonal variation in a South Florida adult population. jclin endocrinol metab 2005;90:1557-62. see summary.

li j, chen n, wang d, zhang j, gong x. efficacy of vitamin d in the treatment of inflammatory bowel disease: a meta-analysis. Medicine (Baltimore). 2018;97(46):e12662. see summary.

li q, xing b. Vitamin D3-supplemented yogurt drink improves insulin resistance and lipid profiles in women with gestational diabetes mellitus: a double-blind randomized clinical trial. ann nutr metab. 2016;68(4):285-90. see summary.

li w, qin z, gao j, et al. Vitamin d supplementation during pregnancy and the risk of wheezing in the offspring: a systematic review and dose-response meta-analysis. j asthma. 2019;56(12):1266-1273. see summary.

li y, cao z, guo j, li q, su j. Effects of serum vitamin d levels and vitamin d supplementation on urticaria: a systematic review and meta-analysis. int j environment res public health 2021;18(9):4911. see summary.

lim sk, ha jm, lee yh, et al. Comparison of vitamin d levels in patients with and without acne: a case-control study combined with a randomized controlled trial. plus one. 2016;11(8):e0161162. see summary.

lin j, manson je, lee im, et al. Calcium and vitamin D intake and breast cancer risk in women. archiintern med 2007;167:1050-9. see summary.

linden kg, weinstein gd. Psoriasis: Current Perspectives with an Emphasis on Treatment. am j med 1999;107:595-605. see summary.

ling y, xu f, xia x, et al. Vitamin d supplementation reduces fall risk in the elderly with vitamin d deficiency: an updated meta-analysis. clin nutr 2021;40(11):5531-5537. see summary.

linhartova k, veselka j, sterbakova g, et al. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. circ j 2008;72:245-50. see summary.

lips p, wc graafmans, ooms me, et al. Vitamin D supplementation and incidence of fractures in older people. a randomized, placebo-controlled clinical trial. ann intern med 1996;124:400-6. . see summary.

litonjua aa, carey vj, laranjo n, et al. Six-year follow-up of a trial of prenatal vitamin d for asthma reduction. n english j med 2020 Feb 6;382(6):525-33. see summary.

liu s, song y, ford es, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older American women. diabetes care 2005;28:2926-32. see summary.

liu y, ding c, xu r, et al. Effects of vitamin d supplementation during pregnancy on the health of the offspring at birth: a meta-analysis of randomized controlled trials. clin nutr 2022;41(7):1532-1540. see summary.

viewer ac. body fat and vitamin d status in black versus white women. jclin endocrinol metab 2005;90:635-40. see summary.

luo c, sun y, zeng z, liu y, peng s. Vitamin d supplementation in pregnant women or infants to prevent allergic diseases: a systematic review and meta-analysis of randomized controlled trials. Chin Med J (Eng) 2022;135(3):276-284. see summary.

ma h, zhou t, heianza y, qi l. Habitual use of vitamin d supplements and risk of coronavirus disease 2019 (covid-19) infection: a prospective study in the uk biobank. i am j clin nutr. 2021:nqaa381. see summary.

maalouf j, nabulsi m, vieth r, et al. Short-term and long-term safety of weekly high-dose vitamin D3 supplementation in schoolchildren. jclin endocrinol metab 2008;93:2693-701. see summary.

Mayor GC, Alarie F, Dore J, et al. calcium + vitamin d supplementation potentiates the beneficial effect of weight loss on plasma concentrations of lipids and lipoproteins. am j clin nutr 2007;85:54-9. see summary.

malluche hh, monier-faugere mc, koszewski nj. use and indication of vitamin d and vitamin d analogs in patients with renal bone disease. nephrol dial transplant 2002;17 suppl 10:6-9. see summary.

manson je, brannon pm, rosen cj, taylor cl. vitamin d deficiency: is there really a pandemic? n english j med 2016;375(19):1817-1820. see summary

manson je, cook nr, lee im, et al. vitamin d supplements and prevention of cancer and cardiovascular diseases. n english j med 2019;380(1):33-44. see summary.

mao pj, zhang c, tang l, et al. Effect of calcium or vitamin d supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. int j cardiol. October 30, 2013; 169 (2): 106-11. see summary.

margolis kl, ray rm, van horn l, et al. effect of calcium and vitamin d supplementation on blood pressure: a randomized trial of the women’s health initiative. hypertension 2008;52:847-55. see summary.

mariani j, antonietti l, tajer c, et al. High-dose vitamin d versus placebo to prevent complications in patients with covid-19: multicenter randomized controlled clinical trial. pls one 2022;17(5):e0267918. see summary.

martineau ar, cates cj, urashima m, et al. vitamin d for asthma treatment database system cochrane rev. September 5, 2016; 9: cd011511. see summary.

martineau ar, jolliffe da, hooper rl, et al. Vitamin d supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. bmj. 2017;356:i6583. see summary.

martineau ar, maclaughlin bd, hooper rl, et al. Randomized double-blind placebo-controlled trial of bolus-dose vitamin d3 supplementation in adults with asthma (Vidias). thorax 2015;70(5):451-7. see summary.

martineau p, tawil n. Low molecular weight heparins in the treatment of deep vein thrombosis. ann pharmacother 1998;32:588-98,601. see summary.

martins d, wolf m, pan d, et al. prevalence of cardiovascular risk factors and serum levels of 25-hydroxyvitamin d in the united states. arch intern med 2007;167:1159-65.. see abstract.

marx sj. hyperparathyroid and hypoparathyroid disorders. n engl j med 2000;343:1863-75. see summary.

mason c, xiao l, imayama i, d